Annual Statements Open main menu

SARATOGA INVESTMENT CORP. - Quarter Report: 2021 May (Form 10-Q)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

Form 10-Q

 

 

 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the Quarterly Period Ended May 31, 2021

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Commission File No. 814-00732

 

 

 

SARATOGA INVESTMENT CORP.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland   20-8700615
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification Number)

 

535 Madison Avenue

New York, New York 10022

(Address of principal executive offices)

 

(212) 906-7800

(Registrant’s telephone number, including area code)

 

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   SAR   The New York Stock Exchange
6.25% Notes due 2025   SAF   The New York Stock Exchange
7.25% Notes due 2025   SAK   The New York Stock Exchange

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒  No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☐  No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☒

 

The number of outstanding common shares of the registrant as of July 7, 2021 was 11,183,471.

 

 

 

 

 

 

TABLE OF CONTENTS

 

      Page
PART I. FINANCIAL INFORMATION  
       
Item 1. Consolidated Financial Statements   1
       
  Consolidated Statements of Assets and Liabilities as of May 31, 2021 (unaudited) and February 28, 2021   1
       
  Consolidated Statements of Operations for the three months ended May 31, 2021 (unaudited) and May 31, 2020 (unaudited)   2
       
  Consolidated Statements of Changes in Net Assets for three months ended May 31, 2021 (unaudited) and May 31, 2020 (unaudited)   3
       
 

Consolidated Statements of Cash Flows for the three months ended May 31, 2021 (unaudited) and May 31, 2020 (unaudited)

  4
       
  Consolidated Schedules of Investments as of May 31, 2021 (unaudited) and February 28, 2021   5
       
  Notes to Consolidated Financial Statements as of May 31, 2021 (unaudited)   17
       
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   75
       
Item 3. Quantitative and Qualitative Disclosures About Market Risk   110
       
Item 4. Controls and Procedures   111
       
PART II. OTHER INFORMATION    
       
Item 1. Legal Proceedings   112
       
Item 1A. Risk Factors   112
       
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   112
       
Item 3. Defaults Upon Senior Securities   112
       
Item 4. Mine Safety Disclosures   112
       
Item 5. Other Information   112
       
Item 6. Exhibits   113
     
Signatures   116

 

i

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Consolidated Financial Statements

 

Saratoga Investment Corp.

Consolidated Statements of Assets and Liabilities

 

   May 31, 2021   February 28, 2021 
   (unaudited)     
ASSETS        
Investments at fair value        
Non-control/Non-affiliate investments (amortized cost of $546,808,095 and $471,328,212, respectively)  $550,875,264   $469,946,494 
Affiliate investments (amortized cost of $34,774,328 and $17,331,707, respectively)   39,872,709    19,367,740 
Control investments (amortized cost of $75,078,830 and $61,353,761, respectively)   87,024,892    64,998,481 
Total investments at fair value (amortized cost of $656,661,253 and $550,013,680, respectively)   677,772,865    554,312,715 
Cash and cash equivalents   317,932    18,828,047 
Cash and cash equivalents, reserve accounts   19,659,681    11,087,027 
Interest receivable (net of reserve of $588,904 and $1,152,086, respectively)   6,622,330    4,223,630 
Due from affiliate (See Note 6)   2,600,000    2,719,000 
Management fee receivable   852,876    34,644 
Other assets   848,278    947,315 
Total assets  $708,673,962   $592,152,378 
           
LIABILITIES          
Revolving credit facility  $39,000,000   $- 
Deferred debt financing costs, revolving credit facility   (715,161)   (639,983)
SBA debentures payable   168,000,000    158,000,000 
Deferred debt financing costs, SBA debentures payable   (3,397,674)   (2,642,622)
6.25% Notes Payable 2025   60,000,000    60,000,000 
Deferred debt financing costs, 6.25% notes payable 2025   (1,581,383)   (1,675,064)
7.25% Notes Payable 2025   43,125,000    43,125,000 
Deferred debt financing costs, 7.25% notes payable 2025   (1,319,867)   (1,401,307)
7.75% Notes Payable 2025   5,000,000    5,000,000 
Deferred debt financing costs, 7.75% notes payable 2025   (225,397)   (239,222)
4.375% Notes Payable 2026   50,000,000    - 
Deferred debt financing costs,   (1,205,274)   - 
6.25% Notes Payable 2027   15,000,000    15,000,000 
Deferred debt financing costs, 6.25% notes payable 2027   (469,585)   (476,820)
Base management and incentive fees payable   10,727,948    6,556,674 
Deferred tax liability   2,180,727    1,922,664 
Accounts payable and accrued expenses   1,986,517    1,750,267 
Interest and debt fees payable   1,763,342    2,645,784 
Directors fees payable   92,000    70,500 
Due to manager   368,013    279,065 
Excise tax payable   -    691,672 
Total liabilities   388,329,206    287,966,608 
           
Commitments and contingencies (See Note 8)          
           
NET ASSETS          
Common stock, par value $0.001, 100,000,000 common shares authorized, 11,159,995 and 11,161,416 common shares issued and outstanding, respectively   11,160    11,161 
Capital in excess of par value   304,784,840    304,874,957 
Total distributable earnings (deficit)   15,548,756    (700,348)
Total net assets   320,344,756    304,185,770 
Total liabilities and net assets  $708,673,962   $592,152,378 
NET ASSET VALUE PER SHARE  $28.70   $27.25 

 

See accompanying notes to consolidated financial statements.

 

1

 

 

Saratoga Investment Corp.

Consolidated Statements of Operations

(unaudited)

 

   For the three months ended 
   May 31, 2021   May 31, 2020 
INVESTMENT INCOME        
Interest from investments        
Interest income:        
Non-control/Non-affiliate investments  $11,236,737   $9,955,562 
Affiliate investments   340,512    398,370 
Control investments   1,854,985    1,133,584 
Payment-in-kind interest income:          
Non-control/Non-affiliate investments   176,766    581,946 
Affiliate investments   -    46,223 
Control investments   77,675    34,782 
Total interest from investments   13,686,675    12,150,467 
Interest from cash and cash equivalents   522    11,796 
Management fee income   818,232    634,572 
Structuring and advisory fee income   1,301,875    313,306 
Other income   1,008,686    187,000 
Total investment income   16,815,990    13,297,141 
           
OPERATING EXPENSES          
Interest and debt financing expenses   4,340,912    2,563,876 
Base management fees   2,758,908    2,160,528 
Incentive management fees expense (benefit)   5,262,536    (1,858,310)
Professional fees   507,061    386,888 
Administrator expenses   693,750    556,250 
Insurance   86,318    67,726 
Directors fees and expenses   92,000    60,000 
General & administrative   490,651    350,814 
Income tax expense (benefit)   27,919    (8,945)
Total operating expenses   14,260,055    4,278,827 
NET INVESTMENT INCOME   2,555,935    9,018,314 
           
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS          
Net realized gain (loss) from investments:          
Non-control/Non-affiliate investments   1,910,141    8,480 
Net realized gain (loss) from investments   1,910,141    8,480 
Net change in unrealized appreciation (depreciation) on investments:          
Non-control/Non-affiliate investments   5,448,887    (24,422,894)
Affiliate investments   3,062,348    (2,444,252)
Control investments   8,301,342    (5,083,223)
Net change in unrealized appreciation (depreciation) on investments   16,812,577    (31,950,369)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   (230,144)   267,740 
Net realized and unrealized gain (loss) on investments   18,492,574    (31,674,149)
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS  $21,048,509   $(22,655,835)
           
WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE  $1.88   $(2.02)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC AND DILUTED   11,170,045    11,217,545 

 

See accompanying notes to consolidated financial statements.

 

2

 

 

Saratoga Investment Corp.

Consolidated Statements of Changes in Net Assets

(unaudited)

 

   For the three months ended 
   May 31, 2021   May 31, 2020 
INCREASE (DECREASE) FROM OPERATIONS:        
Net investment income  $2,555,935   $9,018,314 
Net realized gain from investments   1,910,141    8,480 
Net change in unrealized appreciation (depreciation) on investments   16,812,577    (31,950,369)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   (230,144)   267,740 
Net increase (decrease) in net assets resulting from operations   21,048,509    (22,655,835)
           
DECREASE FROM SHAREHOLDER DISTRIBUTIONS:          
Total distributions to shareholders   (4,799,405)   - 
Net decrease in net assets from shareholder distributions   (4,799,405)   - 
           
CAPITAL SHARE TRANSACTIONS:          
Stock dividend distribution   914,102    - 
Repurchases of common stock   (1,003,420)   - 
Repurchase fees   (800)   - 
Net increase in net assets from capital share transactions   (90,118)   - 
Total increase (decrease) in net assets   16,158,986    (22,655,835)
Net assets at beginning of period   304,185,770    304,286,853 
Net assets at end of period  $320,344,756   $281,631,018 

 

See accompanying notes to consolidated financial statements.

 

3

 

 

Saratoga Investment Corp.

Consolidated Statements of Cash Flows

(unaudited)

 

   For the three months ended 
   May 31, 2021   May 31, 2020 
Operating activities        
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS  $21,048,509   $(22,655,835)
ADJUSTMENTS TO RECONCILE NET INCREASE (DECREASE) IN NET ASSETS RESULTING          
FROM OPERATIONS TO NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES:          
Payment-in-kind and other adjustments to cost   (191,699)   703,636 
Net accretion of discount on investments   (321,106)   (312,430)
Amortization of deferred debt financing costs   470,314    272,683 
Income tax expense (benefit)   27,919    (8,945)
Net realized (gain) loss from investments   (1,910,141)   (8,480)
Net change in unrealized (appreciation) depreciation on investments   (16,812,577)   31,950,369 
Net change in provision for deferred taxes on unrealized appreciation (depreciation) on investments   230,144    (267,740)
Proceeds from sales and repayments of investments   14,941,409    9,350,378 
Purchases of investments   (119,166,038)   (38,998,731)
(Increase) decrease in operating assets:          
Interest receivable   (2,398,700)   501,475 
Due from affiliate   119,000    - 
Management and incentive fee receivable   (818,232)   (13,381)
Other assets   78,581    40,232 
Increase (decrease) in operating liabilities:          
Base management and incentive fees payable   4,171,274    (12,247,640)
Accounts payable and accrued expenses   236,250    (132,244)
Interest and debt fees payable   (882,442)   (1,239,086)
Directors fees payable   21,500    1,500 
Excise tax payable   (691,672)   - 
Due to manager   88,948    (104,112)
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES   (101,758,759)   (33,168,351)
           
Financing activities          
Borrowings on debt   49,000,000    20,000,000 
Paydowns on debt   -    (487,000)
Issuance of notes   50,000,000    - 
Repayments of notes   -    - 
Payments of deferred debt financing costs   (2,289,179)   - 
Proceeds from issuance of common stock   -    - 
Payments of cash dividends   (3,885,303)   - 
Repurchases of common stock   (1,003,420)   - 
Repurchases fees   (800)   - 
Payments of offering costs   -    - 
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES   91,821,298    19,513,000 
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS   (9,937,461)   (13,655,351)
CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, BEGINNING OF PERIOD   29,915,074    39,450,352 
CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, END OF PERIOD  $19,977,613   $25,795,001 
           
Supplemental information:          
Interest paid during the period  $4,753,043   $3,530,278 
Cash paid for taxes   692,740    1,006 
Supplemental non-cash information:          
Payment-in-kind interest income and other adjustments to cost   191,699    (703,636)
Net accretion of discount on investments   321,106    312,430 
Amortization of deferred debt financing costs   470,314    272,683 
Stock dividend distribution   914,102    - 

 

See accompanying notes to consolidated financial statements.

 

4

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

May 31, 2021

(unaudited)

 

Company  Industry  Investment Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair Value
(c)
   % of
Net Assets
 
Non-control/Non-affiliate investments - 171.9% (b)                             
Targus Holdings, Inc. (d), (h)  Consumer Products  Common Stock  12/31/2009   210,456    1,589,630   $522,061    0.2%
      Total Consumer Products           1,589,630    522,061    0.2%
My Alarm Center, LLC (k)  Consumer Services  Preferred Equity Class A Units
8.00% PIK
  7/14/2017   2,227    2,357,879    -    0.0%
My Alarm Center, LLC (h)  Consumer Services  Preferred Equity Class B Units  7/14/2017   1,797    1,796,880    -    0.0%
My Alarm Center, LLC (h)  Consumer Services  Preferred Equity Class Z Units  9/12/2018   676    712,343    -    0.0%
My Alarm Center, LLC (h)  Consumer Services  Common Stock  7/14/2017   96,224    -    -    0.0%
      Total Consumer Services           4,867,102    -    0.0%
Schoox, Inc. (h), (i)  Corporate Education Software  Series 1 Membership Interest  12/8/2020   226,782    1,050,000    3,107,700    1.0%
      Total Corporate Education Software           1,050,000    3,107,700    1.0%
Passageways, Inc.  Corporate Governance  First Lien Term Loan
(3M USD LIBOR+7.00%), 8.75% Cash, 12/31/2025
  7/5/2018  $5,000,000   $4,972,664    5,050,000    1.6%
Passageways, Inc. (j)  Corporate Governance  Delayed Draw Term Loan
(3M USD LIBOR+7.00%), 8.75% Cash, 12/31/2025
  1/3/2020  $5,000,000    4,981,026    5,050,000    1.6%
Passageways, Inc. (h)  Corporate Governance  Series A Preferred Stock  7/5/2018   2,027,205    1,000,000    7,498,384    2.3%
      Total Corporate Governance           10,953,690    17,598,384    5.5%
New England Dental Partners  Dental Practice Management  First Lien Term Loan
(3M USD LIBOR+8.00%), 8.50% Cash, 11/25/2025
  11/25/2020  $6,555,000    6,496,025    6,632,349    2.1%
New England Dental Partners (j)  Dental Practice Management  Delayed Draw Term Loan
(3M USD LIBOR+8.00%), 8.50% Cash, 11/25/2025
  11/25/2020  $2,150,000    2,130,433    2,175,370    0.7%
      Total Dental Practice Management           8,626,458    8,807,719    2.8%
PDDS Buyer, LLC  Dental Practice Management Software  First Lien Term Loan
(3M USD LIBOR+7.00%), 9.50% Cash, 7/15/2024
  7/15/2019  $14,000,000    13,904,721    14,278,600    4.5%
PDDS Buyer, LLC  Dental Practice Management Software  Delayed Draw Term Loan
(3M USD LIBOR+7.00%), 9.50% Cash, 7/15/2024
  7/15/2019  $7,000,000    6,943,964    7,139,300    2.2%
PDDS Buyer, LLC (h)  Dental Practice Management Software  Series A-1 Preferred Shares  8/10/2020   1,755,831    2,000,000    2,472,430    0.8%
      Total Dental Practice Management Software           22,848,685    23,890,330    7.5%
C2 Educational Systems (d)  Education Services  First Lien Term Loan
(3M USD LIBOR+8.50%), 10.00% Cash, 5/31/2023
  5/31/2017  $18,500,000    18,474,451    16,033,950    5.0%
C2 Education Systems, Inc. (h)  Education Services  Series A-1 Preferred Stock  5/18/2021   3,127    499,904    502,621    0.2%
Texas Teachers of Tomorrow, LLC (h), (i)  Education Services  Common Stock  12/2/2015   750    750,000    1,163,583    0.4%
Texas Teachers of Tomorrow, LLC (d)  Education Services  First Lien Term Loan
(3M USD LIBOR+7.25%), 9.75% Cash, 6/28/2024
  6/28/2019  $25,763,417    25,581,181    25,737,653    8.0%

 

5

 

 

Company  Industry  Investment Interest Rate/
Maturity
  Original Acquisition Date  Principal/
Number of Shares
   Cost   Fair Value (c)   % of
Net Assets
 
Zollege PBC  Education Services  First Lien Term Loan
(3M USD LIBOR+5.50%), 6.50% Cash, 5/11/2026
  5/11/2021  $16,000,000    15,860,000    15,840,000    4.9%
Zollege PBC (j)  Education Services  Delayed Draw Term Loan
(3M USD LIBOR+5.50%), 6.50% Cash, 5/11/2026
  5/11/2021  $-    -    -    0.0%
Zollege PBC (h)  Education Services  Class A Units  5/11/2021   250,000    250,000    250,000    0.1%
      Total Education Services           61,415,536    59,527,807    18.6%
Destiny Solutions Inc. (d)  Education Software  First Lien Term Loan
(3M USD LIBOR+7.50%), 9.50% Cash, 10/24/2024
  5/16/2018  $43,500,000    43,240,511    43,500,000    13.6%
Destiny Solutions Inc. (h), (i)  Education Software  Limited Partner Interests  5/16/2018   2,342    2,468,464    3,894,965    1.2%
Identity Automation Systems (d)  Education Software  First Lien Term Loan
(3M USD LIBOR+9.24%), 10.99% Cash, 5/8/2024
  8/25/2014  $17,203,750    17,203,750    17,203,750    5.4%
Identity Automation Systems (h)  Education Software  Common Stock Class A-2 Units  8/25/2014   232,616    232,616    697,848    0.2%
Identity Automation Systems (h)  Education Software  Common Stock Class A-1 Units  3/6/2020   43,715    171,571    189,269    0.1%
GoReact  Education Software  First Lien Term Loan
(3M USD LIBOR+7.50%), 9.50% Cash, 1/17/2025
  1/17/2020  $5,000,000    4,944,183    5,100,000    1.6%
GoReact (j)  Education Software  Delayed Draw Term Loan
(3M USD LIBOR+7.50%), 9.50% Cash, 1/17/2025
  1/17/2020  $1,200,000    1,200,000    1,224,000    0.4%
Kev Software Inc. (a)  Education Software  First Lien Term Loan
(1M USD LIBOR+8.63%), 9.63% Cash, 9/13/2023
  9/13/2018  $17,701,539    17,624,605    17,889,175    5.6%
      Total Education Software           87,085,700    89,699,007    28.1%
Top Gun Pressure Washing, LLC  Facilities Maintenance  First Lien Term Loan
(3M USD LIBOR+7.00%), 9.50% Cash, 12/31/2025
  8/12/2019  $5,000,000    4,964,114    4,958,500    1.5%
Top Gun Pressure Washing, LLC (j)  Facilities Maintenance  Delayed Draw Term Loan
(3M USD LIBOR+7.00%), 9.50% Cash, 12/31/2025
  8/12/2019  $5,500,000    5,449,645    5,454,350    1.8%
TG Pressure Washing Holdings, LLC (f), (h)  Facilities Maintenance  Preferred Equity  8/12/2019   488,148    488,148    318,329    0.1%
      Total Facilities Maintenance           10,901,907    10,731,179    3.4%
Davisware, LLC  Field Service Management  First Lien Term Loan
(3M USD LIBOR+7.00%), 9.00% Cash, 7/31/2024
  9/6/2019  $3,000,000    2,979,495    3,032,400    0.9%
Davisware, LLC  Field Service Management  Delayed Draw Term Loan
(3M USD LIBOR+7.00%), 9.00% Cash, 7/31/2024
  9/6/2019  $977,790    974,822    988,350    0.3%
      Total Field Service Management           3,954,317    4,020,750    1.2%
GDS Software Holdings, LLC (h)  Financial Services  Common Stock Class A Units  8/23/2018   250,000    250,000    445,913    0.1%
      Total Financial Services           250,000    445,913    0.1%
Ohio Medical, LLC (h)  Healthcare Products Manufacturing  Common Stock  1/15/2016   5,000    380,353    564,042    0.2%
      Total Healthcare Products Manufacturing           380,353    564,042    0.2%
Axiom Parent Holdings, LLC (h)  Healthcare Services  Common Stock Class A Units  6/19/2018   400,000    400,000    900,986    0.3%
Axiom Purchaser, Inc. (d)  Healthcare Services  First Lien Term Loan
(3M USD LIBOR+6.00%), 7.75% Cash, 6/19/2023
  6/19/2018  $10,000,000    9,959,761    10,059,000    3.1%
Axiom Purchaser, Inc. (d)  Healthcare Services  Delayed Draw Term Loan
(3M USD LIBOR+6.00%), 7.75% Cash, 6/19/2023
  6/19/2018  $6,000,000    5,965,638    6,035,400    1.9%
ComForCare Health Care  Healthcare Services  First Lien Term Loan
(3M USD LIBOR+7.75%), 8.75% Cash, 1/31/2025
  1/31/2017  $25,000,000    24,875,298    24,957,500    7.8%
      Total Healthcare Services           41,200,697    41,952,886    13.1%

 

6

 

 

Company  Industry  Investment Interest Rate/
Maturity
  Original Acquisition Date  Principal/
Number of Shares
   Cost   Fair Value (c)   % of
Net Assets
 
Greenphire, Inc. (h), (i)  Healthcare Software  Series A Preferred Stock  3/24/2021   102    10,181,700    10,381,661    3.2%
TRC HemaTerra, LLC (h)  Healthcare Software  Class D Membership Interests  4/15/2019   2,241    2,310,929    2,816,291    0.9%
HemaTerra Holding Company, LLC  Healthcare Software  First Lien Term Loan
(3M USD LIBOR+6.75%), 8.25% Cash, 1/31/2026
  4/15/2019  $36,000,000    35,660,359    35,776,800    11.2%
HemaTerra Holding Company, LLC (d), (j)  Healthcare Software  Delayed Draw Term Loan
(3M USD LIBOR+6.75%), 8.25% Cash, 1/31/2026
  4/15/2019  $12,000,000    11,919,627    11,925,600    3.7%
Procurement Partners, LLC  Healthcare Software  First Lien Term Loan
(3M USD LIBOR+6.50%), 7.50% Cash, 11/12/2025
  11/12/2020  $8,000,000    7,928,456    8,023,200    2.5%
Procurement Partners, LLC (j)  Healthcare Software  Delayed Draw Term Loan
(3M USD LIBOR+6.50%), 7.50% Cash, 11/12/2025
  11/12/2020  $-    -    -    0.0%
Procurement Partners Holdings LLC (h)  Healthcare Software     11/12/2020   300,000    300,000    339,111    0.1%
      Total Healthcare Software           68,301,071    69,262,663    21.6%
Roscoe Medical, Inc. (d), (h)  Healthcare Supply  Common Stock  3/26/2014   5,081    508,077    187,153    0.1%
Roscoe Medical, Inc.  Healthcare Supply  Second Lien Term Loan
11.25% Cash, 6/28/2021
  3/26/2014  $5,141,413    5,141,413    5,141,413    1.6%
      Total Healthcare Supply           5,649,490    5,328,566    1.7%
Book4Time, Inc. (a)  Hospitality/Hotel  First Lien Term Loan
(3M USD LIBOR+8.50%), 10.25%, 12/22/2025
  12/22/2020  $3,136,517    3,108,278    3,105,152    1.0%
Book4Time, Inc. (a), (j)  Hospitality/Hotel  Delayed Draw Term Loan
(3M USD LIBOR+8.50%), 10.25%, 12/22/2025
  12/22/2020  $-    -    -    0.0%
Book4Time, Inc. (a), (i)  Hospitality/Hotel  Class A Preferred Shares  12/22/2020   200,000    156,826    200,000    0.1%
Knowland Group, LLC  Hospitality/Hotel  Second Lien Term Loan
(3M USD LIBOR+8.00%), 10.00% Cash/1.00% PIK, 5/9/2024
  11/9/2018  $15,767,918    15,767,918    11,280,368    3.5%
Sceptre Hospitality Resources, LLC  Hospitality/Hotel  First Lien Term Loan
(1M USD LIBOR+9.00%), 10.00% Cash, 4/27/2025
  4/27/2020  $3,000,000    2,975,728    3,000,000    0.9%
      Total Hospitality/Hotel           22,008,750    17,585,520    5.5%
Granite Comfort, LP  HVAC Services and Sales  First Lien Term Loan
(1M USD LIBOR+9.00%), 10.00% Cash, 11/16/2025
  11/16/2020  $20,000,000    19,815,082    19,950,000    6.2%
Granite Comfort, LP (j)  HVAC Services and Sales  Delayed Draw Term Loan
(1M USD LIBOR+9.00%), 10.00% Cash, 11/16/2025
  11/16/2020  $-    -    -    0.0%
      Total HVAC Services and Sales           19,815,082    19,950,000    6.2%
Vector Controls Holding Co., LLC (d)  Industrial Products  First Lien Term Loan
11.50% (9.75% Cash/1.75% PIK), 3/6/2022
  3/6/2013  $6,843,746    6,843,746    6,843,746    2.1%
Vector Controls Holding Co., LLC (d), (h)  Industrial Products  Warrants to Purchase Limited Liability Company Interests, Expires 11/30/2027  5/31/2015   343    -    2,188,389    0.7%
      Total Industrial Products           6,843,746    9,032,135    2.8%
CLEO Communications Holding, LLC (d)  IT Services  First Lien Term Loan
(3M USD LIBOR+8.00%), 9.00% Cash/2.00% PIK, 3/31/2022
  3/31/2017  $14,146,020    14,138,542    14,249,286    4.4%
CLEO Communications Holding, LLC (d), (j)  IT Services  Delayed Draw Term Loan
(3M USD LIBOR+8.00%), 9.00% Cash/2.00% PIK, 3/31/2022
  3/31/2017  $20,556,466    20,507,075    20,706,528    6.5%
LogicMonitor, Inc.  IT Services  First Lien Term Loan
(3M USD LIBOR+5.00), 6.00% Cash, 5/17/2023
  3/20/2020  $23,000,000    22,883,641    23,101,200    7.2%
      Total IT Services           57,529,258    58,057,014    18.1%
inMotionNow, Inc.  Marketing Services  First Lien Term Loan
(3M USD LIBOR+7.50), 10.00% Cash, 5/15/2024
  5/15/2019  $12,200,000    12,124,363    12,389,100    3.9%

 

7

 

 

Company  Industry  Investment Interest Rate/
Maturity
  Original Acquisition Date  Principal/
Number of Shares
   Cost   Fair Value (c)   % of
Net Assets
 
inMotionNow, Inc.  Marketing Services  Delayed Draw Term Loan
(3M USD LIBOR+7.50) 10.00% Cash, 5/15/2024
  5/15/2019  $5,000,000    4,963,878    5,077,500    1.6%
      Total Marketing Services           17,088,241    17,466,600    5.5%
Omatic Software, LLC  Non-profit Services  First Lien Term Loan
(3M USD LIBOR+8.00%), 9.75% Cash, 5/29/2023
  5/29/2018  $5,500,000    5,474,886    5,500,000    1.7%
      Total Non-profit Services           5,474,886    5,500,000    1.7%
Emily Street Enterprises, L.L.C.  Office Supplies  Senior Secured Note
(3M USD LIBOR+8.50%), 10.00% Cash, 12/31/2023
  12/28/2012  $3,300,000    3,300,000    3,248,190    1.0%
Emily Street Enterprises, L.L.C. (h)  Office Supplies  Warrant Membership Interests
Expires 12/28/2022
  12/28/2012   49,318    400,000    151,202    0.0%
      Total Office Supplies           3,700,000    3,399,392    1.0%
Apex Holdings Software Technologies, LLC  Payroll Services  First Lien Term Loan
(3M USD LIBOR+8.00%), 9.00% Cash, 9/21/2024
  9/21/2016  $18,000,000    17,983,170    17,380,801    5.3%
Apex Holdings Software Technologies, LLC  Payroll Services  Delayed Draw Term Loan
(3M USD LIBOR+8.00%), 9.00% Cash, 9/21/2024
  10/1/2018  $1,000,000    994,942    965,600    0.3%
      Total Payroll Services           18,978,112    18,346,401    5.6%
Lexipol, LLC (h), (i)  Public Safety/Local Government Software  Series A Preferred Stock  3/30/2021   102    10,204,900    10,204,900    3.2%
      Total Public Safety/Local Government Software           10,204,900    10,204,900    3.2%
Buildout, Inc.  Real Estate Services  First Lien Term Loan
(3M USD LIBOR+7.75%), 9.25% Cash, 7/9/2025
  7/9/2020  $14,000,000    13,880,144    13,976,200    4.4%
Buildout, Inc.  Real Estate Services  Delayed Draw Term Loan
(3M USD LIBOR+7.75%), 9.25% Cash, 7/9/2025
  2/12/2021  $3,000,000    2,971,412    2,994,900    0.8%
Buildout, Inc. (h), (i)  Real Estate Services  Limited Partner Interests  7/9/2020   1,071    1,071,301    1,215,084    0.4%
      Total Real Estate Services           17,922,857    18,186,184    5.6%
TMAC Acquisition Co., LLC (k)  Restaurant  Unsecured Term Loan
8.00% PIK, 9/01/2023
  3/1/2018  $2,261,017    2,261,017    2,169,383    0.7%
      Total Restaurant           2,261,017    2,169,383    0.7%
ArbiterSports, LLC (d)  Sports Management  First Lien Term Loan
(3M USD LIBOR+6.50%), 8.25% Cash, 2/21/2025
  2/21/2020  $26,000,000    25,818,242    24,603,800    7.6%
ArbiterSports, LLC (d)  Sports Management  Delayed Draw Term Loan
(3M USD LIBOR+6.50%), 8.25% Cash, 2/21/2025
  2/21/2020  $1,000,000    1,000,000    946,300    0.3%
      Total Sports Management           26,818,242    25,550,100    7.9%
Avionte Holdings, LLC (h)  Staffing Services  Class A Units  1/8/2014   100,000    100,000    968,628    0.3%
      Total Staffing Services           100,000    968,628    0.3%
National Waste Partners (d)  Waste Services  Second Lien Term Loan
10.00% Cash, 2/13/2022
  2/13/2017  $9,000,000    8,988,368    9,000,000    2.8%
      Total Waste Services           8,988,368    9,000,000    2.8%
Sub Total Non-control/Non-affiliate investments                 546,808,095    550,875,264    171.9%
                              
Affiliate investments - 12.4% (b)                             
Artemis Wax Corp. (f), (j)  Consumer Services  Delayed Draw Term Loan
(1M USD LIBOR+9.00%), 12.00% Cash, 5/20/2026
  5/20/2021  $15,295,662    15,142,705    15,142,705    4.7%
Artemis Wax Corp. (f) (h)  Consumer Services  Series B-1 Preferred Stock  5/20/2021   934,463    1,500,000    1,500,000    0.5%
Artemis Wax Corp. (f) (h)  Consumer Services  Series C Preferred Stock  5/20/2021   4,099    4,099,260    4,099,261    1.3%
      Total Consumer Services           20,741,965    20,741,966    6.5%

 

8

 

 

Company  Industry  Investment Interest Rate/
Maturity
  Original Acquisition Date  Principal/
Number of Shares
   Cost   Fair Value (c)   % of
Net Assets
 
GreyHeller LLC (f)  Cyber Security  First Lien Term Loan
(3M USD LIBOR+9.00%), 10.00% Cash, 12/31/2025
  11/17/2016  $7,000,000    6,988,553    7,000,000    2.2%
GreyHeller LLC (d), (f), (j)  Cyber Security  Delayed Draw Term Loan
(3M USD LIBOR+9.00%), 10.00% Cash, 12/31/2025
  10/19/2020  $6,250,000    6,193,810    6,250,001    1.9%
GreyHeller LLC (f), (h)  Cyber Security  Series A Preferred Units  11/17/2016   850,000    850,000    5,880,742    1.8%
      Total Cyber Security           14,032,363    19,130,743    5.9%
Sub Total Affiliate investments                 34,774,328    39,872,709    12.4%
                              
Control investments - 27.2% (b)                             
Netreo Holdings, LLC (g)  IT Services  First Lien Term Loan
(3M USD LIBOR +6.25%), 9.00% Cash/2.75% PIK, 12/31/2025
  7/3/2018  $5,332,239    5,304,439    5,361,034    1.6%
Netreo Holdings, LLC (g), (j)  IT Services  Delayed Draw Term Loan
(3M USD LIBOR +6.25%), 9.00% Cash/2.75% PIK, 12/31/2025
  5/26/2020  $10,241,069    10,142,979    10,296,371    3.2%
Netreo Holdings, LLC (g), (h)  IT Services  Common Stock Class A Unit  7/3/2018   4,600,677    8,344,500    17,946,180    5.6%
      Total IT Services           23,791,918    33,603,585    10.4%
Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (e), (g)  Structured Finance Securities  Other/Structured Finance Securities
15.87%, 4/20/2033
  1/22/2008  $111,000,000    33,411,912    35,546,307    11.1%
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-R-3 Note (a), (g)  Structured Finance Securities  Other/Structured Finance Securities
(3M USD LIBOR+10.00%), 10.13%, 4/20/2033
  2/26/2021  $17,875,000    17,875,000    17,875,000    5.7%
      Total Structured Finance Securities           51,286,912    53,421,307    16.8%
Sub Total Control investments                 75,078,830    87,024,892    27.2%
TOTAL INVESTMENTS - 211.5% (b)                $656,661,253   $677,772,865    211.5%

 

   Number of
Shares
   Cost   Fair Value   % of
Net Assets
 
Cash and cash equivalents and cash and cash equivalents, reserve accounts - 6.1% (b)                    
U.S. Bank Money Market (l)   19,659,681   $19,659,681   $19,659,681    6.1%
Total cash and cash equivalents and cash and cash equivalents, reserve accounts   19,659,681   $19,659,681   $19,659,681    6.1%

 

(a)Represents an ineligible investment as defined under Section 55(a) of the Investment Company Act of 1940, as amended. As of May 31, 2021 non-qualifying assets represent 8.4% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b)Percentages are based on net assets of $320,344,756 as of May 31, 2021.
(c)Because there is no readily available market value for these investments, the fair values of these investments were determined using significant unobservable inputs and approved in good faith by our board of directors. These investments have been included as Level 3 in the Fair Value Hierarchy (see Note 3 to the consolidated financial statements).
(d)These securities are either fully or partially pledged as collateral under a senior secured revolving credit facility (see Note 7 to the consolidated financial statements).
(e)This investment does not have a stated interest rate that is payable thereon. As a result, the 15.87% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f)As defined in the Investment Company Act, this portfolio company is an Affiliate as we own between 5.0% and 25.0% of the voting securities. Transactions during the quarter ended May 31, 2021 in which the issuer was an Affiliate are as follows:

 

9

 

 

Company  Purchases   Sales   Total Interest from Investments   Management
Fee Income
   Net Realized
Gain (Loss) from
Investments
   Net Change in Unrealized Appreciation (Depreciation) 
Artemis Wax Corp.  $20,732,455   $        -   $31,122   $        -   $        -   $1 
GreyHeller LLC   3,960,000    -    309,390    -    -    1,995,811 
Total  $24,692,455   $-   $340,512   $-   $-   $1,995,812 

 

(g)As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the quarter ended May 31, 2021 in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

Company  Purchases   Sales   Total Interest from Investments   Management
Fee Income
   Net Realized
Gain (Loss) from Investments
   Net Change in Unrealized Appreciation (Depreciation) 
Netreo Holdings, LLC  $14,104,500   $         -   $279,628   $-   $         2   $4,224,061 
Saratoga Investment Corp. CLO 2013-1, Ltd.   -    -    1,133,296    818,232    -    4,531,306 
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-R-3 Note   -    -    465,738    -    -    (454,025)
Total  $14,104,500   $-   $1,878,661   $818,232   $2   $8,301,342 

 

(h)Non-income producing at May 31, 2021.
(i)Includes securities issued by an affiliate of the company.
(j)All or a portion of this investment has an unfunded commitment as of May 31, 2021. (see Note 8 to the consolidated financial statements).
(k)As of May 31, 2021, the investment was on non-accrual status. The fair value of these investments was approximately $2.2 million, which represented 0.3% of the Company’s portfolio (see Note 2 to the consolidated financial statements).
(l)Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s consolidated statements of assets and liabilities as of May 31, 2021.

 

LIBOR - London Interbank Offered Rate

 

1M USD LIBOR - The 1 month USD LIBOR rate as of May 31, 2021 was 0.09%.

3M USD LIBOR - The 3 month USD LIBOR rate as of May 31, 2021 was 0.13%.

PIK - Payment-in-Kind (see Note 2 to the consolidated financial statements).

 

See accompanying notes to consolidated financial statements.

 

10

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2021

 

Company  Industry  Investment Interest Rate/
Maturity
  Original Acquisition Date  Principal/
Number of Shares
   Cost   Fair Value (c)   % of
Net Assets
 
Non-control/Non-affiliate investments - 154.5% (b)                             
Targus Holdings, Inc. (d), (h)  Consumer Products  Common Stock  12/31/2009   210,456    1,589,630   $475,116    0.2%
      Total Consumer Products           1,589,630    475,116    0.2%
My Alarm Center, LLC (k)  Consumer Services  Preferred Equity Class A Units
8.00% PIK
  7/14/2017   2,227    2,357,879    -    0.0%
My Alarm Center, LLC (h)  Consumer Services  Preferred Equity Class B Units  7/14/2017   1,797    1,796,880    -    0.0%
My Alarm Center, LLC (h)  Consumer Services  Preferred Equity Class Z Units  9/12/2018   676    712,343    181,240    0.1%
My Alarm Center, LLC (h)  Consumer Services  Common Stock  7/14/2017   96,224    -    -    0.0%
      Total Consumer Services           4,867,102    181,240    0.1%
Schoox, Inc. (h), (i)  Corporate Education Software  Series 1 Membership Interest  12/8/2020   226,782    1,050,000    1,050,000    0.3%
      Total Corporate Education Software           1,050,000    1,050,000    0.3%
Passageways, Inc.  Corporate Governance  First Lien Term Loan
(3M USD LIBOR+7.00%), 8.75% Cash, 12/31/2025
  7/5/2018  $5,000,000   $4,972,250    5,050,000    1.7%
Passageways, Inc. (j)  Corporate Governance  Delayed Draw Term Loan
(3M USD LIBOR+7.00%), 8.75% Cash, 12/31/2025
  1/3/2020  $5,000,000    4,980,871    5,050,000    1.7%
Passageways, Inc. (h)  Corporate Governance  Series A Preferred Stock  7/5/2018   2,027,205    1,000,000    3,164,579    1.0%
      Total Corporate Governance           10,953,121    13,264,579    4.4%
New England Dental Partners  Dental Practice Management  First Lien Term Loan
(3M USD LIBOR+8.00%), 8.50% Cash, 11/25/2025
  11/25/2020  $6,555,000    6,491,331    6,489,450    2.1%
New England Dental Partners (j)  Dental Practice Management  Delayed Draw Term Loan
(3M USD LIBOR+8.00%), 8.50% Cash, 11/25/2025
  11/25/2020  $650,000    644,419    643,500    0.2%
      Total Dental Practice Management           7,135,750    7,132,950    2.3%
PDDS Buyer, LLC  Dental Practice Management Software  First Lien Term Loan
(3M USD LIBOR+7.00%), 9.50% Cash, 7/15/2024
  7/15/2019  $14,000,000    13,895,777    14,278,600    4.7%
PDDS Buyer, LLC  Dental Practice Management Software  Delayed Draw Term Loan
(3M USD LIBOR+7.00%), 9.50% Cash, 7/15/2024
  7/15/2019  $7,000,000    6,938,964    7,139,300    2.3%
PDDS Buyer, LLC (h)  Dental Practice Management Software  Series A-1 Preferred Shares  8/10/2020   1,755,831    2,000,000    2,240,946    0.7%
      Total Dental Practice Management Software           22,834,741    23,658,846    7.7%
C2 Educational Systems (d)  Education Services  First Lien Term Loan
(3M USD LIBOR+8.50%), 10.00% Cash, 5/31/2023
  5/31/2017  $16,000,000    15,998,379    13,499,200    4.4%
Texas Teachers of Tomorrow, LLC (h), (i)  Education Services  Common Stock  12/2/2015   750    750,000    1,011,596    0.3%
Texas Teachers of Tomorrow, LLC (d)  Education Services  First Lien Term Loan
(3M USD LIBOR+7.25%), 9.75% Cash, 6/28/2024
  6/28/2019  $25,947,024    25,748,711    25,874,372    8.5%
      Total Education Services           42,497,090    40,385,168    13.2%
Destiny Solutions Inc. (d)  Education Software  First Lien Term Loan
(3M USD LIBOR+7.50%), 9.50% Cash, 10/24/2024
  5/16/2018  $43,500,000    43,204,446    43,630,500    14.3%
Destiny Solutions Inc. (h), (i)  Education Software  Limited Partner Interests  5/16/2018   2,342    2,468,464    3,069,267    1.0%
Identity Automation Systems (d)  Education Software  First Lien Term Loan
(3M USD LIBOR+9.24%), 10.99% Cash, 5/8/2024
  8/25/2014  $17,247,500    17,247,500    17,357,884    5.7%

 

11

 

 

Company  Industry  Investment Interest Rate/
Maturity
  Original Acquisition Date  Principal/
Number of Shares
   Cost   Fair Value (c)   % of
Net Assets
 
Identity Automation Systems (h)  Education Software  Common Stock Class A-2 Units  8/25/2014   232,616    232,616    725,726    0.2%
Identity Automation Systems (h)  Education Software  Common Stock Class A-1 Units  3/6/2020   43,715    171,571    185,553    0.1%
GoReact  Education Software  First Lien Term Loan
(3M USD LIBOR+7.50%), 9.50% Cash, 1/17/2025
  1/17/2020  $5,000,000    4,940,297    5,100,000    1.7%
GoReact (j)  Education Software  Delayed Draw Term Loan
(3M USD LIBOR+7.50%), 9.50% Cash, 1/17/2025
  1/17/2020  $-    -    -    0.0%
Kev Software Inc. (a)  Education Software  First Lien Term Loan
(1M USD LIBOR+8.63%), 9.63% Cash, 9/13/2023
  9/13/2018  $17,835,914    17,745,629    18,021,407    5.9%
      Total Education Software           86,010,523    88,090,337    28.9%
Davisware, LLC  Field Service Management  First Lien Term Loan
(3M USD LIBOR+7.00%), 9.00% Cash, 7/31/2024
  9/6/2019  $3,000,000    2,977,590    3,030,000    1.0%
Davisware, LLC  Field Service Management  Delayed Draw Term Loan
(3M USD LIBOR+7.00%), 9.00% Cash, 7/31/2024
  9/6/2019  $977,790    974,399    987,568    0.3%
      Total Field Service Management           3,951,989    4,017,568    1.3%
GDS Software Holdings, LLC (h)  Financial Services  Common Stock Class A Units  8/23/2018   250,000    250,000    418,531    0.1%
      Total Financial Services           250,000    418,531    0.1%
Ohio Medical, LLC (h)  Healthcare Products Manufacturing  Common Stock  1/15/2016   5,000    380,353    566,592    0.2%
      Total Healthcare Products Manufacturing           380,353    566,592    0.2%
Axiom Parent Holdings, LLC (h)  Healthcare Services  Common Stock Class A Units  6/19/2018   400,000    400,000    1,415,301    0.5%
Axiom Purchaser, Inc. (d)  Healthcare Services  First Lien Term Loan
(3M USD LIBOR+6.00%), 7.75% Cash, 6/19/2023
  6/19/2018  $10,000,000    9,955,177    10,059,000    3.3%
Axiom Purchaser, Inc. (d)  Healthcare Services  Delayed Draw Term Loan
(3M USD LIBOR+6.00%), 7.75% Cash, 6/19/2023
  6/19/2018  $6,000,000    5,961,748    6,035,400    2.0%
ComForCare Health Care  Healthcare Services  First Lien Term Loan
(3M USD LIBOR+7.75%), 8.75% Cash, 1/31/2025
  1/31/2017  $25,000,000    24,871,639    24,900,000    8.2%
      Total Healthcare Services           41,188,564    42,409,701    14.0%
TRC HemaTerra, LLC (h)  Healthcare Software  Class D Membership Interests  4/15/2019   2,000,000    2,000,000    2,572,002    0.8%
HemaTerra Holding Company, LLC  Healthcare Software  First Lien Term Loan
(3M USD LIBOR+6.75%), 9.25% Cash, 4/15/2024
  4/15/2019  $6,000,000    5,956,593    6,060,000    2.0%
HemaTerra Holding Company, LLC (d), (j)  Healthcare Software  Delayed Draw Term Loan
(3M USD LIBOR+6.75%), 9.25% Cash, 4/15/2024
  4/15/2019  $12,000,000    11,914,035    12,120,000    4.0%
Procurement Partners, LLC  Healthcare Software  First Lien Term Loan
(3M USD LIBOR+6.50%), 7.50% Cash, 11/12/2025
  11/12/2020  $8,000,000    7,924,230    7,920,000    2.6%
Procurement Partners, LLC (j)  Healthcare Software  Delayed Draw Term Loan
(3M USD LIBOR+6.50%), 7.50% Cash, 11/12/2025
  11/12/2020  $-    -    -    0.0%
Procurement Partners Holdings LLC (h)  Healthcare Software     11/12/2020   300,000    300,000    300,000    0.1%
      Total Healthcare Software           28,094,858    28,972,002    9.5%
Roscoe Medical, Inc. (d), (h)  Healthcare Supply  Common Stock  3/26/2014   5,081    508,077    280,346    0.1%
Roscoe Medical, Inc.  Healthcare Supply  Second Lien Term Loan
11.25% Cash, 6/28/2021
  3/26/2014  $5,141,413    5,141,413    5,141,413    1.7%
      Total Healthcare Supply           5,649,490    5,421,759    1.8%
Book4Time, Inc. (a)  Hospitality/Hotel  First Lien Term Loan
(3M USD LIBOR+8.50%), 10.25%, 12/22/2025
  12/22/2020  $3,136,517    3,105,788    3,105,152    1.0%
Book4Time, Inc. (a), (j)  Hospitality/Hotel  Delayed Draw Term Loan
(3M USD LIBOR+8.50%), 10.25%, 12/22/2025
  12/22/2020  $-    -    -    0.0%

 

12

 

 

Company  Industry  Investment Interest Rate/
Maturity
  Original Acquisition Date  Principal/
Number of Shares
   Cost   Fair Value (c)   % of
Net Assets
 
Book4Time, Inc. (a), (i)  Hospitality/Hotel  Class A Preferred Shares  12/22/2020   200,000    156,826    156,826    0.1%
Knowland Group, LLC  Hospitality/Hotel  Second Lien Term Loan
(3M USD LIBOR+8.00%), 10.00% Cash, 5/9/2024
  11/9/2018  $15,767,918    15,767,918    10,788,409    3.5%
Sceptre Hospitality Resources, LLC  Hospitality/Hotel  First Lien Term Loan
(1M USD LIBOR+9.00%), 10.00% Cash, 4/27/2025
  4/27/2020  $3,000,000    2,973,387    3,030,000    1.0%
      Total Hospitality/Hotel           22,003,919    17,080,387    5.6%
Granite Comfort, LP  HVAC Services and Sales  First Lien Term Loan
(1M USD LIBOR+9.00%), 10.00% Cash, 11/16/2025
  11/16/2020  $7,000,000    6,932,689    6,950,300    2.3%
Granite Comfort, LP  HVAC Services and Sales  Delayed Draw Term Loan
(1M USD LIBOR+9.00%), 10.00% Cash, 11/16/2025
  11/16/2020  $8,000,000    7,922,181    7,943,200    2.6%
      Total HVAC Services and Sales           14,854,870    14,893,500    4.9%
Vector Controls Holding Co., LLC (d)  Industrial Products  First Lien Term Loan
11.50% (9.75% Cash/1.75% PIK), 3/6/2022
  3/6/2013  $7,021,046    7,021,046    7,021,046    2.3%
Vector Controls Holding Co., LLC (d), (h)  Industrial Products  Warrants to Purchase Limited Liability Company Interests, Expires 11/30/2027  5/31/2015   343    -    2,025,598    0.7%
      Total Industrial Products           7,021,046    9,046,644    3.0%
CLEO Communications Holding, LLC (d)  IT Services  First Lien Term Loan
(3M USD LIBOR+8.00%), 9.00% Cash/2.00% PIK, 3/31/2022
  3/31/2017  $14,073,964    14,064,807    14,176,704    4.7%
CLEO Communications Holding, LLC (d), (j)  IT Services  Delayed Draw Term Loan
(3M USD LIBOR+8.00%), 9.00% Cash/2.00% PIK, 3/31/2022
  3/31/2017  $20,451,756    20,388,504    20,601,054    6.8%
LogicMonitor, Inc.  IT Services  First Lien Term Loan
(3M USD LIBOR+5.00), 6.00% Cash, 5/17/2023
  3/20/2020  $23,000,000    22,865,749    23,089,700    7.6%
      Total IT Services           57,319,060    57,867,458    19.1%
inMotionNow, Inc.  Marketing Services  First Lien Term Loan
(3M USD LIBOR+7.50), 10.00% Cash, 5/15/2024
  5/15/2019  $12,200,000    12,116,232    12,322,000    4.1%
inMotionNow, Inc.  Marketing Services  Delayed Draw Term Loan
(3M USD LIBOR+7.50) 10.00% Cash, 5/15/2024
  5/15/2019  $5,000,000    4,960,820    5,050,000    1.7%
      Total Marketing Services           17,077,052    17,372,000    5.8%
Omatic Software, LLC  Non-profit Services  First Lien Term Loan
(3M USD LIBOR+8.00%), 9.75% Cash, 5/29/2023
  5/29/2018  $5,500,000    5,470,787    5,554,450    1.8%
      Total Non-profit Services           5,470,787    5,554,450    1.8%
Emily Street Enterprises, L.L.C.  Office Supplies  Senior Secured Note
(3M USD LIBOR+8.50%), 10.00% Cash, 12/31/2023
  12/28/2012  $3,300,000    3,300,000    3,287,460    1.1%
Emily Street Enterprises, L.L.C. (h)  Office Supplies  Warrant Membership Interests Expires 12/28/2022  12/28/2012   49,318    400,000    322,853    0.1%
      Total Office Supplies           3,700,000    3,610,313    1.2%
Apex Holdings Software Technologies, LLC  Payroll Services  First Lien Term Loan
(3M USD LIBOR+8.00%), 9.00% Cash, 9/21/2024
  9/21/2016  $18,000,000    17,981,413    17,368,200    5.7%
Apex Holdings Software Technologies, LLC  Payroll Services  Delayed Draw Term Loan
(3M USD LIBOR+8.00%), 9.00% Cash, 9/21/2024
  10/1/2018  $1,000,000    994,557    964,900    0.3%
      Total Payroll Services           18,975,970    18,333,100    6.0%
Village Realty Holdings LLC  Property Management  First Lien Term Loan
(3M USD LIBOR+6.50%), 8.75% Cash, 10/8/2024
  10/8/2019  $7,250,000    7,189,591    7,395,000    2.4%
Village Realty Holdings LLC (j)  Property Management  Delayed Draw Term Loan
(3M USD LIBOR+6.50%), 8.75% Cash, 10/8/2024
  10/8/2019  $4,876,322    4,838,617    4,973,850    1.6%

 

13

 

 

Company  Industry  Investment Interest Rate/
Maturity
  Original Acquisition Date  Principal/
Number of Shares
   Cost   Fair Value (c)   % of
Net Assets
 
V Rental Holdings LLC (h)  Property Management  Class A-1 Membership Units  10/8/2019   122,578    365,914    2,208,681    0.7%
      Total Property Management           12,394,122    14,577,531    4.7%
Buildout, Inc.  Real Estate Services  First Lien Term Loan
(3M USD LIBOR+7.75%), 9.25% Cash, 7/9/2025
  7/9/2020  $14,000,000    13,873,317    13,952,400    4.6%
Buildout, Inc.  Real Estate Services  Delayed Draw Term Loan
(3M USD LIBOR+7.75%), 9.25% Cash, 7/9/2025
  2/12/2021  $3,000,000    2,970,361    2,989,800    1.0%
Buildout, Inc. (h), (i)  Real Estate Services  Limited Partner Interests  7/9/2020   1,071    1,071,301    1,090,002    0.4%
      Total Real Estate Services           17,914,979    18,032,202    6.0%
TMAC Acquisition Co., LLC (k)  Restaurant  Unsecured Term Loan
8.00% PIK, 9/01/2023
  3/1/2018  $2,261,017    2,261,017    2,140,911    0.7%
      Total Restaurant           2,261,017    2,140,911    0.7%
ArbiterSports, LLC (d)  Sports Management  First Lien Term Loan
(3M USD LIBOR+6.50%), 8.25% Cash, 2/21/2025
  2/21/2020  $26,000,000    25,800,743    24,525,800    8.1%
ArbiterSports, LLC (d)  Sports Management  Delayed Draw Term Loan
(3M USD LIBOR+6.50%), 8.25% Cash, 2/21/2025
  2/21/2020  $1,000,000    1,000,000    943,300    0.3%
      Total Sports Management           26,800,743    25,469,100    8.4%
Avionte Holdings, LLC (h)  Staffing Services  Class A Units  1/8/2014   100,000    100,000    924,509    0.3%
      Total Staffing Services           100,000    924,509    0.3%
National Waste Partners (d)  Waste Services  Second Lien Term Loan
10.00% Cash, 2/13/2022
  2/13/2017  $9,000,000    8,981,436    9,000,000    3.0%
      Total Waste Services           8,981,436    9,000,000    3.0%
Sub Total Non-control/Non-affiliate investments                 471,328,212    469,946,494    154.5%
                              
Affiliate investments - 6.4% (b)                             
GreyHeller LLC (f)  Cyber Security  First Lien Term Loan
(3M USD LIBOR+11.00%), 12.00% Cash, 12/31/2025
  11/17/2016  $7,000,000    6,988,549    7,000,000    2.3%
GreyHeller LLC (d), (f), (j)  Cyber Security  Delayed Draw Term Loan
(3M USD LIBOR+11.00%), 12.00% Cash, 12/31/2025
  10/19/2020  $2,250,000    2,233,173    2,250,000    0.7%
GreyHeller LLC (f), (h)  Cyber Security  Series A Preferred Units  11/17/2016   850,000    850,000    3,924,291    1.3%
      Total Cyber Security           10,071,722    13,174,291    4.3%
Top Gun Pressure Washing, LLC (f)  Facilities Maintenance  First Lien Term Loan
(3M USD LIBOR+7.00%), 9.50% Cash, 8/12/2024
  8/12/2019  $5,000,000    4,961,639    4,491,500    1.5%
Top Gun Pressure Washing, LLC (f), (j)  Facilities Maintenance  Delayed Draw Term Loan
(3M USD LIBOR+7.00%), 9.50% Cash, 8/12/2024
  8/12/2019  $1,825,000    1,810,198    1,639,397    0.6%
TG Pressure Washing Holdings, LLC (f), (h)  Facilities Maintenance  Preferred Equity  8/12/2019   488,148    488,148    62,552    0.0%
      Total Facilities Maintenance           7,259,985    6,193,449    2.1%
Sub Total Affiliate investments                 17,331,707    19,367,740    6.4%
                              
Control investments - 21.4% (b)                             
Netreo Holdings, LLC (g)  IT Services  First Lien Term Loan
(3M USD LIBOR +6.25%), 9.00% Cash/2.75% PIK,
12/31/2025
  7/3/2018  $5,296,555    5,268,156    5,349,521    1.8%
Netreo Holdings, LLC (g), (j)  IT Services  Delayed Draw Term Loan
(3M USD LIBOR +6.25%), 9.00% Cash/2.75% PIK,
12/31/2020
  5/26/2020  $1,223,203    1,213,962    1,235,435    0.4%
Netreo Holdings, LLC (g), (h)  IT Services  Common Stock Class A Unit  7/3/2018   3,150,000    3,150,000    8,634,768    2.8%
      Total IT Services           9,632,118    15,219,724    5.0%

 

14

 

 

Company  Industry  Investment Interest Rate/
Maturity
  Original Acquisition Date  Principal/
Number of Shares
   Cost   Fair Value (c)   % of
Net Assets
 
Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (e), (g)  Structured Finance Securities  Other/Structured Finance Securities
11.72%, 1/20/2030
  1/22/2008  $111,000,000    33,846,643    31,449,732    10.3%
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-R-3 Note (a), (g)  Structured Finance Securities  Other/Structured Finance Securities
(3M USD LIBOR+10.00%), 10.19%, 4/20/2033
  2/26/2021  $17,875,000    17,875,000    18,329,025    6.1%
      Total Structured Finance Securities           51,721,643    49,778,757    16.4%
Sub Total Control investments                 61,353,761    64,998,481    21.4%
TOTAL INVESTMENTS - 182.2% (b)                $550,013,680   $554,312,715    182.2%
                              
   Number of
Shares
   Cost   Fair Value   % of
Net Assets
 
Cash and cash equivalents and cash and cash equivalents, reserve accounts - 6.2% (b)                
U.S. Bank Money Market (l)   18,828,047   $18,828,047   $18,828,047    6.2%
Total cash and cash equivalents and cash and cash equivalents, reserve accounts   18,828,047   $18,828,047   $18,828,047    6.2%

 

(a)Represents an ineligible investment as defined under Section 55(a) of the Investment Company Act of 1940, as amended. As of February 28, 2021 non-qualifying assets represent 9.5% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b)Percentages are based on net assets of $304,185,770 as of February 28, 2021.
(c)Because there is no readily available market value for these investments, the fair values of these investments were determined using significant unobservable inputs and approved in good faith by our board of directors. These investments have been included as Level 3 in the Fair Value Hierarchy (see Note 3 to the consolidated financial statements).
(d)These securities are either fully or partially pledged as collateral under a senior secured revolving credit facility (see Note 7 to the consolidated financial statements).
(e)This investment does not have a stated interest rate that is payable thereon. As a result, the 11.72% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f)As defined in the Investment Company Act, this portfolio company is an Affiliate as we own between 5.0% and 25.0% of the voting securities. Transactions during the year ended February 28, 2021 in which the issuer was an Affiliate are as follows:

 

Company  Purchases   Sales   Total Interest from Investments   Management
Fee Income
   Net Realized
Gain (Loss) from Investments
   Net Change in Unrealized Appreciation (Depreciation) 
Elyria Foundry Company, L.L.C.  $-   $(2,309,806)  $172,626   $          -   $(8,726,013)  $7,745,228 
GreyHeller LLC   2,227,500    -    987,969    -    -    942,175 
Top Gun Pressure Washing, LLC   1,806,750    -    668,294    -    -    (712,711)
TG Pressure Washing Holdings, LLC   138,148    -    -    -    -    (425,596)
Total  $4,172,398   $(2,309,806)  $1,828,889   $-   $(8,726,013)  $7,549,096 

 

15

 

 

(g)As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the year ended February 28, 2021 in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

Company  Purchases   Sales   Total Interest from Investments   Management
Fee Income
   Net Realized
Gain (Loss) from
Investments
   Net Change in Unrealized Appreciation (Depreciation) 
Netreo Holdings, LLC  $1,188,000   $-   $738,012   $-   $          -   $1,832,136 
Saratoga Investment Corp. CLO 2013-1, Ltd.   14,000,000    -    3,535,591    2,507,626    -    (1,433,723)
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-R-2 Notes   -    (2,500,000)   237,163    -    -    22,000 
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-R-3 Note   17,875,000    -    15,187    -    -    454,025 
Saratoga Investment Corp. CLO 2013-1, Ltd. Class G-R-2 Notes   -    (7,500,000)   805,759    -    -    65,250 
Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd.   22,500,000    (25,000,000)   679,926    -    -    295,459 
Total  $55,563,000   $(35,000,000)  $6,011,638   $2,507,626   $-   $1,235,147 

 

(h)Non-income producing at February 28, 2021.
(i)Includes securities issued by an affiliate of the company.
(j)All or a portion of this investment has an unfunded commitment as of February 28, 2021. (see Note 8 to the consolidated financial statements).
(k)As of February 28, 2021, the investment was on non-accrual status. The fair value of these investments was approximately $2.1 million, which represented 0.4% of the Company’s portfolio (see Note 2 to the consolidated financial statements).
(l)Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s consolidated statements of assets and liabilities as of February 28, 2021.

 

LIBOR - London Interbank Offered Rate

 

1M USD LIBOR - The 1 month USD LIBOR rate as of February 28, 2021 was 0.12%.

3M USD LIBOR - The 3 month USD LIBOR rate as of February 28, 2021 was 0.19%.

PIK - Payment-in-Kind (see Note 2 to the consolidated financial statements).

 

See accompanying notes to consolidated financial statements.

 

16

 

 

SARATOGA INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

May 31, 2021

(unaudited)

 

Note 1. Organization

 

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed end management investment company incorporated in Maryland that has elected to be treated and is regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). The Company commenced operations on March 23, 2007 as GSC Investment Corp. and completed its initial public offering (“IPO”) on March 28, 2007. The Company has elected to be treated as a regulated investment company (“RIC”) under subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). The Company expects to continue to qualify and to elect to be treated, for tax purposes, as a RIC. The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation from its investments.

 

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. As of February 28, 2007, the LLC had not yet commenced its operations and investment activities.

 

On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

 

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.” in connection with the consummation of a recapitalization transaction.

 

The Company is externally managed and advised by the investment adviser, Saratoga Investment Advisors, LLC (the “Manager” or “Saratoga Investment Advisors”), pursuant to an investment advisory and management agreement (the “Management Agreement”). Prior to July 30, 2010, the Company was managed and advised by GSCP (NJ), L.P.

 

The Company has established wholly-owned subsidiaries, SIA-Avionte, Inc., SIA-GH, Inc., SIA-MAC, Inc., SIA-PP, Inc., SIA-TG, Inc., SIA-TT, Inc., SIA-Vector, Inc. and SIA-VR, Inc., which are structured as Delaware entities, or tax blockers (“Taxable Blockers”), to hold equity or equity-like investments in portfolio companies organized as limited liability companies, or LLCs (or other forms of pass through entities). Tax blockers are consolidated for accounting purposes but are not consolidated for income tax purposes and may incur income tax expense as a result of their ownership of portfolio companies.

 

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a Small Business Investment Company (“SBIC”) license from the Small Business Administration (“SBA”). On August 14, 2019, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC II LP (“SBIC II LP”), also received an SBIC license from the SBA. The new license will provide up to $175.0 million in additional long-term capital in the form of SBA debentures.

 

Note 2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”), are stated in U.S. Dollars and include the accounts of the Company and its special purpose financing subsidiaries, Saratoga Investment Funding, LLC (previously known as GSC Investment Funding LLC), SBIC LP, SBIC II LP, SIA-Avionte, Inc., SIA-GH, Inc., SIA-MAC, Inc., SIA-PP, Inc., SIA-TG, Inc., SIA-TT, Inc., SIA-Vector, Inc. and SIA-VR, Inc. All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiaries, except as stated otherwise.

 

17

 

 

The Company, SBIC LP and SBIC II LP are all considered to be investment companies for financial reporting purposes and have applied the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, “Financial Services — Investment Companies” (“ASC 946”). There have been no changes to the Company, SBIC LP or SBIC II LP’s status as investment companies during the three months ended May 31, 2021.

 

Use of Estimates in the Preparation of Financial Statements

 

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

 

Cash and Cash Equivalents

 

Cash and cash equivalents include short-term, liquid investments in a money market fund. Cash and cash equivalents are carried at cost which approximates fair value. Per section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another registered investment company such as a money market fund if such investment would cause the Company to exceed any of the following limitations:

 

we were to own more than 3.0% of the total outstanding voting stock of the money market fund;

 

we were to hold securities in the money market fund having an aggregate value in excess of 5.0% of the value of our total assets, except as allowed pursuant to Rule 12d1-1 of Section 12(d)(1) of the 1940 Act which is designed to permit “cash sweep” arrangements rather than investments directly in short-term instruments; or

 

we were to hold securities in money market funds and other registered investment companies and BDCs having an aggregate value in excess of 10.0% of the value of our total assets.

 

As of May 31, 2021, the Company did not exceed any of these limitations.

 

Cash and Cash Equivalents, Reserve Accounts

 

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds, representing payments received on secured investments or other reserved amounts associated with the Company’s $45.0 million senior secured revolving credit facility with Madison Capital Funding LLC. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the senior secured revolving credit facility.

 

In addition, cash and cash equivalents, reserve accounts also include amounts held in designated bank accounts, in the form of cash and short-term liquid investments in money market funds, within our wholly-owned subsidiaries, SBIC LP and SBIC II LP.

 

The statements of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash and restricted cash equivalents when reconciling the beginning-of-period and end-of-period total amounts.

 

The following table provides a reconciliation of cash and cash equivalents and cash and cash equivalents, reserve accounts reported within the consolidated statements of assets and liabilities that sum to the total of the same such amounts shown in the consolidated statements of cash flows:
 
   May 31, 2021   May 31, 2020 
Cash and cash equivalents  $317,932   $12,842,608 
Cash and cash equivalents, reserve accounts   19,659,681    12,952,393 
Total cash and cash equivalents and cash and cash equivalents, reserve accounts  $19,977,613   $25,795,001 

 

18

 

 

Investment Classification

 

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “Control Investments” are defined as investments in companies in which we own more than 25.0% of the voting securities or maintain greater than 50.0% of the board representation. Under the 1940 Act, “Affiliated Investments” are defined as those non-control investments in companies in which we own between 5.0% and 25.0% of the voting securities. Under the 1940 Act, “Non-affiliated Investments” are defined as investments that are neither Control Investments nor Affiliated Investments.

 

Investment Valuation

 

The Company accounts for its investments at fair value in accordance with the FASB ASC Topic 820, Fair Value Measurement (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold or its liabilities are to be transferred at the measurement date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

 

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third-party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from our Manager, the audit committee of our board of directors and a third-party independent valuation firm.

 

The Company undertakes a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

  · Each investment is initially valued by the responsible investment professionals of the Manager and preliminary valuation conclusions are documented, reviewed and discussed with our senior management; and

 

  · An independent valuation firm engaged by our board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year.

 

In addition, all our investments are subject to the following valuation process:

 

  · The audit committee of our board of directors reviews and approves each preliminary valuation and our Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

  Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of our Manager, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

 

We use multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which the Company determines a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

 

19

 

 

The Company’s investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow valuation technique that utilizes prepayment, re-investment and loss inputs based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flows, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The cash flows use a set of inputs including projected default rates, recovery rates, reinvestment rates and prepayment rates in order to arrive at estimated valuations. The inputs are based on available market data and projections provided by third parties as well as management estimates. The Company uses the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine the valuation for our investment in Saratoga CLO.

 

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. The Company’s net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

  

Derivative Financial Instruments

 

The Company accounts for derivative financial instruments in accordance with FASB ASC Topic 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires recognizing all derivative instruments as either assets or liabilities on the consolidated statements of assets and liabilities at fair value. The Company values derivative contracts at the closing fair value provided by the counterparty. Changes in the values of derivative contracts are included in the consolidated statements of operations.

 

Investment Transactions and Income Recognition

 

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts over the life of the investment and amortization of premiums on investments up to the earliest call date.

 

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection. At May 31, 2021, certain investments in two portfolio companies, including preferred equity interests, were on non-accrual status with a fair value of approximately $2.2 million, or 0.3% of the fair value of our portfolio. At February 28, 2021, certain investments in two portfolio companies, including preferred equity interests, were on non-accrual status with a fair value of approximately $2.1 million, or 0.4% of the fair value of our portfolio.

 

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325, Investments-Other, Beneficial Interests in Securitized Financial Assets, (“ASC 325”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

 

Payment-in-Kind Interest

 

The Company holds debt and preferred equity investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company stops accruing PIK interest if it is expected that the issuer will not be able to pay all principal and interest when due.

 

20

 

 

Structuring and Advisory Fee Income

 

Structuring and advisory fee income represents various fee income earned and received performing certain investment structuring and advisory activities during the closing of new investments.

 

Other Income

 

Other income includes dividends received, prepayment income fees, and origination, monitoring, administration and amendment fees and is recorded in the consolidated statements of operations when earned.

 

Deferred Debt Financing Costs

 

Financing costs incurred in connection with our credit facility and notes are deferred and amortized using the straight-line method over the life of the respective facility and debt securities. Financing costs incurred in connection with our SBA debentures are deferred and amortized using the straight-line method over the life of the debentures.

 

The Company presents deferred debt financing costs on the balance sheet as a contra-liability as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.

 

Contingencies

 

In the ordinary course of business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management feels that the likelihood of such an event is remote. Therefore, the Company has not accrued any liabilities in connection with such indemnifications.

 

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

 

Income Taxes

 

The Company has elected to be treated for tax purposes as a RIC under the Code and, among other things, intends to make the requisite distributions to its stockholders which will relieve the Company from federal income taxes. Therefore, no provision has been recorded for federal income taxes, except as related to the Taxable Blockers and long-term capital gains, when applicable.

 

In order to qualify as a RIC, among other requirements, the Company is required to timely distribute to its stockholders at least 90.0% of its investment company taxable income, as defined by the Code, for each fiscal tax year. The Company will be subject to a nondeductible U.S. federal excise tax of 4.0% on undistributed income if it does not distribute at least (1) 98.0% of its net ordinary income in any calendar year, (2) 98.2% of its capital gain net income for each one-year period ending on October 31and (3) any net ordinary income and capital gain net income that it recognized for preceding years, but were not distributed during such year, and on which the Company paid no U.S federal income tax.

 

Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward taxable income in excess of current year dividend distributions into the next tax year and pay the 4.0% U.S. federal excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions for U.S. federal excise tax purposes, the Company accrues the U.S. federal excise tax, if any, on estimated excess taxable income as taxable income is earned.

 

In accordance with certain applicable U.S. Treasury regulations and private letter rulings issued by the Internal Revenue Service (“IRS”), a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. If too many stockholders elect to receive cash, each stockholder electing to receive cash will receive a pro rata amount of cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20.0% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S. federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

 

21

 

 

The Company may utilize wholly-owned holding companies taxed under Subchapter C of the Code or tax blockers, when making equity investments in portfolio companies taxed as pass-through entities to meet its source-of-income requirements as a RIC. Taxable Blockers are consolidated in the Company’s U.S. GAAP financial statements and may result in current and deferred federal and state income tax expense with respect to income derived from those investments. Such income, net of applicable income taxes, is not included in the Company’s tax-basis net investment income until distributed by the Taxable Blocker, which may result in timing and character differences between the Company’s U.S. GAAP and tax-basis net investment income and realized gains and losses. Income tax expense or benefit from Taxable Blockers related to net investment income are included in total operating expenses, while any expense or benefit related to federal or state income tax originated for capital gains and losses are included together with the applicable net realized or unrealized gain or loss line item. Deferred tax assets of the Taxable Blockers are reduced by a valuation allowance when, in the opinion of management, it is more-likely than-not that some portion or all of the deferred tax assets will not be realized.

 

FASB ASC Topic 740, Income Taxes, (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense on the consolidated statements of operations. During the fiscal year ended February 28, 2021, the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2018, 2019, 2020 and 2021 federal tax years for the Company remain subject to examination by the IRS. As of May 31, 2021 and February 28, 2021, there were no uncertain tax positions. The Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change significantly in the next 12 months.

 

Dividends

 

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain such capital gains for reinvestment.

 

We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of the DRIP by the dividend record date will have their cash dividends automatically reinvested into additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

 

Capital Gains Incentive Fee

 

The Company records an expense accrual on the consolidated statements of operations, relating to the capital gains incentive fee payable on the consolidated statements of assets and liabilities, by the Company to the Manager when the net realized and unrealized gain on its investments exceed all net realized and unrealized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the Manager if the Company were to liquidate its investment portfolio at such time.

 

The actual incentive fee payable to the Company’s Manager related to capital gains will be determined and payable in arrears at the end of each fiscal year and only reflected those realized capital gains net of realized and unrealized losses for the period.

 

New Accounting Pronouncements

 

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (“ASU 2020-04”). The amendments in ASU 2020-04 provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The standard is effective as of March 12, 2020 through December 31, 2022. Management does not believe this optional guidance has a material impact on the Company’s consolidated financial statements and disclosures.

 

22

 

 

Risk Management

 

In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

 

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount. The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

 

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

 

Note 3. Investments

 

As noted above, the Company values all investments in accordance with ASC 820. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between independent market participants at the measurement date.

 

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

 

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

 

Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

Level 2— Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. Such inputs may be quoted prices for similar assets or liabilities, quoted markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full character of the financial instrument, or inputs that are derived principally from, or corroborated by, observable market information. Investments which are generally included in this category include illiquid debt securities and less liquid, privately held or restricted equity securities, for which some level of recent trading activity has been observed.

 

Level 3—Pricing inputs are unobservable for the investment and includes situations where there is little, if any, market activity for the investment. The inputs may be based on the Company’s own assumptions about how market participants would price the asset or liability or may use Level 2 inputs, as adjusted, to reflect specific investment attributes relative to a broader market assumption. Even if observable market data for comparable performance or valuation measures (earnings multiples, discount rates, other financial/valuation ratios, etc.) are available, such investments are grouped as Level 3 if any significant data point that is not also market observable (private company earnings, cash flows, etc.) is used in the valuation technique. We use multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which the Company determines a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

 

23

 

 

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2). Consistent with our valuation policy, we evaluate the source of inputs, including any markets in which our investments are trading, in determining fair value.

 

The following table presents fair value measurements of investments, by major class, as of May 31, 2021 (dollars in thousands), according to the fair value hierarchy:
                 
   Fair Value Measurements 
   Level 1   Level 2   Level 3   Total 
First lien term loans  $          -   $          -   $516,154   $516,154 
Second lien term loans   -    -    25,422    25,422 
Unsecured term loans   -    -    2,169    2,169 
Structured finance securities   -    -    53,421    53,421 
Equity interests   -    -    80,607    80,607 
Total  $-   $-   $677,773   $677,773 

 

The following table presents fair value measurements of investments, by major class, as of February 28, 2021 (dollars in thousands), according to the fair value hierarchy:

 

   Fair Value Measurements 
   Level 1   Level 2   Level 3   Total 
First lien term loans  $          -   $          -   $440,456   $440,456 
Second lien term loans   -    -    24,930    24,930 
Unsecured term loans   -    -    2,141    2,141 
Structured finance securities   -    -    49,779    49,779 
Equity interests   -    -    37,007    37,007 
Total  $-   $-   $554,313   $554,313 

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended May 31, 2021 (dollars in thousands):

 

   First lien term loans   Second lien term loans   Unsecured term loans   Structured finance securities   Equity interests   Total 
Balance as of February 28, 2021  $440,456   $24,930   $2,141   $49,779   $37,007   $554,313 
Payment-in-kind and other adjustments to cost   231              (435)   396    192 
Net accretion of discount on investments   314    7         -    -    321 
Net change in unrealized appreciation (depreciation) on investments   497    485    28    4,077    11,725    16,812 
Purchases   87,321                   31,845    119,166 
Sales and repayments   (12,665)                  (2,276)   (14,941)
Net realized gain (loss) from investments                       1,910    1,910 
Balance as of May 31, 2021  $516,154   $25,422   $2,169   $53,421   $80,607   $677,773 
Net change in unrealized appreciation (depreciation) for the period relating to those Level 3 assets that were still held by the Company at the end of the period  $838   $485   $28   $4,076   $13,568   $18,995 

 

24

 

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK interests.

 

Sales and repayments represent net proceeds received from investments sold, and principal paydowns received during the period.

 

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur. There were no transfers or restructures in or out of Levels 1, 2 or 3 during the three months ended May 31, 2021.

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended May 31, 2020 (dollars in thousands):

 

   First lien term loans   Second lien term loans   Unsecured term loans   Structured finance securities   Equity interests   Total 
Balance as of February 29, 2020  $346,233   $73,570   $4,346   $32,470   $29,013   $485,632 
Payment-in-kind and other adjustments to cost   191    466    -    (1,361)   -    (704)
Net accretion of discount on investments   279    33    -    -    -    312 
Net change in unrealized appreciation (depreciation) on investments   (19,115)   (4,582)   (1,035)   (3,803)   (3,415)   (31,950)
Purchases   36,189    -    2,500    -    310    38,999 
Sales and repayments   (9,350)   -    -    -    -    (9,350)
Net realized gain (loss) from investments   8    -    -    -    -    8 
Balance as of May 31, 2020  $354,435   $69,487   $5,811   $27,306   $25,908   $482,947 
Net change in unrealized appreciation (depreciation) for the year relating to those Level 3 assets that were still held by the Company at the end of the period  $(18,880)  $(4,583)  $(1,034)  $(3,804)  $(3,414)  $(31,715)

 

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur. There were no transfers or restructures in or out of Levels 1, 2 or 3 during the three months ended May 31, 2020.

 

25

 

 

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of May 31, 2021 were as follows (dollars in thousands):

 

   Fair Value   Valuation Technique  Unobservable Input  Range   Weighted Average* 
First lien term loans  $516,154   Market Comparables  Market Yield (%)  5.8% - 18.1%   9.6%
           EBITDA Multiples (x)  6.8x  6.8x
           Revenue Multiples (x)  4.7x - 11.2x   8.2x
Second lien term loans   25,422   Market Comparables  Market Yield (%)  10.0% - 23.7%   17.6%
           EBITDA Multiples (x)  7.5x  7.5x
Unsecured term loans   2,169   Market Comparables  Market Yield (%)  25.2%  25.2%
           EBITDA Multiples (x)  5.2x  5.2x
Structured finance securities   53,421   Discounted Cash Flow  Discount Rate (%)  10.0% - 15.0%   13.9%
           Recovery Rate (%)  35% - 70%   70.0%
           Prepayment Rate (%)  20.0%  20.0%
Equity interests   80,607   Enterprise Value Waterfall  EBITDA Multiples (x)  3.3x - 74.0x   32.6x
           Revenue Multiples (x)  0.5x - 21.8x   9.2x
Total  $677,773               

 

 

*The weighted average in the table above is calculated based on each investment’s fair value weighting, using the applicable unobservable input.

 

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2021 were as follows (dollars in thousands):

 
   Fair Value   Valuation Technique  Unobservable Input  Range   Weighted Average* 
First lien term loans  $440,456   Market Comparables  Market Yield (%)  5.8% - 18.7%   9.7%
           EBITDA Multiples (x)  6.8x  6.8x
           Revenue Multiples (x)  4.1x - 8.0x   7.5x
Second lien term loans   24,930   Market Comparables  Market Yield (%)  10.0% - 24.5%   16.5%
           EBITDA Multiples (x)  7.5x  7.5x
Unsecured term loans   2,141   Market Comparables  Market Yield (%)  31.1%  31.1%
           EBITDA Multiples (x)  5.2x  5.2x
Structured finance securities   49,779   Discounted Cash Flow  Discount Rate (%)  10.0% - 15.00%   13.8%
           Recovery Rate (%)  35.0% - 70.0%   70.0%
           Prepayment Rate (%)  20.0%  20.0%
Equity interests   37,007   Enterprise Value Waterfall  EBITDA Multiples (x)  4.0x - 14.0x   9.7x
           Revenue Multiples (x)  0.5x - 38.3x   4.6x
Total  $554,313               

 

 

*The weighted average in the table above is calculated based on each investment’s fair value weighting, using the applicable unobservable input.

 

26

 

 

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the earnings before interest, tax, depreciation and amortization (“EBITDA”) or revenue valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, and prepayment rate, in isolation, would result in a significantly lower (higher) fair value measurement while a significant increase (decrease) in recovery rate, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a market quote in deriving a value, a significant increase (decrease) in the market quote, in isolation, would result in a significantly higher (lower) fair value measurement.

 

The composition of our investments as of May 31, 2021 at amortized cost and fair value was as follows (dollars in thousands):

 

    Investments at Amortized Cost    Amortized Cost Percentage of Total Portfolio    Investments at Fair Value    Fair Value Percentage of Total Portfolio 
First lien term loans  $516,790    78.7%  $516,154    76.2%
Second lien term loans   29,898    4.6    25,422    3.7 
Unsecured term loans   2,261    0.3    2,169    0.3 
Structured finance securities   51,287    7.8    53,421    7.9 
Equity interests   56,425    8.6    80,607    11.9 
Total  $656,661    100.0%  $677,773    100.0%

 

The composition of our investments as of February 28, 2021 at amortized cost and fair value was as follows (dollars in thousands):

 

    Investments at Amortized Cost    Amortized Cost Percentage of Total Portfolio    Investments at Fair Value    Fair Value Percentage of Total Portfolio 
First lien term loans  $441,590    80.3%  $440,456    79.5%
Second lien term loans   29,891    5.4    24,930    4.4 
Unsecured term loans   2,261    0.4    2,141    0.4 
Structured finance securities   51,722    9.4    49,779    9.0 
Equity interests   24,550    4.5    37,007    6.7 
Total  $550,014    100.0%  $554,313    100.0%

 

For loans and debt securities for which market quotations are not available, we determine their fair value based on third party indicative broker quotes, where available, or the inputs that a hypothetical market participant would use to value the security in a current hypothetical sale using a market comparables valuation technique. In applying the market comparables valuation technique, we determine the fair value based on such factors as market participant inputs including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in our judgment, the market comparables technique is not sufficient or appropriate, we may use additional techniques such as an asset liquidation or expected recovery model.

 

For equity securities of portfolio companies and partnership interests, we determine the fair value using an enterprise value waterfall valuation technique. Under the enterprise value waterfall valuation technique, we determine the enterprise fair value of the portfolio company and then waterfall the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, we weigh some or all of the traditional market valuation techniques and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The techniques for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, we may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. We also take into account historical and anticipated financial results.

 

27

 

 

Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flow valuation technique that utilizes prepayment, re-investment and loss inputs based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flows, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The cash flows use a set of inputs including projected default rates, recovery rates, reinvestment rates and prepayment rates in order to arrive at estimated valuations. The inputs are based on available market data and projections provided by third parties as well as management estimates. In connection with the refinancing of the Saratoga CLO liabilities, we ran Intex models based on inputs about the refinanced Saratoga CLO’s structure, including capital structure, cost of liabilities and reinvestment period. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO at May 31, 2021. The inputs at May 31, 2021 for the valuation model include:

 

Default rate: 2%

 

Recovery rate: 35% -70%

 

Discount rate: 10% – 15%

 

Prepayment rate: 20%

 

Reinvestment rate / price: L+365bps / $99.00

 

Investment Concentration

 

Set forth is a brief description of each portfolio company in which the fair value of our investment represents greater than 5% of our total assets as of May 31, 2021.

 

CLEO Communications Holding, LLC

 

CLEO Communications Holding, LLC (“Cleo”) is a provider of technology enabled data communication and integration platform for daily business transactions. Cleo’s platform allows for the automation of business-to-business transaction information for customers operating in the retail, manufacturing, logistics and the healthcare verticals. The platform also allows for internal application-to-application communication, allowing customers’ core enterprise software applications to easily share and transfer data.

 

Destiny Solutions Inc.

 

Destiny Solutions Inc. (“Destiny”) provides a SaaS-based student lifecycle management (“SLM”) software solution used by higher education institutions to manage their continuing education (“CE”) and non-degree educational programs for “non-traditional” students who fall outside of the “traditional” student profile. Traditional students are full-time students working toward an undergraduate, graduate, or doctorate degree. Destiny’s software acts as the ERP, CRM, e-commerce platform, and student information management system for non-traditional student programs.

 

Hematerra Holdings Company, LLC

 

HemaTerra Holding Company, LLC (“HemaTerra”) provides SaaS-based software solutions addressing complex supply chain issues across a variety of medical environments, including blood, plasma, tissue, implants and DNA sample management, to customers in blood centers, hospitals, pharmaceuticals, and law enforcement settings.

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

 

The Company has a collateral management agreement with Saratoga CLO, pursuant to which the Company acts as its collateral manager. The Saratoga CLO invests primarily in senior secured first lien term loans. The Company also holds an investment in the subordinated note and Class F-R-3.

 

28

 

 

Note 4. Investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”)

 

On January 22, 2008, the Company entered into a collateral management agreement with Saratoga CLO, pursuant to which the Company acts as its collateral manager. The Saratoga CLO was initially refinanced in October 2013 with its reinvestment period extended to October 2016. On November 15, 2016, the Company completed a second refinancing of the Saratoga CLO with its reinvestment period extended to October 2018.

 

On December 14, 2018, the Company completed a third refinancing and upsize of the Saratoga CLO (the “2013-1 Reset CLO Notes”). The third Saratoga CLO refinancing, among other things, extended its reinvestment period to January 2021, and extended its legal maturity date to January 2030. A non-call period ending January 2020 was also added. Following this refinancing, the Saratoga CLO portfolio increased from approximately $300.0 million in aggregate principal amount to approximately $500.0 million of predominantly senior secured first lien term loans. In addition to refinancing its liabilities, the Company invested an additional $13.8 million in all of the newly issued subordinated notes of the Saratoga CLO and also purchased $2.5 million in aggregate principal amount of the Class F-R-2 and $7.5 million aggregate principal amount of the Class G-R-2 notes tranches at par, with a coupon of 3M USD LIBOR plus 8.75% and 3M USD LIBOR plus 10.00%, respectively. As part of this refinancing, the Company also redeemed our existing $4.5 million aggregate amount of the Class F notes tranche at par.

 

On February 11, 2020, the Company entered into an unsecured loan agreement with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd., (“CLO 2013-1 Warehouse 2”) a wholly-owned subsidiary Saratoga CLO.

 

On February 26, 2021, the Company completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, and extended its legal maturity to April 2033. A non-call period ending February 2022 was also added. In addition, and as part of the refinancing, the Saratoga CLO has also been upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, the Company invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million of the CLO 2013-1 Warehouse 2 Loan were repaid. The Company also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. As of May 31, 2021, there remained an outstanding receivable of $2.6 million for such transaction costs which is presented as due from affiliate on the Company’s consolidated statement of assets and liabilities.

 

The Saratoga CLO remains 100.0% owned and managed by the Company. We receive a base management fee of 0.10% per annum and a subordinated management fee of 0.40% per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. Following the third refinancing and the issuance of the 2013-1 Reset CLO Notes on December 14, 2018, we are no longer entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%.

 

For the three months ended May 31, 2021 and May 31, 2020, we accrued management fee income of $0.8 million and $0.6 million, respectively, and interest income of $1.1 million and $0.6 million, respectively, from the Saratoga CLO.

 

As of May 31, 2021, the aggregate principal amounts of the Company’s investments in the subordinated notes and Class F-R-3 Notes of the Saratoga CLO was $111.0 million and $17.9 million, respectively, which had a corresponding fair value of $35.5 million and $17.9 million, respectively. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. As of May 31, 2021, Saratoga CLO had investments with a principal balance of $685.6 million and a weighted average spread over LIBOR of 3.8% and had debt with a principal balance of $611.0 million with a weighted average spread over LIBOR of 2.2%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. As of May 31, 2021, the present value of the projected future cash flows of the subordinated notes was approximately $36.2 million, using a 15.0% discount rate. The Company’s total investment in the subordinate notes of Saratoga CLO is $57.8 which consists of investments of $30 million in January 2008, $13.8 million in December 2018 and $14.0 million in February 2021; to date the Company has since received distributions of $68.4 million, management fees of $25.7 million and incentive fees of $1.2 million. In conjunction with the third refinancing of the 2013-1 Reset CLO Notes on December 14, 2018, the Company is no longer entitled to receive an incentive management fee from Saratoga CLO.

 

29

 

 

As of February 28, 2021, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $31.4 million. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. As of February 28, 2021, the fair value of its investment in the Class F-R-3 Notes was $18.3 million, As of February 28, 2021, Saratoga CLO had investments with a principal balance of $603.7 million and a weighted average spread over LIBOR of 3.8% and had debt with a principal balance of $611.0 million with a weighted average spread over LIBOR of 2.2%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. As of February 28, 2021, the present value of the projected future cash flows of the subordinated notes was approximately $31.7 million, using a 15.0% discount rate.

 

Below is certain financial information from the separate financial statements of Saratoga CLO as of May 31, 2021 (unaudited) and February 28, 2021 and for the three months ended May 31, 2021 (unaudited) and May 31, 2020 (unaudited).

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Assets and Liabilities

 

   May 31, 2021   February 28, 2021 
   (unaudited)     
ASSETS        
Investments at fair value        
Loans at fair value (amortized cost of $676,759,933 and $594,722,350, respectively)  $672,967,501   $591,518,866 
Equities at fair value (amortized cost of $385,327 and $527,124, respectively)   467,214    501,175 
Total investments at fair value (amortized cost of $677,145,260 and $595,249,474, respectively)   673,434,715    592,020,041 
Cash and cash equivalents   10,710,367    114,145,406 
Receivable from open trades   4,531,236    1,901,754 
Interest receivable (net of reserve of $37,834 and $35,000, respectively)   2,027,683    1,497,333 
Prepaid expenses and other assets   71,753    118,868 
Total assets  $690,775,754   $709,683,402 
           
LIABILITIES          
Interest payable  $3,847,101   $124,233 
Payable from open trades   41,198,406    66,298,568 
Accrued base management fee   170,576    6,930 
Accrued subordinated management fee   682,301    27,715 
Accounts payable and accrued expenses   78,545    809,760 
Due to Affiliate   2,600,000    2,600,000 
Saratoga Investment Corp. CLO 2013-1, Ltd. Notes:          
Class A-1-R-3 Senior Secured Floating Rate Notes   357,500,000    357,500,000 
Class A-2-R-3 Senior Secured Floating Rate Notes   65,000,000    65,000,000 
Class B-FL-R-3 Senior Secured Floating Rate Notes   60,500,000    60,500,000 
Class B-FXD-R-3 Senior Secured Fixed Rate Notes   11,000,000    11,000,000 
Class C-FL-R-3 Deferrable Mezzanine Floating Rate Notes   26,000,000    26,000,000 
Class C-FXD-R-3 Deferrable Mezzanine Fixed Rate Notes   6,500,000    6,500,000 
Class D-R-3 Deferrable Mezzanine Floating Rate Notes   39,000,000    39,000,000 
Discount on Class D-R-3 Notes   (286,302)   (292,368)
Class E-R-3 Deferrable Mezzanine Floating Rate Notes   27,625,000    27,625,000 
Discount on Class E-R-3 Notes   (2,974,358)   (3,037,380)
Class F-R-3 Notes Deferrable Junior Floating Rate Notes   17,875,000    17,875,000 
Deferred debt financing costs   (2,229,317)   (2,276,780)
Subordinated Notes   111,000,000    111,000,000 
Discount on Subordinated Notes   (47,042,654)   (48,039,412)
Total liabilities  $718,044,298   $738,221,266 
           
NET ASSETS          
Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 common shares issued and outstanding, respectively  $250   $250 
Total distributable earnings (loss)   (27,268,794)   (28,538,114)
Total net assets   (27,268,544)   (28,537,864)
Total liabilities and net assets  $690,775,754   $709,683,402 

 

See accompanying notes to financial statements.

 

30

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Operations

(unaudited)

 

   For the three months ended 
   May 31, 2021   May 31, 2020 
INVESTMENT INCOME        
Total interest from investments  $7,747,740   $7,213,489 
Interest from cash and cash equivalents   572    3,287 
Other income   317,057    109,641 
Total investment income   8,065,369    7,326,417 
EXPENSES          
Interest and debt financing expenses   4,836,177    7,288,568 
Base management fee   163,646    125,521 
Subordinated management fee   654,586    502,085 
Professional fees   35,666    88,490 
Trustee expenses   -    51,858 
Other expense   59,783    28,052 
Total expenses   5,749,858    8,084,574 
NET INVESTMENT INCOME (LOSS)   2,315,511    (758,157)
           
REALIZED AND UNREALIZED LOSS ON INVESTMENTS          
Net realized loss from investments   (565,094)   (1,803,884)
Net change in unrealized depreciation on investments   (481,097)   (31,575,429)
Net realized and unrealized gain (loss) on investments   (1,046,191)   (33,379,313)
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS  $1,269,320   $(34,137,470)

 

See accompanying notes to financial statements

 

31

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

May 31, 2021

(unaudited)

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value 
Covia Holdings C/S (Unimin)  Metals & Mining  Common Stock  Equity  -   -    -    -    -    49,312    385,327   $369,840 
Fusion Connect Warrant  Telecommunications  Warrants  Equity  -   -    -    -    -    32,832    -    - 
J Jill Common Stock  Retail  Common Stock  Equity  -   -    -    -    -    5,085    -    97,374 
ABB Con-Cise Optical Group LLC  Consumer goods: Non-durable  Term Loan B  Loan   6M USD LIBOR+   5.00%   1.00%   6.00%   6/15/2023   $2,055,028   $2,042,826    1,972,827 
Adtalem Global Education Inc.  Services: Business  Term Loan B (02/21)  Loan   1M USD LIBOR+   4.50%   0.75%   5.25%   2/12/2028    2,000,000    1,980,000    1,984,580 
Aegis Sciences Corporation  Healthcare & Pharmaceuticals  Term Loan  Loan   3M USD LIBOR+   5.50%   1.00%   6.50%   5/9/2025    3,386,421    3,367,055    3,265,797 
Agiliti Health Inc.  Healthcare & Pharmaceuticals  Term Loan (1/19)  Loan   1M USD LIBOR+   2.75%   0.00%   2.88%   1/4/2026    490,000    490,000    488,775 
Agiliti Health Inc.  Healthcare & Pharmaceuticals  Term Loan (09/20)  Loan   1M USD LIBOR+   2.75%   0.75%   3.50%   1/4/2026    384,464    381,065    383,503 
AHEAD DB Holdings, LLC  Services: Business  Term Loan (04/21)  Loan   3M USD LIBOR+   3.75%   0.75%   4.50%   10/18/2027    3,000,000    2,888,935    2,995,770 
AI Convoy (Luxembourg) S.a.r.l.  Aerospace & Defense  Term Loan B (USD)  Loan   3M USD LIBOR+   3.50%   1.00%   4.50%   1/18/2027    1,485,000    1,479,037    1,484,376 
AIS HoldCo, LLC  Services: Business  Term Loan  Loan   3M USD LIBOR+   5.00%   0.00%   5.19%   8/15/2025    5,212,127    5,058,226    5,107,885 
Alchemy Copyrights, LLC  Media: Diversified & Production  Term Loan B  Loan   1M USD LIBOR+   3.00%   0.50%   3.50%   3/10/2028    497,503    494,212    496,259 
Alchemy US Holdco 1, LLC  Metals & Mining  Term Loan  Loan   1M USD LIBOR+   5.50%   0.00%   5.59%   10/10/2025    1,887,500    1,868,406    1,850,939 
Alion Science and Technology Corporation  Aerospace & Defense  Term Loan (2/21)  Loan   1M USD LIBOR+   2.75%   0.75%   3.50%   7/23/2024    3,990,000    3,975,478    3,974,040 
AlixPartners, LLP  Banking, Finance, Insurance & Real Estate  Term Loan B (01/21)  Loan   1M USD LIBOR+   2.75%   0.50%   3.25%   2/4/2028    250,000    249,391    248,958 
Alkermes, Inc.  Healthcare & Pharmaceuticals  Term Loan B (3/21)  Loan   3M USD LIBOR+   2.50%   0.50%   3.00%   3/12/2026    500,000    498,791    496,250 
Allen Media, LLC  Media: Diversified & Production  Term Loan  Loan   3M USD LIBOR+   5.50%   0.00%   5.70%   2/10/2027    2,969,527    2,957,931    2,962,103 
Alliant Holdings I, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B3  Loan   1M USD LIBOR+   3.75%   0.50%   4.25%   11/6/2027    500,000    497,500    500,375 
Altisource Solutions S.a r.l.  Banking, Finance, Insurance & Real Estate  Term Loan B (03/18)  Loan   3M USD LIBOR+   4.00%   1.00%   5.00%   4/3/2024    1,223,297    1,219,007    1,026,554 
Altium Packaging LLC  Containers, Packaging & Glass  Term Loan (01/21)  Loan   1M USD LIBOR+   2.75%   0.50%   2.84%   1/29/2028    500,000    497,552    496,485 
Altra Industrial Motion Corp.  Capital Equipment  Term Loan  Loan   1M USD LIBOR+   2.00%   0.00%   2.09%   10/1/2025    1,477,611    1,475,296    1,470,223 
American Greetings Corporation  Media: Advertising, Printing & Publishing  Term Loan  Loan   1M USD LIBOR+   4.50%   1.00%   5.50%   4/6/2024    3,878,028    3,876,039    3,878,028 
American Trailer World Corp  Automotive  Term Loan  Loan   1M USD LIBOR+   3.75%   0.75%   4.50%   3/3/2028    2,000,000    1,990,352    1,996,260 
AmeriLife Holdings LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   1M USD LIBOR+   4.00%   0.00%   4.11%   3/18/2027    1,488,901    1,480,666    1,487,040 
AmWINS Group, LLC  Banking, Finance, Insurance & Real Estate  Term Loan 2/21  Loan   1M USD LIBOR+   2.25%   0.75%   3.00%   2/17/2028    1,995,000    1,990,338    1,984,826 
Anastasia Parent LLC  Consumer goods: Non-durable  Term Loan  Loan   3M USD LIBOR+   3.75%   0.00%   3.95%   8/11/2025    975,000    971,940    698,519 
Anchor Glass Container Corporation  Containers, Packaging & Glass  Term Loan (07/17)  Loan   3M USD LIBOR+   2.75%   1.00%   3.75%   12/7/2023    478,844    477,830    431,333 

 

 

 

32

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value   Issuer Name 
Anchor Packaging, LLC  Containers, Packaging & Glass  Term Loan B  Loan  1M USD LIBOR+   4.00%   0.00%   4.11%   7/18/2026    994,937    985,812    996,180 
ANI Pharmaceuticals, Inc.  Healthcare & Pharmaceuticals  ANI Pharmaceuticals 5/21 T/L B  Loan  3M USD LIBOR+   6.00%   0.75%   6.75%   5/24/2027    3,000,000    2,940,000    2,947,500 
APi Group DE, Inc. (J2 Acquisition)  Services: Business  Term Loan B  Loan  1M USD LIBOR+   2.50%   0.00%   2.59%   10/1/2026    987,500    983,568    980,094 
APLP Holdings Limited Partnership  Energy: Electricity  Term Loan B (3/21)  Loan  3M USD LIBOR+   3.75%   1.00%   4.75%   4/1/2027    1,000,000    990,055    1,000,630 
Apollo Commercial Real Estate Finance, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  1M USD LIBOR+   2.75%   0.00%   2.84%   5/15/2026    2,992,386    2,954,312    2,962,462 
Apollo Commercial Real Estate Finance, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B1 (2/21)  Loan  1M USD LIBOR+   3.50%   0.50%   4.00%   3/6/2028    1,000,000    990,216    997,500 
AppLovin Corporation  High Tech Industries  Term Loan B  Loan  1M USD LIBOR+   3.25%   0.00%   3.34%   8/15/2025    997,449    997,449    995,893 
Aramark Corporation  Services: Consumer  Term Loan  Loan  1M USD LIBOR+   1.75%   0.00%   1.84%   1/15/2027    2,475,000    2,398,873    2,438,915 
Aramark Corporation  Services: Consumer  Term Loan B (4/21)  Loan  1M USD LIBOR+   2.50%   0.00%   2.59%   4/1/2028    2,000,000    1,990,169    1,989,580 
Arctic Glacier U.S.A., Inc.  Beverage, Food & Tobacco  Term Loan (3/18)  Loan  3M USD LIBOR+   3.50%   1.00%   4.50%   3/20/2024    3,350,967    3,338,111    3,200,174 
Aretec Group, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (10/18)  Loan  1M USD LIBOR+   4.25%   0.00%   4.34%   10/1/2025    2,455,000    2,447,156    2,444,763 
ARISTOCRAT LEISURE LIMITED  Hotel, Gaming & Leisure  Term Loan (5/20)  Loan  1M USD LIBOR+   3.75%   1.00%   4.75%   10/19/2024    992,500    976,985    993,741 
ASP MSG Acquisition Co., Inc  Beverage, Food & Tobacco  Term Loan (2/17)  Loan  1M USD LIBOR+   4.00%   1.00%   5.00%   8/16/2023    3,820,663    3,787,713    3,820,663 
Aspen Dental Management, Inc.  Services: Consumer  Term Loan B  Loan  1M USD LIBOR+   2.75%   0.00%   2.84%   4/30/2025    1,945,276    1,939,344    1,922,069 
Asplundh Tree Expert, LLC  Services: Business  Term Loan 2/21  Loan  1M USD LIBOR+   1.75%   0.00%   1.84%   9/7/2027    995,000    990,535    992,353 
Asurion, LLC  Banking, Finance, Insurance & Real Estate  Term Loan B6  Loan  1M USD LIBOR+   3.00%   0.00%   3.09%   11/3/2023    328,929    327,614    328,037 
Asurion, LLC  Banking, Finance, Insurance & Real Estate  Term Loan B8  Loan  1M USD LIBOR+   3.25%   0.00%   3.34%   12/18/2026    3,017,802    3,005,209    3,001,777 
Avast Software S.R.O. (Sybil Finance)  High Tech Industries  Term Loan (Sybil Software)  Loan  3M USD LIBOR+   2.00%   0.00%   2.20%   3/12/2028    2,000,000    1,995,063    1,993,920 
Avaya, Inc.  Telecommunications  Term Loan B1  Loan  1M USD LIBOR+   4.25%   0.00%   4.35%   12/15/2027    1,755,766    1,746,470    1,760,156 
Avaya, Inc.  Telecommunications  Term Loan B-2 (2/21)  Loan  1M USD LIBOR+   4.00%   0.00%   4.10%   12/15/2027    1,000,000    1,000,000    1,001,880 
Avison Young (Canada) Inc  Services: Business  Term Loan  Loan  3M USD LIBOR+   6.00%   0.00%   6.19%   1/31/2026    3,432,330    3,386,981    3,380,845 
Avolon TLB Borrower 1 (US) LLC  Capital Equipment  Term Loan B3  Loan  1M USD LIBOR+   1.75%   0.75%   2.50%   1/15/2025    1,000,000    877,024    996,350 
Avolon TLB Borrower 1 (US) LLC  Capital Equipment  Term Loan B5  Loan  1M USD LIBOR+   2.50%   0.75%   3.25%   12/1/2027    498,750    494,114    499,234 
Azalea TopCo, Inc.  Services: Business  Incremental Term Loan (4/21)  Loan  1M USD LIBOR+   3.75%   0.75%   4.50%   7/24/2026    998,750    991,814    998,331 
B&G Foods, Inc.  Beverage, Food & Tobacco  Term Loan  Loan  1M USD LIBOR+   2.50%   0.00%   2.59%   10/10/2026    706,458    701,043    705,724 
B.C. Unlimited Liability Co (Burger King)  Beverage, Food & Tobacco  Term Loan B4  Loan  1M USD LIBOR+   1.75%   0.00%   1.84%   11/19/2026    1,481,250    1,445,382    1,457,639 
Baldwin Risk Partners, LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD LIBOR+   4.00%   0.75%   4.75%   10/14/2027    995,000    981,284    996,244 
Baldwin Risk Partners, LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  3M USD LIBOR+   3.50%   0.50%   4.00%   10/14/2027    250,000    249,375    250,313 
BALL METALPACK, LLC (PE Spray)  Containers, Packaging & Glass  Term Loan  Loan  3M USD LIBOR+   4.50%   0.00%   4.64%   7/25/2025    3,894,875    3,882,778    3,881,905 
Bass Pro Group, LLC  Retail  Term Loan B (02/21)  Loan  6M USD LIBOR+   4.25%   0.75%   5.00%   3/6/2028    997,500    992,617    1,004,233 

 

 

33

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value   Issuer Name 
Belfor Holdings Inc.  Services: Consumer  Term Loan  Loan   1M USD LIBOR+   4.00%   0.00%   4.09%   4/6/2026    250,000    249,697    250,625 
Belron Finance US LLC  Automotive  Term Loan B (3/21)  Loan   3M USD LIBOR+   2.75%   0.50%   3.25%   4/13/2028    2,000,000    1,980,293    1,993,760 
Blackstone Mortgage Trust, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan   1M USD LIBOR+   2.25%   0.00%   2.34%   4/23/2026    997,468    990,420    987,494 
Blackstone Mortgage Trust, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B-2  Loan   1M USD LIBOR+   4.75%   1.00%   5.75%   4/23/2026    1,491,237    1,480,658    1,491,237 
Blount International, Inc.  Forest Products & Paper  Term Loan B (09/18)  Loan   1M USD LIBOR+   3.75%   1.00%   4.75%   4/12/2023    3,410,063    3,408,500    3,415,757 
Blucora, Inc.  Services: Consumer  Term Loan (11/17)  Loan   3M USD LIBOR+   4.00%   1.00%   5.00%   5/22/2024    2,449,255    2,442,432    2,455,378 
Blue Tree Holdings, Inc.  Chemicals, Plastics, & Rubber  Term Loan (2/21)  Loan   3M USD LIBOR+   2.50%   0.00%   2.65%   3/4/2028    1,000,000    997,582    992,500 
Bombardier Recreational Products, Inc.  Consumer goods: Durable  Term Loan (1/20)  Loan   1M USD LIBOR+   2.00%   0.00%   2.09%   5/24/2027    1,481,300    1,470,721    1,463,613 
Boxer Parent Company, Inc.  High Tech Industries  Term Loan (2/21)  Loan   1M USD LIBOR+   3.75%   0.00%   3.84%   10/2/2025    527,385    527,385    524,442 
Bracket Intermediate Holding Corp  Healthcare & Pharmaceuticals  Term Loan  Loan   3M USD LIBOR+   4.25%   0.00%   4.44%   9/5/2025    975,000    971,950    972,563 
BrightSpring Health Services (Phoenix Guarantor)  Healthcare & Pharmaceuticals  Term Loan B-3  Loan   1M USD LIBOR+   3.50%   0.00%   3.60%   3/5/2026    1,000,000    1,000,000    992,500 
BroadStreet Partners, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B3  Loan   1M USD LIBOR+   3.25%   0.00%   3.34%   1/22/2027    3,001,849    2,995,634    2,972,251 
Brookfield WEC Holdings Inc.  Energy: Electricity  Term Loan (1/21)  Loan   1M USD LIBOR+   2.75%   0.50%   3.25%   8/1/2025    1,488,731    1,491,426    1,478,504 
Buckeye Partners, L.P.  Utilities: Oil & Gas  Term Loan (1/21)  Loan   1M USD LIBOR+   2.25%   0.00%   2.36%   11/1/2026    1,985,012    1,971,201    1,973,321 
BW Gas & Convenience Holdings LLC  Beverage, Food & Tobacco  Term Loan B  Loan   1M USD LIBOR+   3.50%   0.00%   4.00%   3/31/2028    2,500,000    2,475,522    2,503,125 
Cable & Wireless Communications Limited  Telecommunications  Term Loan B-5  Loan   1M USD LIBOR+   2.25%   0.00%   2.34%   1/31/2028    4,000,000    3,985,297    3,941,440 
Callaway Golf Company  Retail  Term Loan B  Loan   1M USD LIBOR+   4.50%   0.00%   4.59%   1/4/2026    688,125    678,077    691,394 
Cardtronics Inc  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   1M USD LIBOR+   4.00%   1.00%   5.00%   6/29/2027    1,491,237    1,485,752    1,490,119 
CareerBuilder, LLC  Services: Business  Term Loan  Loan   3M USD LIBOR+   6.75%   1.00%   7.75%   7/31/2023    5,393,388    5,178,845    5,140,600 
CareStream Health, Inc.  Healthcare & Pharmaceuticals  Term Loan  Loan   6M USD LIBOR+   6.75%   1.00%   7.75%   5/8/2023    2,266,801    2,263,321    2,265,849 
Casa Systems, Inc  Telecommunications  Term Loan  Loan   3M USD LIBOR+   4.00%   1.00%   5.00%   12/20/2023    1,402,375    1,396,875    1,391,857 
Castle US Holding Corporation  Media: Advertising, Printing & Publishing  Term Loan B (USD)  Loan   3M USD LIBOR+   3.75%   0.00%   3.95%   1/27/2027    1,992,689    1,979,966    1,958,135 
CBI BUYER, INC.  Consumer goods: Durable  Term Loan  Loan   1M USD LIBOR+   3.25%   0.50%   3.75%   1/6/2028    1,000,000    997,820    997,500 
CCI Buyer, Inc  Telecommunications  Term Loan  Loan   3M USD LIBOR+   4.00%   0.75%   4.75%   12/17/2027    250,000    247,660    250,313 
CCRR Parent, Inc.  Healthcare & Pharmaceuticals  Term Loan B  Loan   3M USD LIBOR+   4.25%   0.75%   5.00%   3/5/2028    1,000,000    995,059    1,003,750 
CCS-CMGC Holdings, Inc.  Healthcare & Pharmaceuticals  Term Loan  Loan   1M USD LIBOR+   5.50%   0.00%   5.59%   9/25/2025    2,443,750    2,427,421    2,405,872 
Cengage Learning Acquisitions, Inc.  Media: Advertising, Printing & Publishing  Term Loan  Loan   6M USD LIBOR+   4.25%   1.00%   5.25%   6/7/2023    3,922,164    3,896,977    3,917,811 
CenturyLink, Inc.  Telecommunications  Term Loan B (1/20)  Loan   1M USD LIBOR+   2.25%   0.00%   2.34%   3/15/2027    3,959,975    3,953,704    3,921,880 
Chemours Company, (The)  Chemicals, Plastics, & Rubber  Term Loan  Loan   1M USD LIBOR+   1.75%   0.00%   1.84%   4/3/2025    987,277    940,471    972,468 
Churchill Downs Incorporated  Hotel, Gaming & Leisure  Term Loan B1 (3/21)  Loan   1M USD LIBOR+   2.00%   0.00%   2.10%   3/17/2028    500,000    498,779    495,625 
CIMPRESS PUBLIC LIMITED COMPANY  Media: Advertising, Printing & Publishing  USD Term Loan  Loan   1M USD LIBOR+   3.50%   0.50%   4.00%   4/30/2028    1,000,000    990,029    998,130 

 

 

34

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value   Issuer Name 
CITADEL SECURITIES LP  Banking, Finance, Insurance & Real Estate  Term Loan B (01/21)  Loan   1M USD LIBOR+   2.50%   0.00%   2.59%   2/2/2028    5,000,000    4,993,963    4,963,400 
Clarios Global LP  Automotive  Term Loan B1  Loan   1M USD LIBOR+   3.25%   0.00%   3.34%   4/30/2026    1,432,521    1,421,559    1,424,915 
Claros Mortgage Trust, Inc  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan   1M USD LIBOR+   5.00%   1.00%   6.00%   8/9/2026    2,989,886    2,968,157    2,997,361 
CNT Holdings I Corp  Retail  Term Loan  Loan   6M USD LIBOR+   3.75%   0.75%   4.50%   11/8/2027    500,000    497,761    500,625 
Cole Haan  Consumer goods: Non-durable  Term Loan B  Loan   3M USD LIBOR+   5.50%   0.00%   5.64%   2/7/2025    943,750    936,747    898,922 
Columbus McKinnon Corporation  Capital Equipment  Term Loan (4/21)  Loan   1M USD LIBOR+   2.75%   0.50%   3.25%   4/7/2028    500,000    498,750    500,625 
Compass Power Generation, LLC  Utilities: Electric  Term Loan B (08/18)  Loan   1M USD LIBOR+   3.50%   1.00%   4.50%   12/20/2024    1,796,999    1,794,130    1,787,260 
Concordia Healthcare Corp.  Healthcare & Pharmaceuticals  Term Loan  Loan   1W USD LIBOR+   5.50%   1.00%   6.50%   9/6/2024    1,153,300    1,114,883    1,146,092 
Connect Finco SARL  Telecommunications  Term Loan (1/21)  Loan   1M USD LIBOR+   3.50%   1.00%   4.50%   12/11/2026    2,970,000    2,829,372    2,971,485 
Consolidated Communications, Inc.  Telecommunications  Term Loan B  Loan   1M USD LIBOR+   3.50%   0.75%   4.25%   10/2/2027    714,005    704,187    714,133 
CoreCivic, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (12/19)  Loan   1M USD LIBOR+   4.50%   1.00%   5.50%   12/18/2024    3,386,364    3,340,744    3,259,375 
Corelogic, Inc.  Services: Business  Term Loan (4/21)  Loan   3M USD LIBOR+   3.50%   0.50%   4.00%   4/14/2028    2,500,000    2,487,500    2,487,500 
Cortes NP Acquisition Corp (Vertiv)  Capital Equipment  Term Loan 2/21  Loan   1M USD LIBOR+   2.75%   0.00%   2.86%   3/2/2027    1,995,000    1,995,000    1,986,282 
COWEN INC.  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   6M USD LIBOR+   3.25%   0.00%   4.00%   3/12/2028    2,992,500    2,977,753    2,977,538 
Cross Financial Corp  Banking, Finance, Insurance & Real Estate  Term Loan B (3/21)  Loan   1M USD LIBOR+   4.00%   0.75%   4.75%   9/15/2027    500,000    499,401    500,000 
Crown Subsea Communications Holding, Inc.  Construction & Building  Term Loan (4/21)  Loan   1M USD LIBOR+   5.00%   0.75%   5.75%   4/27/2027    2,876,712    2,848,428    2,881,516 
CSC Holdings LLC (Neptune Finco Corp.)  Media: Broadcasting & Subscription  Term Loan B (03/17)  Loan   1M USD LIBOR+   2.25%   0.00%   2.35%   7/15/2025    1,949,239    1,932,192    1,925,361 
CSC Holdings LLC (Neptune Finco Corp.)  Media: Broadcasting & Subscription  Term Loan B  Loan   1M USD LIBOR+   2.25%   0.00%   2.35%   1/15/2026    488,750    487,986    483,007 
CSC Holdings LLC (Neptune Finco Corp.)  Media: Broadcasting & Subscription  Term Loan B-5  Loan   1M USD LIBOR+   2.50%   0.00%   2.60%   4/15/2027    493,750    493,750    490,417 
CTS Midco, LLC  High Tech Industries  Term Loan B  Loan   3M USD LIBOR+   6.00%   1.00%   7.00%   11/2/2027    1,995,000    1,939,439    1,995,000 
Daseke Inc  Transportation: Cargo  Term Loan 2/21  Loan   1M USD LIBOR+   4.00%   0.75%   4.75%   3/5/2028    1,500,000    1,492,658    1,497,495 
DCert Buyer, Inc.  High Tech Industries  Term Loan  Loan   1M USD LIBOR+   4.00%   0.00%   4.09%   10/16/2026    1,496,222    1,496,222    1,496,222 
Dealer Tire, LLC  Automotive  Term Loan B-1  Loan   1M USD LIBOR+   4.25%   0.00%   4.34%   12/12/2025    2,962,500    2,956,828    2,958,797 
Delek US Holdings, Inc.  Utilities: Oil & Gas  Term Loan B  Loan   1M USD LIBOR+   2.25%   0.00%   2.34%   3/31/2025    6,364,352    6,313,748    6,192,514 
Dell International LLC  High Tech Industries  Term Loan B-2  Loan   1M USD LIBOR+   1.75%   0.25%   2.00%   9/19/2025    2,524,048    2,522,032    2,523,594 
Delta 2 (Lux) S.a.r.l.  Hotel, Gaming & Leisure  Term Loan B  Loan   1M USD LIBOR+   2.50%   1.00%   3.50%   2/1/2024    818,289    817,607    812,536 
Diamond Sports Group, LLC  Media: Broadcasting & Subscription  Term Loan  Loan   1M USD LIBOR+   3.25%   0.00%   3.35%   8/24/2026    3,435,126    2,925,919    2,459,344 
Digital Room LLC  Media: Advertising, Printing & Publishing  Term Loan  Loan   6M USD LIBOR+   5.00%   0.00%   5.20%   5/21/2026    2,947,500    2,920,541    2,890,024 
Dispatch Acquisition Holdings, LLC  Environmental Industries  Term Loan B  Loan   3M USD LIBOR+   4.25%   0.75%   5.00%   3/25/2028    500,000    495,153    498,750 
Dole Food Company Inc.  Beverage, Food & Tobacco  Term Loan B  Loan   1M USD LIBOR+   2.75%   1.00%   3.75%   4/6/2024    451,599    450,672    451,098 
DRW Holdings, LLC  Banking, Finance, Insurance & Real Estate  Term Loan (2/21)  Loan   1M USD LIBOR+   3.75%   0.00%   3.84%   2/24/2028    6,500,000    6,450,231    6,467,500 

 

 

35

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value   Issuer Name 
DTZ U.S. Borrower, LLC  Construction & Building  Term Loan  Loan   1M USD LIBOR+   2.75%   0.00%   2.84%   8/21/2025    3,905,600    3,893,098    3,857,483 
EagleTree - Carbride Acquisition (Corsair Components)  Consumer goods: Durable  Term Loan  Loan   1M USD LIBOR+   3.75%   1.00%   4.75%   8/28/2024    2,622,418    2,622,540    2,625,696 
Edelman Financial Group Inc., The  Banking, Finance, Insurance & Real Estate  Term Loan B (3/21)  Loan   1M USD LIBOR+   3.75%   0.75%   4.50%   4/7/2028    2,221,875    2,213,226    2,223,275 
Electrical Components Inter., Inc.  Capital Equipment  Term Loan (6/18)  Loan   2M USD LIBOR+   4.25%   0.00%   4.37%   6/26/2025    1,918,921    1,918,167    1,884,534 
ELO Touch Solutions, Inc.  Media: Diversified & Production  Term Loan (12/18)  Loan   1M USD LIBOR+   6.50%   0.00%   6.59%   12/14/2025    2,466,935    2,374,020    2,466,935 
Encapsys, LLC (Cypress Performance Group)  Chemicals, Plastics, & Rubber  Term Loan B2  Loan   1M USD LIBOR+   3.25%   1.00%   4.25%   11/7/2024    490,998    487,627    490,384 
Endo Luxembourg Finance Company I S.a.r.l.  Healthcare & Pharmaceuticals  Term Loan (3/21)  Loan   1M USD LIBOR+   5.00%   0.75%   5.75%   3/27/2028    2,364,846    2,355,240    2,306,056 
Endure Digital, Inc.  High Tech Industries  Term Loan B  Loan   6M USD LIBOR+   3.50%   0.75%   4.25%   2/10/2028    2,500,000    2,488,102    2,481,775 
Ensemble RCM LLC  Services: Business  Term Loan  Loan   3M USD LIBOR+   3.75%   0.00%   3.94%   8/3/2026    2,992,405    2,985,523    2,995,397 
Enterprise Merger Sub Inc.  Healthcare & Pharmaceuticals  Term Loan B (06/18)  Loan   1M USD LIBOR+   3.75%   0.00%   3.84%   10/10/2025    4,887,500    4,880,760    4,162,000 
EVERI Payments Inc.  Hotel, Gaming & Leisure  Term Loan B  Loan   1M USD LIBOR+   2.75%   0.75%   3.50%   5/9/2024    3,000,000    3,000,000    2,983,140 
EyeCare Partners, LLC  Healthcare & Pharmaceuticals  Term Loan  Loan   1M USD LIBOR+   3.75%   0.00%   3.84%   2/18/2027    1,982,868    1,981,856    1,963,535 
Finco I LLC  Banking, Finance, Insurance & Real Estate  Term Loan B (9/20)  Loan   1M USD LIBOR+   2.50%   0.00%   2.59%   6/27/2025    2,815,198    2,810,264    2,808,751 
First Brands Group, LLC  Automotive  1st Lien Term Loan (3/21)  Loan   3M USD LIBOR+   5.00%   1.00%   6.00%   3/30/2027    9,000,000    8,879,410    9,039,420 
First Eagle Investment Management  Banking, Finance, Insurance & Real Estate  Refinancing Term Loan  Loan   3M USD LIBOR+   2.50%   0.00%   2.70%   2/1/2027    5,241,509    5,223,448    5,184,167 
Fitness International, LLC (LA Fitness)  Services: Consumer  Term Loan B (4/18)  Loan   1M USD LIBOR+   3.25%   1.00%   4.25%   4/18/2025    1,330,058    1,324,600    1,259,951 
FOCUS FINANCIAL PARTNERS, LLC  Banking, Finance, Insurance & Real Estate  Term Loan (1/20)  Loan   1M USD LIBOR+   2.00%   0.00%   2.09%   7/3/2024    498,718    498,194    493,626 
Franchise Group, Inc.  Services: Consumer  First Out Term Loan  Loan   3M USD LIBOR+   4.75%   0.75%   5.50%   3/10/2026    1,000,000    990,447    1,000,000 
Franklin Square Holdings, L.P.  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   1M USD LIBOR+   2.25%   0.00%   2.38%   8/1/2025    4,387,491    4,364,611    4,343,616 
Froneri International (R&R Ice Cream)  Beverage, Food & Tobacco  Term Loan B-2  Loan   1M USD LIBOR+   2.25%   0.00%   2.34%   1/29/2027    1,985,000    1,981,071    1,956,972 
Fusion Telecommunications International Inc.  Telecommunications  Take Back 2nd Out Term Loan  Loan   6M USD LIBOR+   1.00%   2.00%   3.00%   7/14/2025    827,334    811,091    442,624 
Garrett LX III S.a r.l.  Automotive  Dollar Term Loan  Loan   3M USD LIBOR+   3.25%   0.50%   3.75%   4/28/2028    1,500,000    1,492,558    1,494,375 
Gemini HDPE LLC  Chemicals, Plastics, & Rubber  Term Loan B (12/20)  Loan   3M USD LIBOR+   3.00%   0.50%   3.50%   12/31/2027    2,467,432    2,448,531    2,463,311 
General Nutrition Centers, Inc.  Retail  Second Lien Term Loan  Loan   3M USD LIBOR+   6.00%   0.00%   6.20%   10/7/2026    362,697    362,697    327,033 
Genesee & Wyoming, Inc.  Transportation: Cargo  Term Loan (11/19)  Loan   3M USD LIBOR+   2.00%   0.00%   2.20%   12/30/2026    1,485,000    1,479,107    1,478,080 
GEO Group, Inc., The  Banking, Finance, Insurance & Real Estate  Term Loan Refinance  Loan   1M USD LIBOR+   2.00%   0.75%   2.75%   3/22/2024    3,953,674    3,679,283    3,339,946 
GGP Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan   1M USD LIBOR+   2.50%   0.00%   2.59%   8/27/2025    3,959,389    3,232,212    3,820,811 
GI Chill Acquisition LLC  Services: Business  Term Loan  Loan   3M USD LIBOR+   4.00%   0.00%   4.20%   8/1/2025    3,937,500    3,915,210    3,907,969 
Gigamon Inc.  Services: Business  Term Loan B  Loan   3M USD LIBOR+   3.75%   0.75%   4.50%   12/27/2024    2,923,000    2,906,780    2,915,693 

 

 

36

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value   Issuer Name 
Global Business Travel (GBT) III Inc.  Hotel, Gaming & Leisure  Term Loan  Loan   1M USD LIBOR+   2.50%   0.00%   2.59%   8/13/2025    4,387,500    4,386,754    4,213,843 
Global Tel*Link Corporation  Telecommunications  Term Loan B  Loan   1M USD LIBOR+   4.25%   0.00%   4.34%   11/29/2025    4,938,649    4,716,522    4,517,481 
Go Daddy Operating Company, LLC  High Tech Industries  Term Loan 2/21  Loan   1M USD LIBOR+   2.00%   0.00%   2.09%   8/10/2027    1,994,975    1,994,975    1,985,319 
Go Wireless Holdings, Inc.  Telecommunications  Term Loan  Loan   1M USD LIBOR+   6.50%   1.00%   7.50%   12/22/2024    2,980,195    2,950,622    2,970,271 
Goodyear Tire & Rubber Company, The  Chemicals, Plastics, & Rubber  Second Lien Term Loan  Loan   1M USD LIBOR+   2.00%   -    2.12%   3/3/2025    3,000,000    2,937,621    2,949,990 
Graham Packaging Co Inc  Containers, Packaging & Glass  Term Loan (2/21)  Loan   1M USD LIBOR+   3.00%   0.75%   3.75%   8/7/2027    979,661    973,157    978,995 
Greenhill & Co., Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan   1M USD LIBOR+   3.25%   0.00%   3.34%   4/12/2024    3,210,385    3,187,540    3,202,359 
Grosvenor Capital Management Holdings, LLLP  Banking, Finance, Insurance & Real Estate  Amendment 5 Term Loan  Loan   1M USD LIBOR+   2.50%   0.50%   3.00%   2/24/2028    3,899,991    3,894,681    3,886,575 
Guidehouse LLP (fka PricewaterhouseCoopers)  Aerospace & Defense  Term Loan  Loan   1M USD LIBOR+   4.00%   0.00%   4.09%   5/1/2025    4,924,683    4,905,261    4,922,910 
Harbor Freight Tools USA, Inc.  Retail  Term Loan B (10/20)  Loan   1M USD LIBOR+   3.00%   0.75%   3.75%   10/20/2027    2,985,000    2,960,963    2,989,358 
Harland Clarke Holdings Corp.  Media: Advertising, Printing & Publishing  Term Loan  Loan   3M USD LIBOR+   4.75%   1.00%   5.75%   11/3/2023    1,585,355    1,581,292    1,402,596 
Helix Gen Funding, LLc  Energy: Electricity  Term Loan B (02/17)  Loan   1M USD LIBOR+   3.75%   1.00%   4.75%   6/3/2024    238,657    238,480    230,354 
Hillman Group Inc. (The) (New)  Consumer goods: Durable  Term Loan B-1  Loan   6M USD LIBOR+   2.75%   0.50%   3.25%   2/23/2028    4,156,118    4,145,728    4,148,346 
Hillman Group Inc. (The) (New)(a)  Consumer goods: Durable  Delayed Draw Term Loan (2/21)  Loan   6M USD LIBOR+   2.75%   0.50%   3.25%   2/24/2028    -    (2,110)   (1,578)
HLF Financing SARL (Herbalife)  Consumer goods: Non-durable  Term Loan B (08/18)  Loan   1M USD LIBOR+   2.50%   0.00%   2.59%   8/18/2025    3,900,000    3,888,684    3,875,625 
Holley Purchaser, Inc  Automotive  Term Loan B  Loan   3M USD LIBOR+   5.00%   0.00%   5.19%   10/24/2025    2,443,750    2,427,780    2,435,612 
Howden Group Holdings  Banking, Finance, Insurance & Real Estate  Term Loan (1/21)  Loan   1M USD LIBOR+   3.25%   0.75%   4.00%   11/12/2027    1,688,104    1,682,245    1,686,230 
Hudson River Trading LLC  Banking, Finance, Insurance & Real Estate  Term Loan (3/21)  Loan   1M USD LIBOR+   3.00%   0.00%   3.09%   3/17/2028    6,000,000    5,941,399    5,958,000 
Idera, Inc.  High Tech Industries  Term Loan (02/21)  Loan   6M USD LIBOR+   3.75%   0.75%   4.50%   3/2/2028    4,896,805    4,884,403    4,871,293 
INEOS US PETROCHEM LLC  Chemicals, Plastics, & Rubber  Term Loan (1/21)  Loan   3M USD LIBOR+   2.75%   0.50%   3.25%   1/29/2026    1,000,000    995,462    995,420 
INFINITE BIDCO LLC  Wholesale  Term Loan  Loan   1M USD LIBOR+   3.75%   0.50%   4.25%   3/2/2028    1,500,000    1,496,283    1,492,500 
Ingram Micro Inc.  High Tech Industries  Term Loan B  Loan   3M USD LIBOR+   3.50%   0.50%   4.00%   3/31/2028    1,500,000    1,485,000    1,500,630 
Inmar Acquisition Sub, Inc.  Services: Business  Term Loan B  Loan   3M USD LIBOR+   4.00%   1.00%   5.00%   5/1/2024    3,412,722    3,356,456    3,399,924 
Innophos, Inc.  Chemicals, Plastics, & Rubber  Term Loan B  Loan   1M USD LIBOR+   3.50%   0.00%   3.59%   2/4/2027    495,000    492,965    492,936 
INSTANT BRANDS HOLDINGS INC.  Consumer goods: Durable  Term Loan 4/21  Loan   3M USD LIBOR+   5.00%   0.75%   5.75%   4/7/2028    2,500,000    2,475,429    2,481,250 
Intermediate Dutch Holdings  Services: Business  Term Loan B  Loan   1M USD LIBOR+   4.00%   0.00%   4.11%   3/6/2028    1,250,000    1,249,974    1,253,438 
Isagenix International, LLC  Beverage, Food & Tobacco  Term Loan  Loan   3M USD LIBOR+   5.75%   1.00%   6.75%   6/14/2025    2,573,824    2,540,638    2,060,681 
Ivory Merger Sub, Inc.  Healthcare & Pharmaceuticals  Term Loan  Loan   1M USD LIBOR+   3.50%   0.00%   3.61%   3/14/2025    2,957,262    2,935,237    2,879,634 
J Jill Group, Inc  Retail  Priming Term Loan  Loan   3M USD LIBOR+   5.00%   1.00%   6.00%   5/8/2024    1,773,779    1,772,060    1,259,383 
Jane Street Group  Banking, Finance, Insurance & Real Estate  Term Loan (1/21)  Loan   1M USD LIBOR+   2.75%   0.00%   2.84%   1/31/2028    3,990,000    3,983,483    3,960,793 
Jefferies Finance LLC / JFIN Co-Issuer Corp  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   1M USD LIBOR+   3.00%   0.00%   3.13%   6/3/2026    3,785,681    3,771,444    3,765,579 

 

 

37

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value   Issuer Name 
Journey Personal Care Corp.  Consumer goods: Non-durable  Term Loan B  Loan   3M USD LIBOR+   4.25%   0.75%   5.00%   3/1/2028    1,000,000    995,057    1,002,500 
JP Intermediate B, LLC  Consumer goods: Non-durable  Term Loan  Loan   3M USD LIBOR+   5.50%   1.00%   6.50%   11/15/2025    4,356,412    4,321,901    4,149,483 
KAR Auction Services, Inc.  Automotive  Term Loan B (09/19)  Loan   1M USD LIBOR+   2.25%   0.00%   2.38%   9/19/2026    246,250    245,803    240,709 
Kindred Healthcare, Inc.  Healthcare & Pharmaceuticals  Term Loan (6/18)  Loan   1M USD LIBOR+   4.50%   0.00%   4.63%   7/2/2025    1,979,747    1,964,017    1,974,797 
Klockner-Pentaplast of America, Inc.  Containers, Packaging & Glass  Term Loan (1/21) (USD)  Loan   3M USD LIBOR+   4.75%   0.50%   5.25%   2/12/2026    1,500,000    1,492,500    1,495,620 
Kodiak BP, LLC  Construction & Building  Term Loan  Loan   3M USD LIBOR+   3.25%   0.75%   4.00%   3/13/2028    500,000    497,544    498,540 
KREF Holdings X LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   3M USD LIBOR+   4.75%   1.00%   5.75%   9/1/2027    498,750    487,470    501,244 
Lakeland Tours, LLC  Hotel, Gaming & Leisure  Priority Exit PIK Term Loan (9/20)  Loan   3M USD LIBOR+   6.00%   1.25%   7.25%   9/25/2023    310,482    296,563    310,560 
Lakeland Tours, LLC  Hotel, Gaming & Leisure  2nd Out Take Back PIK Term Loan  Loan   3M USD LIBOR+   1.50%   1.25%   2.75%   9/25/2025    593,161    490,262    556,089 
Lakeland Tours, LLC  Hotel, Gaming & Leisure  Third Out PIK Term Loan  Loan   3M USD LIBOR+   1.50%   1.25%   2.75%   9/25/2025    787,437    472,454    653,572 
Lakeland Tours, LLC  Hotel, Gaming & Leisure  Holdco Fixed Term Loan  Loan   Fixed   0.00%   0.00%   13.25%   9/27/2027    814,236    168,153    419,331 
Lealand Finance Company B.V.  Energy: Oil & Gas  Exit Term Loan  Loan   1M USD LIBOR+   1.00%   0.00%   1.09%   6/30/2025    327,151    327,151    142,965 
Learfield Communications, Inc  Media: Advertising, Printing & Publishing  Initial Term Loan (A-L Parent)  Loan   1M USD LIBOR+   3.25%   1.00%   4.25%   12/1/2023    478,750    477,864    444,979 
LIAISON ACQUISITION, LLC  High Tech Industries  Term Loan (3/21)  Loan   6M USD LIBOR+   3.75%   0.75%   4.50%   3/4/2028    997,500    995,060    997,500 
Lifetime Brands, Inc  Consumer goods: Non-durable  Term Loan B  Loan   1M USD LIBOR+   3.50%   1.00%   4.50%   2/28/2025    2,694,077    2,668,083    2,673,871 
Liftoff Mobile, Inc.  Media: Advertising, Printing & Publishing  Term Loan  Loan   3M USD LIBOR+   3.50%   0.75%   4.25%   3/16/2028    997,500    992,653    995,006 
Lightstone Generation LLC  Energy: Electricity  Term Loan B  Loan   3M USD LIBOR+   3.75%   1.00%   4.75%   1/30/2024    1,322,520    1,321,304    1,051,020 
Lightstone Generation LLC  Energy: Electricity  Term Loan C  Loan   3M USD LIBOR+   3.75%   1.00%   4.75%   1/30/2024    74,592    74,526    59,279 
Lindblad Expeditions, Inc.  Hotel, Gaming & Leisure  US 2018 Term Loan  Loan   1M USD LIBOR+   4.00%   0.75%   4.75%   3/21/2025    393,005    392,519    368,442 
Lindblad Expeditions, Inc.  Hotel, Gaming & Leisure  Cayman Term Loan  Loan   1M USD LIBOR+   4.00%   0.75%   4.75%   3/21/2025    98,251    98,130    92,110 
Liquid Tech Solutions Holdings, LLC  Services: Business  Term Loan  Loan   6M USD LIBOR+   4.75%   0.00%   5.50%   3/17/2028    1,000,000    995,165    995,000 
LogMeIn, Inc.  High Tech Industries  Term Loan (8/20)  Loan   1M USD LIBOR+   4.75%   0.00%   4.85%   8/31/2027    3,990,000    3,920,399    3,989,362 
LPL Holdings, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B1  Loan   1M USD LIBOR+   1.75%   0.00%   1.84%   11/11/2026    1,229,647    1,227,310    1,220,806 
MA FinanceCo LLC  High Tech Industries  Term Loan B4  Loan   3M USD LIBOR+   4.25%   1.00%   5.25%   6/5/2025    2,459,296    2,451,618    2,477,741 
MAGNITE, INC.  Services: Business  Term Loan  Loan   3M USD LIBOR+   5.00%   0.75%   5.75%   4/1/2028    2,000,000    1,940,468    1,985,000 
Marriott Ownership Resorts, Inc.  Hotel, Gaming & Leisure  Term Loan (11/19)  Loan   1M USD LIBOR+   1.75%   0.00%   1.84%   8/29/2025    1,317,074    1,317,074    1,295,671 
Match Group, Inc, The  Services: Consumer  Term Loan (1/20)  Loan   3M USD LIBOR+   1.75%   0.00%   1.91%   2/15/2027    250,000    249,518    247,500 
Mayfield Agency Borrower Inc. (FeeCo)  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   1M USD LIBOR+   4.50%   0.00%   4.59%   2/28/2025    3,418,429    3,390,515    3,378,912 
McAfee, LLC  Services: Business  Term Loan B  Loan   1M USD LIBOR+   3.75%   0.00%   3.84%   9/30/2024    1,922,926    1,916,721    1,923,407 
Meredith Corporation  Media: Advertising, Printing & Publishing  Term Loan B2  Loan   1M USD LIBOR+   2.50%   0.00%   2.59%   1/31/2025    578,738    578,006    576,278 
Mermaid Bidco Inc.  High Tech Industries  Term Loan 12/20  Loan   3M USD LIBOR+   4.25%   0.75%   5.00%   12/22/2027    498,750    496,516    497,503 

 

 

38

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value   Issuer Name 
Messer Industries, LLC  Chemicals, Plastics, & Rubber  Term Loan B  Loan   3M USD LIBOR+   2.50%   0.00%   2.70%   3/1/2026    3,844,694    3,824,827    3,812,014 
Michaels Companies Inc  Retail  Term Loan B (Magic Mergeco)  Loan   3M USD LIBOR+   4.25%   0.75%   5.00%   4/8/2028    1,500,000    1,485,239    1,502,970 
Mitchell International, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (7/20)  Loan   1M USD LIBOR+   4.25%   0.50%   4.75%   11/29/2024    995,000    945,375    997,667 
MKS Instruments, Inc.  High Tech Industries  Term Loan B6  Loan   1M USD LIBOR+   1.75%   0.00%   1.84%   2/2/2026    875,615    869,473    872,113 
MLN US Holdco LLC  Telecommunications  Term Loan  Loan   1M USD LIBOR+   4.50%   0.00%   4.61%   12/1/2025    977,500    976,320    864,648 
MMM Holdings, Inc.  Healthcare & Pharmaceuticals  Term Loan B  Loan   1M USD LIBOR+   5.75%   1.00%   6.75%   12/24/2026    6,635,552    6,525,213    6,639,732 
MRC Global Inc.  Metals & Mining  Term Loan B2  Loan   1M USD LIBOR+   3.00%   0.00%   3.09%   9/20/2024    351,484    351,032    348,556 
MW Industries, Inc. (Helix Acquisition Holdings)  Capital Equipment  Term Loan (2019 Incremental)  Loan   3M USD LIBOR+   3.75%   0.00%   3.95%   9/30/2024    2,842,097    2,805,201    2,766,299 
Natgasoline LLC  Chemicals, Plastics, & Rubber  Term Loan  Loan   1M USD LIBOR+   3.50%   0.00%   3.63%   11/14/2025    1,483,661    1,455,310    1,457,697 
National Mentor Holdings, Inc.  Healthcare & Pharmaceuticals  Term Loan 2/21  Loan   3M USD LIBOR+   3.75%   0.75%   4.50%   3/2/2028    2,783,615    2,770,882    2,785,369 
National Mentor Holdings, Inc.  Healthcare & Pharmaceuticals  Term Loan C 2/21  Loan   3M USD LIBOR+   3.75%   0.75%   4.50%   3/2/2028    87,464    87,043    87,519 
National Mentor Holdings, Inc.(a)  Healthcare & Pharmaceuticals  Delayed Draw Term Loan 2/21  Loan   3M USD LIBOR+   3.75%   0.75%   4.50%   3/2/2028    -    -    81 
Neenah, Inc.  Forest Products & Paper  Term Loan B (03/21)  Loan   2M USD LIBOR+   3.00%   0.50%   3.50%   4/6/2028    2,000,000    1,990,101    2,000,000 
NeuStar, Inc.  Telecommunications  Term Loan B4 (03/18)  Loan   3M USD LIBOR+   3.50%   1.00%   4.50%   8/8/2024    2,641,566    2,613,561    2,553,734 
NeuStar, Inc.  Telecommunications  Term Loan B-5  Loan   3M USD LIBOR+   4.50%   1.00%   5.50%   8/8/2024    885,162    874,100    854,624 
Nexstar Broadcasting, Inc. (Mission Broadcasting)  Media: Broadcasting & Subscription  Term Loan  Loan   1M USD LIBOR+   2.50%   0.00%   2.61%   9/18/2026    1,113,795    1,101,650    1,109,930 
Next Level Apparel, Inc.  Retail  Term Loan  Loan   3M PL WIBOR+   6.00%   1.00%   7.00%   8/9/2024    1,762,840    1,752,237    1,621,813 
NM Z Parent Inc (Zep Inc)  Chemicals, Plastics, & Rubber  Term Loan  Loan   6M USD LIBOR+   4.00%   1.00%   5.00%   8/9/2024    2,412,500    2,406,434    2,374,503 
NorthPole Newco S.a.r.l  Aerospace & Defense  Term Loan  Loan   3M USD LIBOR+   7.00%   0.00%   7.20%   3/3/2025    5,239,726    4,845,245    4,506,164 
Novetta Solutions, LLC  Aerospace & Defense  Term Loan  Loan   1M USD LIBOR+   5.00%   1.00%   6.00%   10/16/2022    1,894,870    1,890,672    1,886,589 
Novetta Solutions, LLC  Aerospace & Defense  Second Lien Term Loan  Loan   1M USD LIBOR+   8.50%   1.00%   9.50%   10/16/2023    823,529    820,462    821,471 
Novolex Holdings, Inc (Flex Acquisition)  Containers, Packaging & Glass  Term Loan (02/21)  Loan   3M USD LIBOR+   3.50%   0.50%   4.00%   3/2/2028    1,000,000    995,145    994,110 
NPC International, Inc.(b)  Beverage, Food & Tobacco  Term Loan  Loan   Prime+   4.50%   1.00%   7.75%   4/19/2024    69,157    69,104    2,075 
Nuvei Technologies Corp.  High Tech Industries  US Term Loan  Loan   1M USD LIBOR+   4.00%   0.75%   4.75%   9/29/2025    250,000    249,767    250,000 
Organon & Co.  Healthcare & Pharmaceuticals  Term Loan USD  Loan   3M USD LIBOR+   3.00%   0.50%   3.50%   4/7/2028    2,500,000    2,487,500    2,496,425 
Pacific Gas and Electric Company  Utilities: Electric  Term Loan  Loan   3M USD LIBOR+   3.00%   0.50%   3.50%   6/18/2025    1,491,237    1,484,160    1,478,189 
PAE Holding Corp  Aerospace & Defense  Term Loan B (10/20)  Loan   1M USD LIBOR+   4.50%   0.75%   5.25%   10/14/2027    1,995,000    1,967,492    1,995,000 
Panther Guarantor II, L.P. (Forcepoint)  High Tech Industries  Term Loan 1/21  Loan   3M USD LIBOR+   4.50%   0.50%   5.00%   1/7/2028    500,000    496,497    500,000 
Pathway Partners Vet Management Company LLC  Services: Business  Term Loan  Loan   1M USD LIBOR+   3.75%   0.00%   3.84%   3/30/2027    495,196    485,099    492,720 
PaySafe Group PLC  Services: Business  Term Loan B1 (PI UK Holdco II)  Loan   1M USD LIBOR+   3.00%   1.00%   4.00%   1/3/2025    1,052,873    1,049,412    1,053,010 
PCI Gaming Authority  Hotel, Gaming & Leisure  Term Loan  Loan   1M USD LIBOR+   2.50%   0.00%   2.59%   5/29/2026    855,192    851,939    850,814 
Penn National Gaming  Hotel, Gaming & Leisure  Term Loan B-1  Loan   1M USD LIBOR+   2.25%   0.75%   3.00%   10/15/2025    1,777,903    1,720,767    1,774,134 

 

 

39

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value   Issuer Name 
Peraton Corp.  Aerospace & Defense  Term Loan B  Loan   1M USD LIBOR+   3.75%   0.75%   4.50%   2/1/2028    5,000,000    4,975,338    5,004,850 
PGX Holdings, Inc.  Services: Consumer  Term Loan  Loan   12M USD LIBOR+   5.25%   1.00%   6.25%   9/29/2023    3,075,640    3,057,381    2,919,305 
Pitney Bowes Inc  Services: Business  Term Loan B  Loan   1M USD LIBOR+   4.00%   0.00%   4.10%   3/17/2028    3,000,000    2,981,661    3,001,255 
Pixelle Specialty Solutions LLC  Forest Products & Paper  Term Loan  Loan   1M USD LIBOR+   6.50%   1.00%   7.50%   10/31/2024    3,535,026    3,512,371    3,521,028 
Plastipak Holdings Inc.  Containers, Packaging & Glass  Term Loan B (04/18)  Loan   1M USD LIBOR+   2.50%   0.00%   2.60%   10/14/2024    2,789,599    2,773,113    2,784,132 
Playtika Holding Corp.  High Tech Industries  Term Loan B (3/21)  Loan   1M USD LIBOR+   2.75%   0.00%   2.84%   3/13/2028    4,500,000    4,490,104    4,480,560 
PointClickCare Technologies, Inc.  High Tech Industries  Term Loan B  Loan   6M USD LIBOR+   3.00%   0.75%   3.75%   12/29/2027    500,000    497,710    499,065 
Polymer Process Holdings, Inc.  Containers, Packaging & Glass  Term Loan  Loan   1M USD LIBOR+   4.75%   0.75%   5.50%   2/12/2028    5,500,000    5,427,787    5,493,125 
PPD, Inc.  Healthcare & Pharmaceuticals  Term Loan (12/20)  Loan   1M USD LIBOR+   2.25%   0.50%   2.75%   1/13/2028    500,000    497,667    498,930 
Pre-Paid Legal Services, Inc.  Services: Consumer  Incremental Term Loan  Loan   1M USD LIBOR+   4.00%   0.75%   4.75%   5/1/2025    995,000    982,061    994,383 
Presidio, Inc.  Services: Business  Term Loan B (1/20)  Loan   1M USD LIBOR+   3.50%   0.00%   3.60%   1/22/2027    496,250    495,369    493,977 
Prime Security Services Borrower, LLC (ADT)  Services: Consumer  Term Loan (1/21)  Loan   12M USD LIBOR+   2.75%   0.75%   3.50%   9/23/2026    3,583,174    3,571,738    3,580,952 
PRIORITY HOLDINGS, LLC  Services: Consumer  Term Loan  Loan   3M USD LIBOR+   5.75%   1.00%   6.75%   4/27/2027    4,525,424    4,435,373    4,440,570 
PRIORITY HOLDINGS, LLC(a)  Services: Consumer  Delayed Draw Term Loan  Loan   3M USD LIBOR+   5.75%   1.00%   6.75%   4/21/2027    -    -    (27,648)
PriSo Acquisition Corporation  Construction & Building  Term Loan (01/21)  Loan   3M USD LIBOR+   3.25%   0.75%   4.00%   12/28/2027    500,000    497,590    496,640 
Project Leopard Holdings Inc  High Tech Industries  Term Loan  Loan   6M USD LIBOR+   4.75%   1.00%   5.75%   7/5/2024    498,750    497,503    499,284 
Prometric Inc. (Sarbacane Bidco)  Services: Consumer  Term Loan  Loan   1M USD LIBOR+   3.00%   1.00%   4.00%   1/29/2025    485,100    483,799    477,217 
PUG LLC  Services: Consumer  Term Loan B (02/20)  Loan   1M USD LIBOR+   3.50%   0.00%   3.59%   2/12/2027    488,788    486,755    475,957 
Rackspace Technology Global, Inc.  High Tech Industries  Term Loan (1/21)  Loan   3M USD LIBOR+   2.75%   0.75%   3.50%   2/15/2028    500,000    497,684    497,550 
Radiology Partners Holdings, LLC  Healthcare & Pharmaceuticals  Term Loan  Loan   1M USD LIBOR+   4.25%   0.00%   4.35%   7/4/2025    1,432,727    1,427,844    1,431,452 
RealPage, Inc.  High Tech Industries  Term Loan (04/21)  Loan   1M USD LIBOR+   3.25%   0.50%   3.75%   4/24/2028    1,000,000    997,719    998,500 
Renaissance Learning, Inc.  Services: Consumer  Term Loan (5/18)  Loan   1M USD LIBOR+   3.25%   0.00%   3.34%   5/30/2025    2,982,444    2,954,678    2,951,009 
Rent-A-Center, Inc.  Retail  Term Loan B (01/21)  Loan   1M USD LIBOR+   4.00%   0.75%   4.75%   2/17/2028    500,000    497,671    502,710 
REP WWEX (Worldwide Express) Aquisition Parent, LLC  Transportation: Consumer  Term Loan B  Loan   6M USD LIBOR+   4.00%   1.00%   5.00%   2/2/2024    1,922,830    1,921,852    1,913,812 
Research Now Group, Inc  Media: Advertising, Printing & Publishing  Term Loan  Loan   6M USD LIBOR+   5.50%   1.00%   6.50%   12/20/2024    3,877,311    3,791,756    3,835,630 
Resideo Funding Inc.  Services: Consumer  Term Loan (1/21)  Loan   1M USD LIBOR+   2.25%   0.50%   2.75%   2/11/2028    1,500,000    1,496,263    1,498,125 
Resolute Investment Managers (American Beacon), Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (10/20)  Loan   3M USD LIBOR+   3.75%   1.00%   4.75%   4/30/2024    2,644,078    2,644,078    2,647,383 
Rexnord LLC  Capital Equipment  Term Loan (11/19)  Loan   1M USD LIBOR+   1.75%   0.00%   1.84%   8/21/2024    862,069    862,069    860,681 
Reynolds Consumer Products LLC  Containers, Packaging & Glass  Term Loan  Loan   1M USD LIBOR+   1.75%   0.00%   1.84%   1/29/2027    1,303,182    1,301,941    1,296,666 
Reynolds Group Holdings Inc.  Metals & Mining  Term Loan B2  Loan   1M USD LIBOR+   3.25%   0.00%   3.34%   2/5/2026    3,491,250    3,472,633    3,460,073 
Robertshaw US Holding Corp.  Consumer goods: Durable  Term Loan B  Loan   1M USD LIBOR+   3.50%   1.00%   4.50%   2/28/2025    970,000    968,628    931,811 
Rocket Software, Inc.  High Tech Industries  Term Loan (11/18)  Loan   1M USD LIBOR+   4.25%   0.00%   4.34%   11/28/2025    2,927,595    2,918,755    2,869,951 

 

 

40

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value   Issuer Name 
RP Crown Parent, LLC  High Tech Industries  Term Loan B (07/20)  Loan   1M USD LIBOR+   3.00%   1.00%   4.00%   1/31/2026    1,985,000    1,976,585    1,980,038 
Russell Investments US Inst'l Holdco, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (10/20)  Loan   6M USD LIBOR+   3.50%   1.00%   4.50%   6/2/2025    5,637,965    5,593,655    5,590,381 
RV Retailer LLC  Automotive  Term Loan  Loan   3M USD LIBOR+   4.00%   0.75%   4.75%   2/8/2028    2,000,000    1,981,119    2,002,500 
Ryan Specialty Group LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   1M USD LIBOR+   3.00%   0.75%   3.75%   9/1/2027    497,500    490,812    497,192 
S&S HOLDINGS LLC  Services: Business  Term Loan  Loan   3M USD LIBOR+   5.00%   0.50%   5.50%   3/10/2028    2,000,000    1,941,161    1,960,000 
Sally Holdings LLC  Retail  Term Loan B  Loan   1M USD LIBOR+   2.25%   0.00%   2.35%   7/5/2024    768,409    766,408    767,449 
Samsonite International S.A.  Consumer goods: Non-durable  Term Loan B2  Loan   1M USD LIBOR+   4.50%   1.00%   5.50%   4/25/2025    992,500    968,147    997,463 
Savage Enterprises, LLC  Energy: Oil & Gas  Term Loan B (02/20)  Loan   1M USD LIBOR+   3.00%   0.00%   3.10%   8/1/2025    1,769,504    1,755,546    1,769,186 
Schweitzer-Mauduit International, Inc.  High Tech Industries  Term Loan B  Loan   1M USD LIBOR+   3.75%   0.75%   4.50%   2/9/2028    3,000,000    2,982,752    2,962,500 
Shutterfly Inc  Media: Advertising, Printing & Publishing  Term Loan B  Loan   3M USD LIBOR+   6.00%   1.00%   7.00%   9/25/2026    800,968    768,718    803,539 
Sirius Computer Solutions, Inc.  High Tech Industries  Term Loan 1/20  Loan   1M USD LIBOR+   3.50%   0.00%   3.59%   7/1/2026    1,965,125    1,961,756    1,957,756 
SiteOne Landscape Supply, LLC  Services: Business  Term Loan (3/21)  Loan   3M USD LIBOR+   2.00%   0.50%   2.50%   3/18/2028    1,000,000    997,527    998,125 
SMG US Midco 2, Inc.  Services: Business  Term Loan (01/20)  Loan   1M USD LIBOR+   2.50%   0.00%   2.59%   1/23/2025    493,750    493,750    477,397 
Sotheby's  Services: Business  Term Loan (1/21)  Loan   3M USD LIBOR+   4.75%   0.75%   5.50%   1/15/2027    3,281,059    3,225,334    3,300,188 
Sparta U.S. HoldCo LLC  Chemicals, Plastics, & Rubber  Term Loan (04/21)  Loan   3M USD LIBOR+   3.50%   0.75%   4.25%   4/29/2028    2,000,000    1,990,000    2,001,260 
Specialty Pharma III Inc.  Services: Business  Term Loan  Loan   1M USD LIBOR+   4.50%   0.75%   5.25%   2/24/2028    2,000,000    1,980,475    1,980,000 
Spectrum Brands, Inc.  Consumer goods: Durable  Term Loan (2/21)  Loan   3M USD LIBOR+   2.00%   0.50%   2.50%   3/3/2028    500,000    498,801    496,875 
Spin Holdco, Inc.  Services: Consumer  Term Loan 3/21  Loan   3M USD LIBOR+   4.00%   0.75%   4.75%   3/4/2028    3,000,000    2,982,790    2,994,390 
SRAM, LLC  Consumer goods: Durable  Term Loan (05/21)  Loan   1M USD LIBOR+   2.75%   0.50%   3.25%   5/12/2028    4,000,000    3,993,419    4,003,320 
SS&C Technologies, Inc.  Services: Business  Term Loan B3  Loan   1M USD LIBOR+   1.75%   0.00%   1.84%   4/16/2025    227,838    227,511    225,248 
SS&C Technologies, Inc.  Services: Business  Term Loan B4  Loan   1M USD LIBOR+   1.75%   0.00%   1.84%   4/16/2025    171,974    171,731    170,019 
SS&C Technologies, Inc.  Services: Business  Term Loan B-5  Loan   1M USD LIBOR+   1.75%   0.00%   1.84%   4/16/2025    487,250    486,503    482,455 
Staples, Inc.  Wholesale  Term Loan (03/19)  Loan   3M USD LIBOR+   5.00%   0.00%   5.18%   4/16/2026    4,420,291    4,281,071    4,311,021 
Stats LLC  Hotel, Gaming & Leisure  Term Loan  Loan   3M USD LIBOR+   5.25%   0.00%   5.41%   7/10/2026    1,975,000    1,937,408    1,966,369 
Storable, Inc  High Tech Industries  Term Loan B  Loan   3M USD LIBOR+   3.25%   0.50%   3.75%   4/17/2028    500,000    498,796    497,500 
Syncsort Incorporated  High Tech Industries  Term Loan (3/21)  Loan   3M USD LIBOR+   4.25%   0.75%   5.00%   4/23/2028    2,000,000    1,990,148    1,990,620 
Teneo Holdings LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   1M USD LIBOR+   5.25%   1.00%   6.25%   7/15/2025    4,462,500    4,375,178    4,458,038 
Tenneco Inc  Capital Equipment  Term Loan B  Loan   1M USD LIBOR+   3.00%   0.00%   3.09%   10/1/2025    1,466,250    1,456,872    1,442,057 
Ten-X, LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   1M USD LIBOR+   4.00%   1.00%   5.00%   9/27/2024    1,935,000    1,933,403    1,854,369 
The Octave Music Group, Inc (Touchtunes)  Services: Business  Term Loan B  Loan   1M USD LIBOR+   5.25%   1.00%   6.25%   5/29/2025    3,862,069    3,830,224    3,717,241 
Thor Industries, Inc.  Automotive  USD Term Loan (3/21)  Loan   1M USD LIBOR+   3.00%   0.00%   3.13%   2/1/2026    2,935,080    2,877,153    2,937,276 
Tivity Health, Inc.  Healthcare & Pharmaceuticals  Term Loan A  Loan   1M USD LIBOR+   4.25%   0.00%   4.34%   3/7/2024    558,772    555,397    557,549 

 

 

41

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value   Issuer Name 
Tivity Health, Inc.  Healthcare & Pharmaceuticals  Term Loan B  Loan   1M USD LIBOR+   5.25%   0.00%   5.34%   3/6/2026    1,008,704    990,066    1,006,435 
Tosca Services, LLC  Containers, Packaging & Glass  Term Loan (2/21)  Loan   1M USD LIBOR+   3.50%   0.75%   4.25%   8/18/2027    498,750    492,116    498,750 
Transdigm, Inc.  Aerospace & Defense  Term Loan G (02/20)  Loan   1M USD LIBOR+   2.25%   0.00%   2.34%   8/22/2024    4,054,964    4,058,185    4,004,277 
Travel Leaders Group, LLC  Hotel, Gaming & Leisure  Term Loan B (08/18)  Loan   1M USD LIBOR+   4.00%   0.00%   4.09%   1/25/2024    2,431,250    2,429,510    2,313,748 
TRC Companies, Inc.  Services: Business  Term Loan  Loan   1M USD LIBOR+   3.50%   1.00%   4.50%   6/21/2024    3,315,141    3,308,144    3,290,277 
TRC Companies, Inc.  Services: Business  Term Loan (1/21)  Loan   1M USD LIBOR+   4.50%   0.75%   5.25%   6/21/2024    2,479,433    2,469,041    2,467,035 
Trident LS Merger Sub Corporation  Services: Consumer  Term Loan (03/18)  Loan   1M USD LIBOR+   3.25%   0.00%   3.34%   5/1/2025    2,000,000    2,004,661    1,981,880 
TRITON WATER HOLDINGS, INC.  Beverage, Food & Tobacco  Term Loan (03/21)  Loan   3M USD LIBOR+   3.50%   0.50%   4.00%   3/31/2028    1,500,000    1,492,701    1,498,125 
Tronox Pigments (Netherlands) B.V.  Chemicals, Plastics, & Rubber  Term Loan  Loan   3M USD LIBOR+   2.50%   0.00%   2.68%   3/10/2028    495,769    494,555    492,051 
Truck Hero, Inc.  Transportation: Cargo  Term Loan (1/21)  Loan   1M USD LIBOR+   3.75%   0.75%   4.50%   1/29/2028    1,500,000    1,500,000    1,500,000 
TruGreen Limited Partnership  Services: Consumer  Term Loan  Loan   1M USD LIBOR+   4.00%   0.75%   4.75%   10/29/2027    971,545    964,300    973,061 
Twin River Worldwide Holdings, Inc.  Hotel, Gaming & Leisure  Term Loan B  Loan   3M USD LIBOR+   2.75%   0.00%   2.95%   5/10/2026    982,500    978,885    973,412 
Uber Technologies, Inc.  Transportation: Consumer  Term Loan B (2/21)  Loan   1M USD LIBOR+   3.50%   0.00%   3.59%   2/25/2027    3,979,194    3,935,742    3,976,727 
Ultra Clean Holdings, Inc.  High Tech Industries  Incremental Term Loan 3/21  Loan   1M USD LIBOR+   3.75%   0.00%   3.84%   8/27/2025    993,750    988,949    994,992 
Unimin Corporation  Metals & Mining  Term Loan (12/20)  Loan   3M USD LIBOR+   4.00%   1.00%   5.00%   7/31/2026    496,815    467,847    484,891 
United Natural Foods, Inc  Beverage, Food & Tobacco  Term Loan B  Loan   1M USD LIBOR+   3.50%   0.00%   3.59%   10/22/2025    1,929,662    1,842,097    1,931,418 
United Road Services Inc.  Transportation: Cargo  Term Loan (10/17)  Loan   6M USD LIBOR+   5.75%   1.00%   6.75%   9/1/2024    944,590    937,482    758,034 
Univar Inc.  Chemicals, Plastics, & Rubber  Term Loan B3 (11/17)  Loan   1M USD LIBOR+   2.25%   0.00%   2.34%   7/1/2024    1,627,723    1,623,611    1,625,949 
Univar Inc.  Chemicals, Plastics, & Rubber  Univar 5/21 T/L B6  Loan   3M USD LIBOR+   2.00%   0.00%   2.00%   5/26/2028    2,000,000    1,990,000    1,996,260 
Univision Communications Inc.  Media: Broadcasting & Subscription  2020 Replacement Term Loan  Loan   1M USD LIBOR+   3.75%   1.00%   4.75%   3/13/2026    2,483,907    2,476,102    2,489,769 
US Concrete Inc  Construction & Building  Term Loan (5/21)  Loan   3M USD LIBOR+   3.00%   0.50%   3.50%   6/30/2028    2,000,000    1,995,000    2,000,000 
US Ecology, Inc.  Environmental Industries  Term Loan B  Loan   1M USD LIBOR+   2.50%   0.00%   2.59%   11/2/2026    493,750    492,881    494,061 
Utz Quality Foods, LLC  Beverage, Food & Tobacco  Term Loan B  Loan   1M USD LIBOR+   3.00%   0.00%   3.09%   1/20/2028    99,750    99,524    99,646 
Verifone Systems, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (7/18)  Loan   3M USD LIBOR+   4.00%   0.00%   4.15%   8/20/2025    1,393,034    1,386,950    1,372,724 
VFH Parent LLC  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan   1M USD LIBOR+   3.00%   0.00%   3.10%   3/1/2026    3,100,888    3,091,860    3,098,966 
Virence Intermediate Holdings LLC (Athenahealth / VVC Holding)  Healthcare & Pharmaceuticals  Term Loan B (01/21)  Loan   1M USD LIBOR+   4.25%   0.00%   4.35%   2/11/2026    2,965,000    2,937,251    2,973,154 
Virtus Investment Partners, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan   6M USD LIBOR+   2.25%   0.75%   3.00%   6/3/2024    2,278,506    2,278,252    2,275,658 
Vistra Energy Corp  Utilities: Electric  2018 Incremental Term Loan  Loan   1M USD LIBOR+   1.75%   0.00%   1.85%   12/31/2025    914,798    914,187    909,464 
Vizient, Inc  Healthcare & Pharmaceuticals  Term Loan B-6  Loan   1M USD LIBOR+   2.00%   0.00%   2.09%   5/6/2026    490,000    489,184    487,246 
VM Consolidated, Inc.  Construction & Building  Term Loan B (3/21)  Loan   3M USD LIBOR+   3.25%   0.00%   3.45%   3/19/2028    2,357,005    2,353,437    2,347,176 
Vouvray US Finance LLC  High Tech Industries  Term Loan  Loan   1M USD LIBOR+   3.00%   1.00%   4.00%   3/11/2024    480,000    480,000    429,600 
Warner Music Group Corp. (WMG Acquisition Corp.)  Hotel, Gaming & Leisure  Term Loan G  Loan   1M USD LIBOR+   2.13%   0.00%   2.22%   1/20/2028    1,250,000    1,249,724    1,241,925 

 

 

42

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value   Issuer Name 
Wastequip, LLC (HPCC Merger/Patriot Container)  Environmental Industries  Term Loan (3/18)  Loan   1M USD LIBOR+   3.50%   1.00%   4.50%   3/15/2025    493,639    491,781    488,293 
Watlow Electric Manufacturing Company  High Tech Industries  Term Loan B  Loan   3M USD LIBOR+   4.00%   0.50%   4.50%   3/2/2028    2,500,000    2,487,754    2,504,175 
WeddingWire, Inc.  Services: Consumer  Term Loan  Loan   2M USD LIBOR+   4.50%   0.00%   4.65%   12/19/2025    4,907,449    4,899,471    4,895,180 
West Corporation  Telecommunications  Term Loan B (Olympus Merger)  Loan   3M USD LIBOR+   4.00%   1.00%   5.00%   10/10/2024    1,221,591    1,167,084    1,187,802 
West Corporation  Telecommunications  Term Loan B  Loan   3M USD LIBOR+   3.50%   1.00%   4.50%   10/10/2024    2,923,593    2,870,970    2,828,986 
Western Dental Services, Inc.  Retail  Term Loan (12/18)  Loan   1M USD LIBOR+   5.25%   1.00%   6.25%   6/30/2023    422,920    423,244    421,863 
Western Digital Corporation  High Tech Industries  Term Loan B-4  Loan   1M USD LIBOR+   1.75%   0.00%   1.84%   4/29/2023    583,135    576,100    582,511 
WEX Inc.  Services: Business  Term Loan B (3/21)  Loan   1M USD LIBOR+   2.25%   0.00%   2.34%   3/31/2028    2,000,000    1,990,153    1,990,500 
WildBrain Ltd.  Media: Diversified & Production  Term Loan  Loan   1M USD LIBOR+   4.25%   0.75%   5.00%   3/27/2028    2,000,000    1,960,819    1,987,080 
Wirepath LLC  Consumer goods: Non-durable  Term Loan  Loan   3M USD LIBOR+   4.00%   0.00%   4.20%   8/5/2024    2,917,712    2,901,034    2,859,358 
WP CITYMD BIDCO LLC  Services: Consumer  Term Loan B (1/21)  Loan   6M USD LIBOR+   3.75%   0.75%   4.50%   8/13/2026    5,451,338    5,425,517    5,464,094 
Xperi Corporation  High Tech Industries  Term Loan  Loan   1M USD LIBOR+   4.00%   0.00%   4.09%   6/1/2025    2,811,915    2,673,536    2,811,915 
ZEBRA BUYER LLC  Banking, Finance, Insurance & Real Estate  Term Loan 4/21  Loan   3M USD LIBOR+   3.25%   0.50%   3.75%   4/22/2028    1,000,000    995,000    1,003,330 
Zekelman Industries, Inc.  Metals & Mining  Term Loan (01/20)  Loan   1M USD LIBOR+   2.00%   0.00%   2.10%   1/25/2027    970,775    970,775    961,067 
                                        $677,145,260   $673,434,715 

 

 

   Number of Shares   Cost   Fair Value 
Cash and cash equivalents               
U.S. Bank Money Market (c)   10,710,367   $10,710,367   $10,710,367 
Total cash and cash equivalents   10,710,367   $10,710,367   $10,710,367 

 

(a)All or a portion of this investment has an unfunded commitment as of May 31, 2021
(b)As of May 31, 2021, the investment was in default and on non-accrual status.
(c)Included within cash and cash equivalents in Saratoga CLO's Statements of Assets and Liabilities as of May 31, 2021.

 

LIBOR—London Interbank Offered Rate

 

1W USD LIBOR—The 1 week USD LIBOR rate as of May 31, 2021 was 0.06%.

1M USD LIBOR—The 1 month USD LIBOR rate as of May 31, 2021 was 0.09%.

2M USD LIBOR—The 2 month USD LIBOR rate as of May 31, 2021 was 0.12%.

3M USD LIBOR—The 3 month USD LIBOR rate as of May 31, 2021 was 0.13%.

6M USD LIBOR—The 6 month USD LIBOR rate as of May 31, 2021 was 0.17%.

12M USD LIBOR - The 12 month USD LIBOR rate as of May 31, 2021 was 0.25%

3M PL WIBOR - The 3 month PL WIBOR rate as of May 31, 2021 was 0.21%

Prime—The Prime Rate as of May 31, 2021 was 3.25%.

 

43

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2021

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value 
Covia Holdings C/S (Unimin)  Metals & Mining  Common Stock  Equity  -   -    -    -    -    49,312    385,327   $362,443 
Fusion Connect Warrant  Telecommunications  Warrants  Equity  -   -    -    -    -    32,832    -    328 
J Jill Common Stock  Retail  Common Stock  Equity  -   -    -    -    -    5,085    -    24,966 
McDermott International (Americas), Inc.  Energy: Oil & Gas  Lealand Finance (McDermott International) C/S - Cl  Equity  -   -    -    -    -    141,797    141,797    113,438 
ABB Con-Cise Optical Group LLC  Consumer goods: Non-durable  Term Loan B  Loan  6M USD LIBOR+   5.00%   1.00%   6.00%   6/15/2023    2,060,408   $2,046,779    1,952,875 
Adtalem Global Education Inc.  Services: Business  Adtalem Global Education T/L B (02/21)  Loan  1M USD LIBOR+   4.50%   0.75%   5.25%   2/12/2028    2,000,000    1,980,000    1,980,000 
Advisor Group, Inc.  Banking, Finance, Insurance & Real Estate  Advisor Group Holdings T/L B1  Loan  1M USD LIBOR+   4.50%   0.00%   4.61%   7/31/2026    995,000    994,026    996,383 
Aegis Sciences Corporation  Healthcare & Pharmaceuticals  Term Loan  Loan  3M USD LIBOR+   5.50%   1.00%   6.50%   5/9/2025    3,867,445    3,842,999    3,527,419 
Agiliti Health Inc.  Healthcare & Pharmaceuticals  Term Loan (09/20)  Loan  1M USD LIBOR+   2.75%   0.75%   3.50%   1/4/2026    500,000    495,337    497,500 
Agiliti Health Inc.  Healthcare & Pharmaceuticals  Term Loan (1/19)  Loan  1M USD LIBOR+   2.75%   0.00%   2.88%   1/4/2026    491,250    491,250    487,566 
Ahead Data Blue, LLC  Services: Business  Term Loan (10/20)  Loan  6M USD LIBOR+   5.00%   1.00%   6.00%   9/18/2027    3,000,000    2,885,073    3,017,250 
AI Convoy (Luxembourg) S.a.r.l.  Aerospace & Defense  AI Convoy (Luxembourg) USD T/L B  Loan  6M USD LIBOR+   3.50%   1.00%   4.50%   1/18/2027    1,488,750    1,482,360    1,486,353 
AIS HoldCo, LLC  Services: Business  Term Loan  Loan  3M USD LIBOR+   5.00%   0.00%   5.21%   8/15/2025    5,246,875    5,082,782    5,089,469 
Alchemy Copyrights, LLC  Media: Diversified & Production  Term Loan B  Loan  1M USD LIBOR+   3.25%   0.75%   4.00%   8/16/2027    498,750    495,356    498,750 
Alchemy US Holdco 1, LLC  Metals & Mining  Term Loan  Loan  1M USD LIBOR+   5.50%   0.00%   5.61%   10/10/2025    1,900,000    1,879,839    1,850,923 
Alion Science and Technology Corporation  Aerospace & Defense  Term Loan (2/21)  Loan  1M USD LIBOR+   2.75%   0.75%   3.50%   7/23/2024    3,990,000    3,974,081    3,998,299 
AlixPartners, LLP  Banking, Finance, Insurance & Real Estate  AlixPartners T/L B (01/21)  Loan  1M USD LIBOR+   2.75%   0.50%   3.25%   1/27/2028    250,000    249,375    249,888 
Allen Media, LLC  Media: Diversified & Production  Allen Media T/L B (1/20)  Loan  3M USD LIBOR+   5.50%   0.00%   5.75%   2/10/2027    2,977,027    2,964,383    2,971,460 
Altisource Solutions S.a r.l.  Banking, Finance, Insurance & Real Estate  Term Loan B (03/18)  Loan  3M USD LIBOR+   4.00%   1.00%   5.00%   4/3/2024    1,223,297    1,218,530    1,040,940 
Altium Packaging LLC  Containers, Packaging & Glass  Altium Packaging (Consolidated Container) T/L (01/  Loan  3M USD LIBOR+   2.75%   0.50%   3.25%   1/29/2028    500,000    497,500    499,000 
Altra Industrial Motion Corp.  Capital Equipment  Term Loan  Loan  1M USD LIBOR+   2.00%   0.00%   2.11%   10/1/2025    1,522,387    1,519,700    1,520,012 
American Greetings Corporation  Media: Advertising, Printing & Publishing  Term Loan  Loan  1M USD LIBOR+   4.50%   1.00%   5.50%   4/6/2024    4,230,503    4,228,066    4,239,302 
American Trailer World Corp  Automotive  American Trailer World T/L  Loan  1M USD LIBOR+   3.75%   0.75%   4.50%   2/17/2028    2,000,000    1,990,000    1,990,000 
AmeriLife Holdings LLC  Banking, Finance, Insurance & Real Estate  AmeriLife T/L  Loan  1M USD LIBOR+   4.00%   0.00%   4.12%   3/18/2027    1,492,642    1,484,080    1,490,149 
AmWINS Group, LLC  Banking, Finance, Insurance & Real Estate  AmWINS Group (2/21) T/L  Loan  1M USD LIBOR+   2.25%   0.75%   3.00%   2/17/2028    2,000,000    1,995,000    1,999,160 

 

44

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value 
Anastasia Parent LLC  Consumer goods: Non-durable  Term Loan  Loan  3M USD LIBOR+   3.75%   0.00%   4.00%   8/11/2025    977,500    974,191    669,891 
Anchor Glass Container Corporation  Containers, Packaging & Glass  Term Loan (07/17)  Loan  3M USD LIBOR+   2.75%   1.00%   3.75%   12/7/2023    480,088    478,981    407,076 
Anchor Packaging, LLC  Containers, Packaging & Glass  Term Loan B  Loan  1M USD LIBOR+   4.00%   0.00%   4.11%   7/10/2026    997,468    987,853    999,962 
APi Group DE, Inc. (J2 Acquisition)  Services: Business  Term Loan B  Loan  1M USD LIBOR+   2.50%   0.00%   2.61%   10/1/2026    990,000    985,758    990,000 
APLP Holdings Limited Partnership  Energy: Electricity  APLP Holdings T/L B (01/20)  Loan  1M USD LIBOR+   2.50%   1.00%   3.50%   4/14/2025    1,618,421    1,618,421    1,617,207 
Apollo Commercial Real Estate Finance, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  1M USD LIBOR+   2.75%   0.00%   2.86%   5/15/2026    3,000,000    2,960,051    2,925,000 
AppLovin Corporation  High Tech Industries  Applovin T/L B  Loan  1M USD LIBOR+   3.50%   0.00%   3.61%   8/15/2025    1,000,000    1,000,000    998,100 
Aramark Corporation  Services: Consumer  Term Loan  Loan  1M USD LIBOR+   1.75%   0.00%   1.86%   1/15/2027    2,481,250    2,401,701    2,454,105 
Arctic Glacier U.S.A., Inc.  Beverage, Food & Tobacco  Term Loan (3/18)  Loan  3M USD LIBOR+   3.50%   1.00%   4.50%   3/20/2024    3,350,967    3,337,028    3,140,124 
Aretec Group, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (10/18)  Loan  1M USD LIBOR+   4.25%   0.00%   4.36%   10/1/2025    1,960,000    1,956,623    1,954,492 
ARISTOCRAT LEISURE LIMITED  Hotel, Gaming & Leisure  Term Loan (5/20)  Loan  2M USD LIBOR+   3.75%   1.00%   4.75%   10/19/2024    995,000    978,205    1,000,184 
ASG Technologies Group, Inc  High Tech Industries  Term Loan  Loan  1M USD LIBOR+   3.50%   1.00%   4.50%   7/31/2024    461,401    460,194    454,480 
ASP MSG Acquisition Co., Inc  Beverage, Food & Tobacco  Term Loan (2/17)  Loan  1M USD LIBOR+   4.00%   1.00%   5.00%   8/16/2023    3,830,991    3,793,847    3,835,779 
Aspen Dental Management, Inc.  Services: Consumer  Term Loan B  Loan  1M USD LIBOR+   2.75%   0.00%   2.86%   4/30/2025    1,950,276    1,944,024    1,926,872 
Asplundh Tree Expert, LLC  Services: Business  Term Loan  Loan  1M USD LIBOR+   2.50%   0.00%   2.61%   9/4/2027    997,500    992,854    998,128 
Asurion, LLC  Banking, Finance, Insurance & Real Estate  Term Loan B6  Loan  1M USD LIBOR+   3.00%   0.00%   3.11%   11/3/2023    328,929    327,483    328,244 
Asurion, LLC  Banking, Finance, Insurance & Real Estate  Term Loan B8  Loan  1M USD LIBOR+   3.25%   0.00%   3.36%   12/18/2026    1,525,365    1,515,790    1,520,362 
Avast Software S.R.O. (Sybil Finance)  High Tech Industries  Term Loan B (4/18)  Loan  3M USD LIBOR+   2.25%   1.00%   3.25%   9/29/2023    650,351    642,686    650,351 
Avaya, Inc.  Telecommunications  Term Loan B1  Loan  1M USD LIBOR+   4.25%   0.00%   4.36%   12/15/2027    1,755,766    1,745,975    1,760,437 
Avaya, Inc.  Telecommunications  Avaya T/L B-2  Loan  1M USD LIBOR+   4.00%   0.00%   4.11%   12/15/2027    1,000,000    1,000,000    1,001,250 
Avison Young (Canada) Inc  Services: Business  Term Loan  Loan  3M USD LIBOR+   5.00%   0.00%   5.19%   1/31/2026    3,441,108    3,392,968    3,441,108 
Avolon TLB Borrower 1 (US) LLC  Capital Equipment  Term Loan B3  Loan  1M USD LIBOR+   1.75%   0.75%   2.50%   1/15/2025    1,000,000    869,301    996,390 
Avolon TLB Borrower 1 (US) LLC  Capital Equipment  Term Loan B5  Loan  1M USD LIBOR+   2.50%   0.75%   3.25%   12/20/2027    500,000    495,171    500,625 
Azalea TopCo, Inc.  Services: Business  Incremental Term Loan  Loan  3M USD LIBOR+   4.00%   0.75%   4.75%   7/24/2026    500,000    495,287    501,250 
B&G Foods, Inc.  Beverage, Food & Tobacco  Term Loan  Loan  1M USD LIBOR+   2.50%   0.00%   2.61%   10/10/2026    706,458    700,750    706,960 
B.C. Unlimited Liability Co (Burger King)  Beverage, Food & Tobacco  Term Loan B4  Loan  1M USD LIBOR+   1.75%   0.00%   1.86%   11/19/2026    1,485,000    1,447,423    1,469,912 
Baldwin Risk Partners, LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD LIBOR+   4.00%   0.75%   4.75%   10/14/2027    997,500    983,184    1,002,488 
BALL METALPACK, LLC (PE Spray)  Containers, Packaging & Glass  Term Loan  Loan  3M USD LIBOR+   4.50%   0.00%   4.69%   7/25/2025    3,904,887    3,891,579    3,887,823 
Bass Pro Group, LLC  Retail  Term Loan B (02/21)  Loan  1M USD LIBOR+   4.25%   0.75%   5.00%   2/26/2028    1,000,000    995,000    1,000,780 
Berry Plastics Holding Corporation  Chemicals, Plastics, & Rubber  Term Loan Y  Loan  1M USD LIBOR+   2.00%   0.00%   2.12%   7/1/2026    4,937,374    4,932,962    4,932,980 
Blackstone Mortgage Trust, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  1M USD LIBOR+   2.25%   0.00%   2.36%   4/23/2026    1,000,000    992,500    985,000 

 

45

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value 
Blackstone Mortgage Trust, Inc.  Banking, Finance, Insurance & Real Estate  Blackstone Mortgage T/L B-2  Loan  1M USD LIBOR+   4.75%   1.00%   5.75%   4/23/2026    1,494,994    1,484,017    1,498,731 
Blount International, Inc.  Forest Products & Paper  Term Loan B (09/18)  Loan  1M USD LIBOR+   3.75%   1.00%   4.75%   4/12/2023    3,418,806    3,416,907    3,422,225 
Blucora, Inc.  Services: Consumer  Term Loan (11/17)  Loan  3M USD LIBOR+   4.00%   1.00%   5.00%   5/22/2024    2,451,227    2,443,549    2,454,291 
Bombardier Recreational Products, Inc.  Consumer goods: Durable  Term Loan (1/20)  Loan  1M USD LIBOR+   2.00%   0.00%   2.12%   5/24/2027    1,485,050    1,473,875    1,475,620 
Boxer Parent Company, Inc.  High Tech Industries  Boxer Parent Company T/L (BMC Software) (2/21)  Loan  1M USD LIBOR+   3.75%   0.00%   3.90%   10/2/2025    528,897    528,897    528,829 
Bracket Intermediate Holding Corp  Healthcare & Pharmaceuticals  Term Loan  Loan  3M USD LIBOR+   4.25%   0.00%   4.49%   9/5/2025    977,500    974,177    975,868 
BrightSpring Health Services (Phoenix Guarantor)  Healthcare & Pharmaceuticals  Phoenix Guarantor (Brightspring) T/L (02/21)  Loan  6M USD LIBOR+   3.50%   0.00%   3.76%   3/5/2026    1,000,000    1,000,000    1,000,710 
BroadStreet Partners, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B3  Loan  1M USD LIBOR+   3.25%   0.00%   3.36%   1/22/2027    2,009,429    2,007,872    1,996,207 
Brookfield WEC Holdings Inc.  Energy: Electricity  Brookfield WEC T/L (Westinghouse) (1/21)  Loan  1M USD LIBOR+   2.75%   0.50%   3.25%   8/1/2025    1,492,462    1,495,340    1,488,492 
Buckeye Partners, L.P.  Utilities: Oil & Gas  Buckeye Partners T/L (1/21)  Loan  1M USD LIBOR+   2.25%   0.00%   2.37%   11/1/2026    1,989,987    1,975,617    1,987,182 
BW Gas & Convenience Holdings LLC  Beverage, Food & Tobacco  Term Loan  Loan  1M USD LIBOR+   6.25%   0.00%   6.37%   11/18/2024    2,230,357    2,160,253    2,255,449 
Cable & Wireless Communications Limited  Telecommunications  Term Loan B-5  Loan  1M USD LIBOR+   2.25%   0.00%   2.36%   1/31/2028    2,000,000    2,000,000    1,988,220 
Callaway Golf Company  Retail  Term Loan B  Loan  1M USD LIBOR+   4.50%   0.00%   4.61%   1/4/2026    690,000    679,310    692,298 
Cardtronics Inc  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD LIBOR+   4.00%   1.00%   5.00%   6/29/2027    1,494,994    1,489,184    1,495,936 
CareerBuilder, LLC  Services: Business  Term Loan  Loan  3M USD LIBOR+   6.75%   1.00%   7.75%   7/31/2023    3,393,388    3,230,834    3,230,505 
CareStream Health, Inc.  Healthcare & Pharmaceuticals  Term Loan  Loan  6M USD LIBOR+   6.75%   1.00%   7.75%   5/8/2023    2,306,786    2,302,501    2,298,136 
Casa Systems, Inc  Telecommunications  Term Loan  Loan  6M USD LIBOR+   4.00%   1.00%   5.00%   12/20/2023    1,440,000    1,433,828    1,435,205 
Castle US Holding Corporation  Media: Advertising, Printing & Publishing  Term Loan B (USD)  Loan  3M USD LIBOR+   3.75%   0.00%   4.00%   1/27/2027    496,875    494,809    493,059 
Catalent Pharma Solutions, Inc.  Healthcare & Pharmaceuticals  Term Loan B3 (2/21)  Loan  1M USD LIBOR+   2.00%   0.50%   2.50%   5/18/2026    500,000    500,000    500,780 
CBI BUYER, INC.  Consumer goods: Durable  New Trojan Parent (Careismatic/CBI Buyer) 1st Lien  Loan  1M USD LIBOR+   3.25%   0.50%   3.75%   1/6/2028    1,000,000    997,597    1,000,630 
CCI Buyer, Inc  Telecommunications  Term Loan  Loan  3M USD LIBOR+   4.00%   0.75%   4.75%   12/17/2027    250,000    247,558    251,720 
CCS-CMGC Holdings, Inc.  Healthcare & Pharmaceuticals  Term Loan  Loan  1M USD LIBOR+   5.50%   0.00%   5.61%   9/25/2025    2,450,000    2,432,841    2,417,856 
Cengage Learning Acquisitions, Inc.  Media: Advertising, Printing & Publishing  Term Loan  Loan  6M USD LIBOR+   4.25%   1.00%   5.25%   6/7/2023    1,432,459    1,424,074    1,410,370 
CenturyLink, Inc.  Telecommunications  Term Loan B (1/20)  Loan  1M USD LIBOR+   2.25%   0.00%   2.36%   3/15/2027    2,970,000    2,967,083    2,957,170 
Chemours Company, (The)  Chemicals, Plastics, & Rubber  Term Loan  Loan  1M USD LIBOR+   1.75%   0.00%   1.87%   4/3/2025    989,822    940,018    979,617 
CITADEL SECURITIES LP  Banking, Finance, Insurance & Real Estate  Citadel Securities T/L B (01/21)  Loan  1M USD LIBOR+   2.50%   0.00%   2.61%   2/27/2028    5,000,000    4,993,750    4,970,300 
Clarios Global LP  Automotive  Term Loan B  Loan  1M USD LIBOR+   3.50%   0.00%   3.61%   4/30/2026    1,454,464    1,442,855    1,455,381 

 

46

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value 
Claros Mortgage Trust, Inc  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  1M USD LIBOR+   5.00%   1.00%   6.00%   8/9/2026    997,475    972,272    999,968 
CNT Holdings I Corp  Retail  Term Loan  Loan  6M USD LIBOR+   3.75%   0.75%   4.50%   11/8/2027    500,000    497,627    501,955 
Cole Haan  Consumer goods: Non-durable  Term Loan B  Loan  3M USD LIBOR+   5.50%   0.00%   5.69%   2/7/2025    950,000    942,246    874,000 
Compass Power Generation, LLC  Utilities: Electric  Term Loan B (08/18)  Loan  1M USD LIBOR+   3.50%   1.00%   4.50%   12/20/2024    1,802,012    1,798,648    1,796,390 
Concordia Healthcare Corp.  Healthcare & Pharmaceuticals  Term Loan  Loan  1M USD LIBOR+   5.50%   1.00%   6.50%   9/6/2024    1,159,370    1,118,148    1,156,472 
Connect Finco SARL  Telecommunications  Term Loan (1/21)  Loan  1M USD LIBOR+   3.50%   1.00%   4.50%   12/11/2026    2,977,500    2,831,053    2,987,058 
Consolidated Communications, Inc.  Telecommunications  Term Loan B (10/20)  Loan  1M USD LIBOR+   4.75%   1.00%   5.75%   10/2/2027    997,500    983,260    1,002,328 
CoreCivic, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (12/19)  Loan  1M USD LIBOR+   4.50%   1.00%   5.50%   12/18/2024    3,454,545    3,404,660    3,340,822 
CPI Card Group  Banking, Finance, Insurance & Real Estate  Term Loan B (1st Lien)  Loan  3M USD LIBOR+   4.50%   1.00%   5.50%   8/17/2022    1,436,782    1,431,179    1,422,414 
CSC Holdings LLC (Neptune Finco Corp.)  Media: Broadcasting & Subscription  Term Loan B  Loan  1M USD LIBOR+   2.25%   0.00%   2.36%   1/15/2026    490,000    489,175    486,849 
CSC Holdings LLC (Neptune Finco Corp.)  Media: Broadcasting & Subscription  Term Loan B (03/17)  Loan  1M USD LIBOR+   2.25%   0.00%   2.36%   7/15/2025    1,954,315    1,936,120    1,941,925 
CSC Holdings LLC (Neptune Finco Corp.)  Media: Broadcasting & Subscription  Term Loan B-5  Loan  1M USD LIBOR+   2.50%   0.00%   2.61%   4/15/2027    495,000    495,000    492,911 
CTS Midco, LLC  High Tech Industries  Term Loan B  Loan  3M USD LIBOR+   6.00%   1.00%   7.00%   11/2/2027    2,000,000    1,942,014    2,002,500 
Daseke Inc  Transportation: Cargo  Replacement Term Loan  Loan  1M USD LIBOR+   5.00%   1.00%   6.00%   2/27/2024    1,935,738    1,928,854    1,939,978 
DCert Buyer, Inc.  High Tech Industries  DCert Buyer T/L (Digicert)  Loan  1M USD LIBOR+   4.00%   0.00%   4.11%   10/16/2026    1,500,000    1,500,000    1,500,540 
Dealer Tire, LLC  Automotive  Dealer Tire T/L B-1  Loan  1M USD LIBOR+   4.25%   0.00%   4.36%   12/12/2025    2,970,000    2,963,784    2,966,288 
Delek US Holdings, Inc.  Utilities: Oil & Gas  Term Loan B  Loan  1M USD LIBOR+   2.25%   0.00%   2.36%   3/31/2025    6,380,682    6,326,939    6,247,773 
Dell International LLC  High Tech Industries  Term Loan B-2  Loan  1M USD LIBOR+   1.75%   0.75%   2.00%   9/19/2025    2,530,374    2,528,058    2,537,763 
Delta 2 (Lux) S.a.r.l.  Hotel, Gaming & Leisure  Term Loan B  Loan  1M USD LIBOR+   2.50%   1.00%   3.50%   2/1/2024    818,289    817,549    813,175 
Delta Air Lines, Inc.  Transportation: Consumer  Term Loan B (4/20)  Loan  1M USD LIBOR+   4.75%   1.00%   5.75%   4/29/2023    2,243,737    2,240,713    2,257,761 
DHX Media Ltd.  Media: Broadcasting & Subscription  Term Loan  Loan  1M USD LIBOR+   4.25%   1.00%   5.25%   12/29/2023    279,282    278,315    278,584 
Diamond Sports Group, LLC  Media: Broadcasting & Subscription  Term Loan  Loan  1M USD LIBOR+   3.25%   0.00%   3.37%   8/24/2026    3,443,844    2,912,847    2,582,883 
Digital Room LLC  Media: Advertising, Printing & Publishing  Term Loan  Loan  6M USD LIBOR+   5.00%   0.00%   5.27%   5/21/2026    2,955,000    2,925,480    2,910,675 
Dole Food Company Inc.  Beverage, Food & Tobacco  Term Loan B  Loan  1M USD LIBOR+   2.75%   1.00%   3.75%   4/6/2024    456,250    455,172    456,410 
DRW Holdings, LLC  Banking, Finance, Insurance & Real Estate  DRW Holdings T/L (2/21)  Loan  1M USD LIBOR+   3.75%   0.00%   3.87%   2/24/2028    552,519    549,756    551,138 
DRW Holdings, LLC  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  1M USD LIBOR+   4.25%   0.00%   4.36%   11/29/2026    5,947,481    5,897,811    5,932,612 
DTZ U.S. Borrower, LLC  Construction & Building  Term Loan  Loan  1M USD LIBOR+   2.75%   0.00%   2.86%   8/21/2025    3,915,462    3,901,786    3,886,801 
EagleTree - Carbride Acquisition (Corsair Components)  Consumer goods: Durable  Term Loan  Loan  1M USD LIBOR+   3.75%   1.00%   4.75%   8/28/2024    2,868,047    2,867,816    2,868,047 
Edelman Financial Group Inc., The  Banking, Finance, Insurance & Real Estate  Term Loan B (06/18)  Loan  1M USD LIBOR+   3.00%   0.00%   3.11%   7/21/2025    1,225,000    1,220,875    1,214,502 
Electrical Components Inter., Inc.  Capital Equipment  Term Loan (6/18)  Loan  1M USD LIBOR+   4.25%   0.00%   4.36%   6/26/2025    1,950,000    1,947,116    1,903,083 
ELO Touch Solutions, Inc.  Media: Diversified & Production  Term Loan (12/18)  Loan  1M USD LIBOR+   6.50%   0.00%   6.61%   12/14/2025    2,558,602    2,457,436    2,564,999 

 

47

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value 
Encapsys, LLC (Cypress Performance Group)  Chemicals, Plastics, & Rubber  Term Loan B2  Loan  1M USD LIBOR+   3.25%   1.00%   4.25%   11/7/2024    492,284    488,655    492,284 
Endo Luxembourg Finance Company I S.a.r.l.  Healthcare & Pharmaceuticals  Term Loan B (4/17)  Loan  3M USD LIBOR+   4.25%   0.75%   5.00%   4/29/2024    3,896,646    3,879,939    3,869,057 
Endure Digital, Inc.  High Tech Industries  Endurance International T/L B  Loan  1M USD LIBOR+   3.50%   0.75%   4.25%   1/27/2028    2,500,000    2,487,500    2,481,250 
Ensemble RCM LLC  Services: Business  Term Loan  Loan  3M USD LIBOR+   3.75%   0.00%   3.96%   7/24/2026    3,000,000    2,992,500    3,004,230 
Enterprise Merger Sub Inc.  Healthcare & Pharmaceuticals  Term Loan B (06/18)  Loan  1M USD LIBOR+   3.75%   0.00%   3.86%   10/10/2025    4,900,000    4,891,890    4,204,200 
EVERI Payments Inc.  Hotel, Gaming & Leisure  Everi Payments T/L B  Loan  1M USD LIBOR+   2.75%   0.75%   3.50%   5/9/2024    3,000,000    3,000,000    2,988,120 
EyeCare Partners, LLC  Healthcare & Pharmaceuticals  EyeCare Partners T/L B  Loan  1M USD LIBOR+   3.75%   0.00%   3.86%   2/18/2027    1,987,838    1,986,442    1,956,032 
Finco I LLC  Banking, Finance, Insurance & Real Estate  FinCo T/L B (9/20) (Fortress Investment)  Loan  1M USD LIBOR+   2.50%   0.00%   2.61%   6/27/2025    1,822,272    1,815,715    1,821,142 
First Eagle Investment Management  Banking, Finance, Insurance & Real Estate  Refinancing Term Loan  Loan  3M USD LIBOR+   2.50%   0.00%   2.75%   2/1/2027    5,395,500    5,375,893    5,378,990 
Fitness International, LLC (LA Fitness)  Services: Consumer  Term Loan B (4/18)  Loan  1M USD LIBOR+   3.25%   1.00%   4.25%   4/18/2025    1,330,058    1,324,204    1,196,813 
Flex Acquisition Company (Hilex Poly/Novolex) T/L (02/21)  Containers, Packaging & Glass  Term Loan  Loan  3M USD LIBOR+   4.00%   0.50%   4.50%   3/2/2028    1,000,000    995,000    997,810 
FOCUS FINANCIAL PARTNERS, LLC  Banking, Finance, Insurance & Real Estate  Focus Financial T/L (1/20)  Loan  1M USD LIBOR+   2.00%   0.00%   2.11%   7/3/2024    500,000    499,435    497,815 
Franchise Group, Inc.  Services: Consumer  Franchise Group First Out T/L  Loan  6M USD LIBOR+   4.75%   0.75%   5.50%   10/25/2026    1,000,000    990,000    1,000,000 
Franklin Square Holdings, L.P.  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD LIBOR+   2.25%   0.00%   2.38%   8/1/2025    4,398,742    4,374,564    4,382,247 
Froneri International (R&R Ice Cream)  Beverage, Food & Tobacco  Term Loan B-2  Loan  1M USD LIBOR+   2.25%   0.00%   2.36%   1/29/2027    1,990,000    1,985,937    1,971,453 
Fusion Telecommunications International Inc.  Telecommunications  Take Back 2nd Out Term Loan  Loan  6M USD LIBOR+   1.00%   2.00%   3.00%   7/14/2025    813,105    795,920    412,651 
Gemini HDPE LLC  Chemicals, Plastics, & Rubber  Term Loan B (12/20)  Loan  3M USD LIBOR+   3.00%   0.50%   3.50%   12/31/2027    2,000,000    1,980,103    1,995,000 
General Nutrition Centers, Inc. (b)  Retail  Term Loan B2  Loan  Prime+   7.75%   0.75%   11.00%   3/4/2021    389,896    389,896    292,422 
Genesee & Wyoming, Inc.  Transportation: Cargo  Term Loan (11/19)  Loan  3M USD LIBOR+   2.00%   0.00%   2.25%   12/30/2026    1,488,750    1,482,600    1,489,986 
GEO Group, Inc., The  Banking, Finance, Insurance & Real Estate  Term Loan Refinance  Loan  1M USD LIBOR+   2.00%   0.75%   2.75%   3/22/2024    3,963,971    3,665,551    3,609,710 
GGP Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  1M USD LIBOR+   2.50%   0.00%   2.61%   8/27/2025    3,969,542    3,201,121    3,862,603 
GI Chill Acquisition LLC  Services: Business  Term Loan  Loan  3M USD LIBOR+   4.00%   0.00%   4.25%   8/1/2025    2,443,750    2,435,372    2,448,344 
Gigamon Inc.  Services: Business  Term Loan B  Loan  6M USD LIBOR+   3.75%   0.75%   4.50%   12/27/2024    2,930,400    2,913,040    2,930,400 
Global Business Travel (GBT) III Inc.  Hotel, Gaming & Leisure  Term Loan  Loan  1M USD LIBOR+   2.50%   0.00%   2.61%   8/13/2025    4,398,750    4,397,949    4,215,454 
Global Tel*Link Corporation  Telecommunications  Term Loan B  Loan  1M USD LIBOR+   4.25%   0.00%   4.36%   11/29/2025    5,000,167    4,764,345    4,675,956 
Go Wireless Holdings, Inc.  Telecommunications  Term Loan  Loan  1M USD LIBOR+   6.50%   1.00%   7.50%   12/22/2024    3,024,675    2,992,914    3,017,114 
Goodyear Tire & Rubber Company, The  Chemicals, Plastics, & Rubber  Second Lien Term Loan  Loan  1M USD LIBOR+   2.00%   0.00%   2.12%   3/3/2025    3,000,000    2,933,783    2,953,740 
Graham Packaging T/L (2/21)  Containers, Packaging & Glass  Term Loan  Loan  1M USD LIBOR+   3.75%   0.75%   4.50%   8/4/2027    979,661    972,912    980,660 
Greenhill & Co., Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  1M USD LIBOR+   3.25%   0.00%   3.36%   4/12/2024    3,419,615    3,393,171    3,398,243 

 

48

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value 
Grosvenor Capital Management Holdings, LLLP  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  1M USD LIBOR+   2.75%   1.00%   3.75%   3/31/2025    2,399,991    2,398,303    2,395,791 
Guidehouse LLP (fka PricewaterhouseCoopers)  Aerospace & Defense  Term Loan  Loan  1M USD LIBOR+   4.00%   0.00%   4.11%   5/1/2025    4,924,683    4,903,634    4,951,572 
Harbor Freight Tools USA, Inc.  Retail  Term Loan B (10/20)  Loan  1M USD LIBOR+   3.25%   0.75%   4.00%   10/20/2027    2,992,500    2,967,649    3,004,979 
Harland Clarke Holdings Corp.  Media: Advertising, Printing & Publishing  Term Loan  Loan  3M USD LIBOR+   4.75%   1.00%   5.75%   11/3/2023    1,612,899    1,607,974    1,536,738 
Helix Gen Funding, LLc  Energy: Electricity  Term Loan B (02/17)  Loan  1M USD LIBOR+   3.75%   1.00%   4.75%   6/3/2024    244,627    244,418    243,418 
Hillman Group Inc. (The) (New)  Consumer goods: Durable  Hillman Group T/L B-1 (2/21)  Loan  6M USD LIBOR+   2.75%   0.50%   3.25%   2/23/2028    3,523,207    3,514,399    3,523,207 
Hillman Group Inc. (The) (New)  Consumer goods: Durable  Hillman Group T/L B-2 (2/21)  Loan  6M USD LIBOR+   2.75%   0.50%   2.99%   2/23/2028    632,911    631,329    632,911 
Hillman Group Inc. (The) (New)(a)  Consumer goods: Durable  Unfunded Commitment  Loan  3M USD LIBOR+   2.75%   0.50%   0.00%   2/23/2028    -    (2,110)   - 
HLF Financing SARL (Herbalife)  Consumer goods: Non-durable  Term Loan B (08/18)  Loan  1M USD LIBOR+   2.50%   0.00%   2.61%   8/18/2025    3,910,000    3,897,913    3,912,111 
Holley Purchaser, Inc  Automotive  Term Loan B  Loan  3M USD LIBOR+   5.00%   0.00%   5.21%   10/24/2025    2,450,000    2,432,788    2,423,981 
Howden Group Holdings  Banking, Finance, Insurance & Real Estate  Term Loan (1/21)  Loan  3M USD LIBOR+   3.25%   0.75%   4.00%   11/12/2027    1,692,335    1,686,025    1,695,212 
Hudson River Trading LLC  Banking, Finance, Insurance & Real Estate  Term Loan B (01/20)  Loan  1M USD LIBOR+   3.00%   0.00%   3.11%   2/18/2027    5,940,000    5,920,701    5,925,150 
Idera, Inc.  High Tech Industries  Idera T/L (1/21)  Loan  1M USD LIBOR+   3.75%   0.75%   4.50%   6/28/2028    1,000,000    997,500    1,000,000 
Idera, Inc.  High Tech Industries  Term Loan B  Loan  6M USD LIBOR+   4.00%   1.00%   5.00%   6/27/2024    3,896,805    3,886,520    3,896,805 
INEOS US PETROCHEM LLC  Chemicals, Plastics, & Rubber  INEOS US Petrochem T/L (INEOS Quattro)  Loan  1M USD LIBOR+   2.75%   0.50%   3.25%   1/20/2026    1,000,000    995,073    1,003,750 
INFINITE BIDCO LLC  Wholesale  Infinite Bidco T/L  Loan  1M USD LIBOR+   3.75%   0.75%   4.50%   2/22/2028    1,500,000    1,496,250    1,500,000 
Inmar Acquisition Sub, Inc.  Services: Business  Term Loan B  Loan  3M USD LIBOR+   4.00%   1.00%   5.00%   5/1/2024    3,421,586    3,360,370    3,400,920 
Innophos, Inc.  Chemicals, Plastics, & Rubber  Term Loan B  Loan  1M USD LIBOR+   3.50%   0.00%   3.61%   2/4/2027    496,250    494,123    498,424 
Intermediate Dutch Holdings  Services: Business  Nielsen Consumer T/L B  Loan  1M USD LIBOR+   4.00%   0.00%   4.13%   2/3/2028    250,000    248,750    250,313 
Isagenix International, LLC  Beverage, Food & Tobacco  Term Loan  Loan  3M USD LIBOR+   5.75%   1.00%   6.75%   6/14/2025    2,622,582    2,586,650    1,652,227 
Ivory Merger Sub, Inc.  Healthcare & Pharmaceuticals  Term Loan  Loan  1M USD LIBOR+   3.50%   0.00%   3.62%   3/14/2025    957,262    954,285    944,100 
J Jill Group, Inc  Retail  Priming Term Loan  Loan  6M USD LIBOR+   5.00%   1.00%   6.00%   5/8/2024    1,779,081    1,776,970    1,138,612 
Jane Street Group  Banking, Finance, Insurance & Real Estate  Jane Street Group T/L (1/21)  Loan  1M USD LIBOR+   2.75%   0.00%   2.86%   1/31/2028    2,500,000    2,496,997    2,491,975 
Jefferies Finance LLC / JFIN Co-Issuer Corp  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD LIBOR+   3.00%   0.00%   3.13%   6/3/2026    3,796,822    3,781,950    3,789,380 
Journey Personal Care Corp.  Consumer goods: Non-durable  Journey Personal Care T/L B (Domtar)  Loan  6M USD LIBOR+   4.25%   0.75%   5.00%   2/19/2028    1,000,000    995,000    1,002,500 
JP Intermediate B, LLC  Consumer goods: Non-durable  Term Loan  Loan  3M USD LIBOR+   5.50%   1.00%   6.50%   11/15/2025    4,423,877    4,386,340    4,154,021 
KAR Auction Services, Inc.  Automotive  Term Loan B (09/19)  Loan  1M USD LIBOR+   2.25%   0.00%   2.44%   9/19/2026    246,875    246,391    243,172 
Kindred Healthcare, Inc.  Healthcare & Pharmaceuticals  Term Loan (6/18)  Loan  1M USD LIBOR+   4.50%   0.00%   4.63%   7/2/2025    1,979,747    1,962,749    1,982,222 
Klockner-Pentaplast of America, Inc.  Containers, Packaging & Glass  Klockner Pentaplast T/L (Kleopatra)  Loan  1M USD LIBOR+   4.75%   0.50%   5.25%   2/4/2026    1,500,000    1,492,500    1,500,945 
Kodiak BP, LLC  Construction & Building  Term Loan  Loan  1M USD LIBOR+   3.25%   0.75%   4.00%   2/26/2028    500,000    497,500    499,375 

49

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value 
KREF Holdings X LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  3M USD LIBOR+   4.75%   1.00%   5.75%   8/4/2027    500,000    488,256    501,250 
Lakeland Tours, LLC  Hotel, Gaming & Leisure  2nd Out Take Back PIK Term Loan  Loan  3M USD LIBOR+   1.50%   1.25%   2.75%   9/25/2025    585,723    478,159    524,222 
Lakeland Tours, LLC  Hotel, Gaming & Leisure  Third Out PIK Term Loan  Loan  3M USD LIBOR+   1.50%   1.25%   2.75%   9/25/2025    777,562    451,283    515,780 
Lakeland Tours, LLC  Hotel, Gaming & Leisure  Holdco Fixed Term Loan  Loan  Fixed   8.00%   0.00%   13.25%   9/27/2027    763,381    128,938    277,359 
Lakeland Tours, LLC  Hotel, Gaming & Leisure  Priority Exit PIK Term Loan (9/20)  Loan  3M USD LIBOR+   6.00%   1.25%   7.25%   9/25/2023    306,588    292,181    306,076 
Lealand Finance Company B.V.  Energy: Oil & Gas  Exit Term Loan  Loan  1M USD LIBOR+   1.00%   0.00%   1.11%   6/30/2025    324,682    324,682    209,258 
Learfield Communications, Inc  Media: Advertising, Printing & Publishing  Initial Term Loan (A-L Parent)  Loan  1M USD LIBOR+   3.25%   1.00%   4.25%   12/1/2023    480,000    478,959    439,296 
Lifetime Brands, Inc  Consumer goods: Non-durable  Term Loan B  Loan  1M USD LIBOR+   3.50%   1.00%   4.50%   2/28/2025    2,905,639    2,876,036    2,878,413 
Liftoff Mobile, Inc.  Media: Advertising, Printing & Publishing  Liftoff Mobile T/L  Loan  1M USD LIBOR+   3.50%   0.75%   4.25%   2/17/2028    1,000,000    995,000    997,500 
Lightstone Generation LLC  Energy: Electricity  Term Loan B  Loan  3M USD LIBOR+   3.75%   1.00%   4.75%   1/30/2024    1,322,520    1,321,129    1,133,241 
Lightstone Generation LLC  Energy: Electricity  Term Loan C  Loan  3M USD LIBOR+   3.75%   1.00%   4.75%   1/30/2024    74,592    74,517    63,917 
Lindblad Expeditions, Inc.  Hotel, Gaming & Leisure  Cayman Term Loan  Loan  1M USD LIBOR+   3.50%   0.75%   4.25%   3/21/2025    98,191    98,037    90,827 
Lindblad Expeditions, Inc.  Hotel, Gaming & Leisure  US 2018 Term Loan  Loan  1M USD LIBOR+   3.50%   0.75%   4.25%   3/21/2025    392,764    392,147    363,307 
Liquidnet Holdings, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  6M USD LIBOR+   3.25%   1.00%   4.25%   7/11/2024    1,960,766    1,957,232    1,952,237 
LogMeIn, Inc.  High Tech Industries  Term Loan (8/20)  Loan  1M USD LIBOR+   4.75%   0.00%   4.87%   8/31/2027    4,000,000    3,927,780    3,996,680 
LPL Holdings, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B1  Loan  1M USD LIBOR+   1.75%   0.00%   1.87%   11/11/2026    1,232,760    1,230,271    1,224,032 
MA FinanceCo LLC  High Tech Industries  Term Loan B4  Loan  3M USD LIBOR+   4.25%   1.00%   5.25%   5/29/2025    2,474,961    2,466,727    2,502,804 
Marriott Ownership Resorts, Inc.  Hotel, Gaming & Leisure  Term Loan (11/19)  Loan  1M USD LIBOR+   1.75%   0.00%   1.86%   8/29/2025    1,317,074    1,317,074    1,296,080 
Match Group, Inc, The  Services: Consumer  Term Loan (1/20)  Loan  3M USD LIBOR+   1.75%   0.00%   1.95%   2/15/2027    250,000    249,476    247,735 
Mayfield Agency Borrower Inc. (FeeCo)  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD LIBOR+   4.50%   0.00%   4.61%   2/28/2025    3,427,214    3,397,660    3,380,090 
McAfee, LLC  Services: Business  Term Loan B  Loan  1M USD LIBOR+   3.75%   0.00%   3.86%   9/30/2024    1,928,400    1,921,750    1,932,121 
McGraw-Hill Global Education Holdings, LLC  Media: Advertising, Printing & Publishing  Term Loan B  Loan  3M USD LIBOR+   4.75%   1.00%   5.75%   11/1/2024    2,544,391    2,364,344    2,538,666 
Meredith Corporation  Media: Advertising, Printing & Publishing  Term Loan B2  Loan  1M USD LIBOR+   2.50%   0.00%   2.61%   1/31/2025    578,738    577,965    575,555 
Mermaid Bidco Inc.  High Tech Industries  Term Loan 12/20  Loan  2M USD LIBOR+   4.25%   0.75%   5.00%   12/1/2027    500,000    497,584    501,565 
Messer Industries, LLC  Chemicals, Plastics, & Rubber  Term Loan B  Loan  3M USD LIBOR+   2.50%   0.00%   2.75%   3/1/2026    3,944,962    3,923,644    3,942,003 
Michaels Stores, Inc.  Retail  Term Loan B (9/20)  Loan  1M USD LIBOR+   3.50%   0.75%   4.25%   10/1/2027    2,571,414    2,565,167    2,567,557 
Midwest Physician Administrative Services LLC (Dupage Medical Group)  Healthcare & Pharmaceuticals  Term Loan (2/18)  Loan  1M USD LIBOR+   2.75%   0.75%   3.50%   8/15/2024    961,003    958,186    960,522 
Mitchell International, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (7/20)  Loan  1M USD LIBOR+   4.25%   0.50%   4.75%   11/29/2024    997,500    944,391    1,000,991 

50

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value 
MKS Instruments, Inc.  High Tech Industries  Term Loan B6  Loan  1M USD LIBOR+   1.75%   0.00%   1.86%   2/2/2026    877,977    871,414    878,530 
MLN US Holdco LLC  Telecommunications  Term Loan  Loan  1M USD LIBOR+   4.50%   0.00%   4.61%   12/1/2025    980,000    978,728    913,605 
MMM Holdings, Inc.  Healthcare & Pharmaceuticals  Term Loan B  Loan  6M USD LIBOR+   5.75%   1.00%   6.75%   12/24/2026    6,724,026    6,605,313    6,730,347 
MRC Global Inc.  Metals & Mining  Term Loan B2  Loan  1M USD LIBOR+   3.00%   0.00%   3.11%   9/20/2024    484,961    484,234    477,687 
Murphy USA Inc.  Retail  Murphy Oil USA T/L (Quick Chek)  Loan  1M USD LIBOR+   1.75%   0.50%   2.25%   1/21/2028    250,000    249,384    250,938 
MW Industries, Inc. (Helix Acquisition Holdings)  Capital Equipment  Term Loan (2019 Incremental)  Loan  3M USD LIBOR+   3.75%   0.00%   4.00%   9/30/2024    2,842,097    2,802,381    2,740,265 
Natgasoline LLC  Chemicals, Plastics, & Rubber  Term Loan  Loan  1M USD LIBOR+   3.50%   0.00%   3.63%   11/14/2025    1,487,455    1,457,602    1,483,737 
National Mentor Holdings, Inc.  Healthcare & Pharmaceuticals  National Mentor /Civitas (2/21) T/L C  Loan  1M USD LIBOR+   4.00%   0.75%   4.75%   2/17/2028    87,464    87,026    87,289 
National Mentor Holdings, Inc.  Healthcare & Pharmaceuticals  Term Loan  Loan  1M USD LIBOR+   4.25%   0.00%   4.37%   3/9/2026    1,880,666    1,866,176    1,878,014 
National Mentor Holdings, Inc.  Healthcare & Pharmaceuticals  Term Loan C  Loan  3M USD LIBOR+   4.25%   0.00%   4.51%   3/9/2026    86,065    85,428    85,943 
National Mentor Holdings, Inc.  Healthcare & Pharmaceuticals  National Mentor/ Civitas (2/21) T/L  Loan  1M USD LIBOR+   4.00%   0.75%   4.75%   2/17/2028    2,623,907    2,610,787    2,618,659 
National Mentor/ Civitas (2/21) DDTL (a)  Healthcare & Pharmaceuticals  National Mentor (Civitas) T/L B (2/19)  Loan  1M USD LIBOR+   4.25%   0.00%   4.37%   3/9/2026    -    -    (577)
NeuStar, Inc.  Telecommunications  Term Loan B4 (03/18)  Loan  3M USD LIBOR+   3.50%   1.00%   4.50%   8/8/2024    2,641,566    2,611,256    2,542,032 
NeuStar, Inc.  Telecommunications  Term Loan B-5  Loan  3M USD LIBOR+   4.50%   1.00%   5.50%   8/8/2024    885,162    873,202    859,050 
Nexstar Broadcasting, Inc. (Mission Broadcasting)  Media: Broadcasting & Subscription  Nexstar Broadcasting T/L B4 (6/19)  Loan  1M USD LIBOR+   2.75%   0.00%   2.87%   9/18/2026    1,113,795    1,101,160    1,114,842 
Next Level Apparel, Inc.  Retail  Term Loan  Loan  3M PL WIBOR+   6.00%   1.00%   7.00%   8/9/2024    1,866,250    1,853,906    1,716,950 
NM Z Parent Inc (Zep Inc)  Chemicals, Plastics, & Rubber  Term Loan  Loan  6M USD LIBOR+   4.00%   1.00%   5.00%   8/9/2024    2,418,750    2,411,955    2,392,845 
NorthPole Newco S.a.r.l  Aerospace & Defense  Term Loan  Loan  3M USD LIBOR+   7.00%   0.00%   7.25%   3/3/2025    5,312,500    4,890,323    4,774,609 
Novetta Solutions, LLC  Aerospace & Defense  Term Loan  Loan  3M USD LIBOR+   5.00%   1.00%   6.00%   10/16/2022    1,899,870    1,894,609    1,889,193 
Novetta Solutions, LLC  Aerospace & Defense  Second Lien Term Loan  Loan  3M USD LIBOR+   8.50%   1.00%   9.50%   10/16/2023    1,000,000    995,635    997,500 
NPC International, Inc. (b)  Beverage, Food & Tobacco  Term Loan  Loan  Prime+   4.50%   1.00%   7.75%   4/19/2024    487,500    487,124    430,463 
Nuvei Technologies Corp.  High Tech Industries  US Term Loan  Loan  1M USD LIBOR+   4.00%   0.75%   4.75%   9/29/2025    250,000    249,712    251,563 
Owens & Minor  Healthcare & Pharmaceuticals  Term Loan B  Loan  1M USD LIBOR+   4.50%   0.00%   4.62%   5/2/2025    487,500    481,151    488,631 
Pacific Gas and Electric Company  Utilities: Electric  PG&E Corp T/L  Loan  1M USD LIBOR+   3.00%   0.50%   3.50%   6/18/2025    1,494,994    1,487,395    1,499,195 
PAE Holding Corp  Aerospace & Defense  Term Loan B (10/20)  Loan  3M USD LIBOR+   4.50%   0.75%   5.25%   10/14/2027    2,000,000    1,971,195    2,009,160 
Panther Guarantor II, L.P. (Forcepoint)  High Tech Industries  Panther Commercial T/L (1/21) (Forcepoint)  Loan  3M USD LIBOR+   4.50%   0.50%   4.71%   1/7/2028    500,000    496,307    499,375 
Pathway Partners Vet Management Company LLC  Services: Business  Term Loan  Loan  1M USD LIBOR+   3.75%   0.00%   3.86%   3/31/2027    496,437    485,943    496,934 
PaySafe Group PLC  Services: Business  Term Loan B1 (PI UK Holdco II)  Loan  1M USD LIBOR+   3.50%   1.00%   4.50%   1/3/2025    1,458,750    1,453,593    1,457,320 
PCI Gaming Authority  Hotel, Gaming & Leisure  Term Loan  Loan  1M USD LIBOR+   2.50%   0.00%   2.61%   5/29/2026    878,269    874,719    876,803 
Penn National Gaming  Hotel, Gaming & Leisure  Term Loan B-1  Loan  1M USD LIBOR+   2.25%   0.75%   3.00%   10/15/2025    1,782,979    1,722,678    1,780,109 

51

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value 
Peraton Corp.  Aerospace & Defense  Peraton T/L B  Loan  6M USD LIBOR+   3.75%   0.75%   4.50%   2/22/2028    1,811,655    1,802,597    1,818,449 
Peraton Corp. (a)  Aerospace & Defense  Unfunded Commitment  Loan  6M USD LIBOR+   3.75%   0.75%   4.50%   2/1/2028    -    (15,942)   11,956 
PGX Holdings, Inc.  Services: Consumer  Term Loan  Loan  12M USD LIBOR+   5.25%   1.00%   6.25%   9/29/2023    3,149,230    3,127,880    2,998,508 
Pitney Bowes Inc  Services: Business  Term Loan B  Loan  1M USD LIBOR+   5.50%   0.00%   5.62%   1/7/2025    2,887,500    2,625,587    2,875,459 
Pixelle Specialty Solutions LLC  Forest Products & Paper  Term Loan  Loan  1M USD LIBOR+   6.50%   1.00%   7.50%   10/31/2024    3,535,026    3,510,411    3,531,491 
Plastipak Holdings Inc.  Containers, Packaging & Glass  Plastipak Packaging T/L B (04/18)  Loan  1M USD LIBOR+   2.50%   0.00%   2.62%   10/14/2024    2,789,599    2,771,753    2,788,288 
Playtika Holding Corp.  High Tech Industries  Trm Loan B (12/19)  Loan  6M USD LIBOR+   6.00%   1.00%   7.00%   12/10/2024    2,837,975    2,793,084    2,850,746 
PointClickCare Technologies, Inc.  High Tech Industries  Term Loan B  Loan  6M USD LIBOR+   3.00%   0.75%   3.75%   12/15/2027    500,000    497,597    502,500 
Polymer Process Holdings, Inc.  Containers, Packaging & Glass  Term Loan  Loan  1M USD LIBOR+   4.75%   0.75%   5.50%   2/12/2028    5,000,000    4,932,905    4,950,000 
PPD, Inc.  Healthcare & Pharmaceuticals  Term Loan (12/20)  Loan  1M USD LIBOR+   2.25%   0.50%   2.75%   1/13/2028    500,000    497,556    501,530 
Pre-Paid Legal Services, Inc.  Services: Business  Incremental Term Loan  Loan  1M USD LIBOR+   4.00%   0.75%   4.75%   5/1/2025    997,500    983,807    1,001,869 
Presidio, Inc.  Services: Business  Term Loan B (1/20)  Loan  3M USD LIBOR+   3.50%   0.00%   3.72%   1/22/2027    497,500    496,508    498,120 
Prime Security Services Borrower, LLC (ADT)  Services: Consumer  Term Loan (1/21)  Loan  12M USD LIBOR+   2.75%   0.75%   3.50%   9/23/2026    3,583,174    3,568,406    3,585,178 
Priority Payment Systems LLC  High Tech Industries  Term Loan  Loan  1M USD LIBOR+   6.50%   1.00%   7.50%   1/3/2023    1,690,068    1,685,378    1,681,615 
PriSo Acquisition Corporation  Construction & Building  Park River Holdings T/L (01/21)  Loan  3M USD LIBOR+   3.25%   0.75%   4.00%   12/28/2027    500,000    497,500    500,535 
Project Leopard T/L (Kofax)  High Tech Industries  Term Loan  Loan  3M USD LIBOR+   5.05%   1.00%   5.25%   7/8/2024    500,000    498,750    500,468 
Prometric Inc. (Sarbacane Bidco)  Services: Consumer  Term Loan  Loan  1M USD LIBOR+   3.00%   1.00%   4.00%   1/29/2025    486,338    484,893    472,961 
PUG LLC  Services: Consumer  Term Loan B (02/20)  Loan  1M USD LIBOR+   3.50%   0.00%   3.61%   2/12/2027    490,025    487,871    475,323 
Rackspace Technology Global, Inc.  High Tech Industries  Rackspace Technology Global T/L B  Loan  3M USD LIBOR+   2.75%   0.75%   3.50%   2/2/2028    500,000    497,527    499,615 
Radiology Partners Holdings, LLC  Healthcare & Pharmaceuticals  Term Loan  Loan  1M USD LIBOR+   4.25%   0.00%   4.37%   7/4/2025    1,432,727    1,427,557    1,426,466 
Ravago Holdings America  Chemicals, Plastics, & Rubber  Ravago (2/21) T/L  Loan  6M USD LIBOR+   2.50%   0.00%   2.75%   2/9/2028    1,000,000    997,500    999,380 
RealPage, Inc.  High Tech Industries  RealPage T/L (2/21)  Loan  1M USD LIBOR+   3.25%   0.50%   3.38%   2/17/2028    3,000,000    2,992,500    3,001,260 
Redstone Buyer, LLC  High Tech Industries  Term Loan  Loan  3M USD LIBOR+   5.00%   1.00%   6.00%   9/1/2027    997,500    979,386    1,009,141 
Renaissance Learning T/L (5/18)  Services: Consumer  Term Loan  Loan  1M USD LIBOR+   3.25%   0.00%   3.36%   5/30/2025    3,000,000    2,970,900    2,968,740 
Rent-A-Center, Inc.  Retail  Rent-A-Center T/L B (01/21)  Loan  1M USD LIBOR+   4.00%   0.75%   4.75%   1/17/2028    500,000    497,500    503,125 
REP WWEX (Worldwide Express) Aquisition Parent, LLC  Transportation: Consumer  Term Loan B  Loan  6M USD LIBOR+   4.00%   1.00%   5.00%   2/2/2024    1,927,839    1,926,592    1,932,658 
Research Now Group, Inc  Media: Advertising, Printing & Publishing  Term Loan  Loan  6M USD LIBOR+   5.50%   1.00%   6.50%   12/20/2024    3,887,330    3,796,436    3,881,499 
Resideo Funding Inc.  Services: Consumer  Resideo Funding T/L (1/21) (Resideo Technologies)  Loan  3M USD LIBOR+   2.25%   0.50%   2.75%   2/11/2028    1,500,000    1,496,250    1,496,250 
Resolute Investment Managers (American Beacon), Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (10/20)  Loan  3M USD LIBOR+   3.75%   1.00%   4.75%   4/30/2024    2,651,324    2,651,324    2,657,952 
Rexnord LLC  Capital Equipment  Term Loan (11/19)  Loan  1M USD LIBOR+   1.75%   0.00%   1.86%   8/21/2024    862,069    862,069    860,724 

52

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value 
Reynolds Consumer Products LLC  Containers, Packaging & Glass  Reynolds Consumer Products T/L  Loan  1M USD LIBOR+   1.75%   0.00%   1.86%   1/29/2027    1,306,932    1,305,639    1,307,912 
Reynolds Group Holdings Inc.  Metals & Mining  Term Loan B2  Loan  1M USD LIBOR+   3.25%   0.00%   3.36%   2/5/2026    2,000,000    1,986,099    1,991,660 
Robertshaw US Holding Corp.  Consumer goods: Durable  Term Loan B  Loan  1M USD LIBOR+   3.50%   1.00%   4.50%   2/28/2025    972,500    970,927    916,581 
Rocket Software, Inc.  High Tech Industries  Term Loan (11/18)  Loan  1M USD LIBOR+   4.25%   0.00%   4.36%   11/28/2025    2,935,063    2,925,286    2,939,114 
RP Crown Parent, LLC  High Tech Industries  Term Loan B (07/20)  Loan  1M USD LIBOR+   3.00%   1.00%   4.00%   1/31/2026    1,990,000    1,981,157    1,992,488 
Russell Investments US Inst’l Holdco, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (10/20)  Loan  6M USD LIBOR+   3.00%   1.00%   4.00%   6/2/2025    5,637,965    5,591,015    5,648,565 
RV Retailer LLC  Automotive  RVR Dealership Holdings T/L (RV Retailer)  Loan  3M USD LIBOR+   4.00%   0.75%   4.75%   1/28/2028    2,000,000    1,980,404    1,992,500 
Ryan Specialty Group LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD LIBOR+   3.25%   0.75%   4.00%   9/1/2027    498,750    491,823    499,373 
Sally Holdings LLC  Retail  Term Loan B  Loan  1M USD LIBOR+   2.25%   0.00%   2.37%   7/5/2024    768,409    766,247    768,409 
Samsonite International S.A.  Consumer goods: Non-durable  Term Loan B2  Loan  1M USD LIBOR+   4.50%   1.00%   5.50%   4/25/2025    995,000    968,936    1,002,463 
Savage Enterprises, LLC  Energy: Oil & Gas  Term Loan B (02/20)  Loan  1M USD LIBOR+   3.00%   0.00%   3.12%   8/1/2025    1,769,504    1,754,769    1,771,999 
Schweitzer-Mauduit International, Inc.  High Tech Industries  Schweitzer-Mauduit T/L B  Loan  1M USD LIBOR+   4.00%   0.75%   4.75%   1/27/2028    1,000,000    990,000    997,500 
Seadrill Operating LP (b)  Energy: Oil & Gas  PIK Revolver  Loan  1M USD LIBOR+   0.00%   1.00%   1.00%   3/31/2021    25,683    25,656    27,224 
Seadrill Operating LP (b)  Energy: Oil & Gas  Term Loan B  Loan  1M USD LIBOR+   8.00%   1.00%   9.00%   3/31/2021    897,442    897,442    86,379 
Shutterfly Inc  Media: Advertising, Printing & Publishing  Term Loan B  Loan  3M USD LIBOR+   6.00%   1.00%   7.00%   9/25/2026    800,968    767,474    803,403 
Sirius Computer Solutions, Inc.  High Tech Industries  Term Loan 1/20  Loan  1M USD LIBOR+   3.50%   0.00%   3.61%   7/1/2026    1,970,100    1,966,584    1,970,809 
SMG US Midco 2, Inc.  Services: Business  Term Loan (01/20)  Loan  1M USD LIBOR+   2.50%   0.00%   2.61%   1/23/2025    495,000    495,000    470,869 
Sotheby’s  Services: Business  Term Loan (1/21)  Loan  3M USD LIBOR+   4.75%   0.75%   5.50%   1/15/2027    3,289,283    3,230,819    3,312,571 
Specialty Pharma III Inc.  Services: Business  Term Loan  Loan  1M USD LIBOR+   4.50%   0.75%   5.25%   2/24/2028    2,000,000    1,980,000    1,980,000 
Spectrum Brands, Inc.  Consumer goods: Durable  Spectrum Brands T/L (2/21)  Loan  1M USD LIBOR+   2.00%   0.50%   2.50%   2/19/2028    500,000    498,750    501,250 
SRAM, LLC  Consumer goods: Durable  Term Loan  Loan  1M USD LIBOR+   2.75%   1.00%   3.75%   3/15/2024    2,221,329    2,219,239    2,225,505 
SS&C Technologies, Inc.  Services: Business  Term Loan B4  Loan  1M USD LIBOR+   1.75%   0.00%   1.86%   4/16/2025    178,883    178,618    178,212 
SS&C Technologies, Inc.  Services: Business  Term Loan B-5  Loan  1M USD LIBOR+   1.75%   0.00%   1.86%   4/16/2025    488,567    487,746    486,735 
SS&C Technologies, Inc.  Services: Business  Term Loan B3  Loan  1M USD LIBOR+   1.75%   0.00%   1.86%   4/16/2025    234,915    234,561    234,034 
Staples, Inc.  Wholesale  Term Loan (03/19)  Loan  3M USD LIBOR+   5.00%   0.00%   5.21%   4/16/2026    4,431,567    4,285,772    4,340,853 
Stats LLC  Hotel, Gaming & Leisure  Term Loan  Loan  3M USD LIBOR+   5.25%   0.00%   5.45%   7/10/2026    1,980,000    1,940,067    1,972,575 
Storable, Inc  High Tech Industries  Term Loan B  Loan  1M USD LIBOR+   3.25%   0.50%   3.75%   2/26/2028    500,000    498,750    500,000 
Syncsort Incorporated  High Tech Industries  Term Loan (1/21)  Loan  3M USD LIBOR+   4.75%   0.75%   5.50%   8/16/2024    1,935,450    1,922,522    1,939,476 

53

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value 
Teneo Holdings LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD LIBOR+   5.25%   1.00%   6.25%   7/15/2025    2,468,750    2,392,146    2,471,836 
Tenneco Inc  Capital Equipment  Term Loan B  Loan  1M USD LIBOR+   3.00%   0.00%   3.11%   10/1/2025    1,470,000    1,459,901    1,440,233 
Ten-X, LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD LIBOR+   4.00%   1.00%   5.00%   9/27/2024    1,940,000    1,938,385    1,841,390 
The Octave Music Group, Inc (Touchtunes)  Services: Business  Term Loan B  Loan  1M USD LIBOR+   5.25%   1.00%   6.25%   5/29/2025    3,896,552    3,862,705    3,584,828 
Thor Industries, Inc.  Automotive  Term Loan (USD)  Loan  1M USD LIBOR+   3.75%   0.00%   3.88%   2/1/2026    2,935,080    2,874,260    2,937,839 
Tivity Health, Inc.  Healthcare & Pharmaceuticals  Term Loan A  Loan  1M USD LIBOR+   4.25%   0.00%   4.36%   3/7/2024    558,772    555,085    556,677 
Tivity Health, Inc.  Healthcare & Pharmaceuticals  Term Loan B  Loan  1M USD LIBOR+   5.25%   0.00%   5.36%   3/6/2026    1,064,955    1,044,356    1,060,461 
Tosca Services, LLC  Containers, Packaging & Glass  Term Loan (2/21)  Loan  1M USD LIBOR+   3.50%   0.75%   4.25%   8/18/2027    500,000    493,032    501,565 
Transdigm, Inc.  Aerospace & Defense  Term Loan G (02/20)  Loan  1M USD LIBOR+   2.25%   0.00%   2.36%   8/22/2024    4,065,230    4,068,753    4,014,415 
Travel Leaders Group, LLC  Hotel, Gaming & Leisure  Term Loan B (08/18)  Loan  1M USD LIBOR+   4.00%   0.00%   4.11%   1/25/2024    2,437,500    2,435,050    2,268,411 
TRC Companies, Inc.  Services: Business  Term Loan  Loan  1M USD LIBOR+   3.50%   1.00%   4.50%   6/21/2024    3,315,141    3,307,088    3,311,826 
TRC Companies, Inc.  Services: Business  TRC Companies T/L (1/21)  Loan  1M USD LIBOR+   4.50%   0.75%   5.25%   6/21/2024    2,479,433    2,468,047    2,485,631 
Trico Group LLC  Automotive  Term Loan B-3  Loan  3M USD LIBOR+   7.50%   1.00%   8.50%   2/2/2024    5,070,478    4,962,793    5,150,338 
Trident LS Merger Sub Corporation  Services: Consumer  Term Loan (03/18)  Loan  1M USD LIBOR+   3.25%   0.00%   3.36%   5/1/2025    2,000,000    2,004,987    1,999,500 
Truck Hero, Inc.  Transportation: Cargo  Term Loan (1/21)  Loan  1M USD LIBOR+   3.75%   0.75%   4.50%   1/29/2028    1,500,000    1,500,000    1,501,065 
TruGreen Limited Partnership  Services: Consumer  Term Loan  Loan  1M USD LIBOR+   4.00%   0.75%   4.75%   10/29/2027    973,980    966,347    980,068 
Twin River Worldwide Holdings, Inc.  Hotel, Gaming & Leisure  Term Loan B  Loan  3M USD LIBOR+   2.75%   0.00%   3.00%   5/10/2026    985,000    981,152    975,889 
Uber Technologies T/L B (2/21)  Transportation: Consumer  Term Loan  Loan  1M USD LIBOR+   3.50%   0.00%   3.62%   7/13/2023    1,989,610    1,941,468    1,992,097 
Ultimate Software Group, Inc. (The)  High Tech Industries  Term Loan 1/21  Loan  3M USD LIBOR+   3.25%   0.75%   4.00%   5/4/2026    1,000,000    1,000,000    1,005,690 
Unimin Corporation  Metals & Mining  Term Loan (12/20)  Loan  3M USD LIBOR+   4.00%   1.00%   5.00%   7/31/2026    496,815    466,608    476,232 
United Natural Foods, Inc  Beverage, Food & Tobacco  Term Loan B  Loan  1M USD LIBOR+   3.50%   0.00%   3.61%   10/22/2025    1,973,611    1,879,449    1,978,545 
United Road Services Inc.  Transportation: Cargo  Term Loan (10/17)  Loan  6M USD LIBOR+   5.75%   1.00%   6.75%   9/1/2024    952,506    944,697    880,592 
Univar Inc.  Chemicals, Plastics, & Rubber  Term Loan B3 (11/17)  Loan  1M USD LIBOR+   2.25%   0.00%   2.36%   7/1/2024    1,627,723    1,623,316    1,628,602 
Univision Communications Inc.  Media: Broadcasting & Subscription  2020 Replacement Term Loan  Loan  1M USD LIBOR+   3.75%   1.00%   4.75%   3/13/2026    2,517,037    2,508,528    2,527,433 
US Ecology, Inc.  Environmental Industries  Term Loan B  Loan  1M USD LIBOR+   2.50%   0.00%   2.61%   11/2/2026    495,000    494,095    496,445 
Utz Quality Foods, LLC  Beverage, Food & Tobacco  Term Loan B  Loan  1M USD LIBOR+   3.00%   0.00%   3.11%   1/13/2028    100,000    99,764    100,464 
Verifone Systems, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (7/18)  Loan  3M USD LIBOR+   4.00%   0.00%   4.18%   8/20/2025    1,396,606    1,389,850    1,362,571 
VFH Parent LLC  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  1M USD LIBOR+   3.00%   0.00%   3.11%   3/1/2026    3,209,493    3,199,747    3,215,526 
Virence Intermediate Holdings LLC (Athenahealth / VVC Holding)  Healthcare & Pharmaceuticals  Athenahealth T/L B (01/21)  Loan  3M USD LIBOR+   4.25%   0.00%   4.45%   2/11/2026    3,965,000    3,935,495    3,986,570 
Virtus Investment Partners, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  6M USD LIBOR+   2.25%   0.75%   3.00%   6/3/2024    2,406,176    2,405,891    2,407,692 
Vistra Energy Corp  Utilities: Electric  2018 Incremental Term Loan  Loan  1M USD LIBOR+   1.75%   0.00%   1.86%   12/31/2025    917,338    916,645    913,751 
Vizient, Inc  Healthcare & Pharmaceuticals  Term Loan B-6  Loan  1M USD LIBOR+   2.00%   0.00%   2.11%   5/6/2026    491,250    490,388    490,430 

54

 

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  LIBOR Floor   Current Rate (All In)   Maturity Date   Principal/
Number of Shares
   Cost   Fair Value 
VM Consolidated, Inc.  Construction & Building  Term Loan B1 (02/20)  Loan  1M USD LIBOR+   3.25%   0.00%   3.36%   2/28/2025    475,444    473,957    475,344 
Vouvray US Finance LLC  High Tech Industries  Term Loan  Loan  1M USD LIBOR+   3.00%   1.00%   4.00%   3/11/2024    481,250    481,250    417,605 
Warner Music Group Corp. (WMG Acquisition Corp.)  Hotel, Gaming & Leisure  Term Loan G  Loan  1M USD LIBOR+   2.13%   0.00%   2.24%   1/20/2028    250,000    249,702    250,403 
Wastequip, LLC (HPCC Merger/Patriot Container)  Environmental Industries  Term Loan (3/18)  Loan  1M USD LIBOR+   3.50%   1.00%   4.50%   3/15/2025    494,911    492,859    492,436 
WeddingWire, Inc.  Services: Consumer  Term Loan  Loan  2M USD LIBOR+   4.50%   0.00%   4.66%   12/19/2025    3,920,000    3,914,114    3,875,900 
West Corporation  Telecommunications  Term Loan B  Loan  1M USD LIBOR+   3.50%   1.00%   4.50%   10/10/2024    2,931,109    2,874,412    2,866,742 
West Corporation  Telecommunications  Term Loan B (Olympus Merger)  Loan  3M USD LIBOR+   4.00%   1.00%   5.00%   10/10/2024    1,224,748    1,166,274    1,207,062 
Western Dental Services, Inc.  Retail  Term Loan (12/18)  Loan  1M USD LIBOR+   5.25%   1.00%   6.25%   6/30/2023    424,019    424,421    416,598 
Western Digital Corporation  High Tech Industries  Term Loan B-4  Loan  1M USD LIBOR+   1.75%   0.00%   1.86%   4/29/2023    743,135    732,963    742,867 
Wirepath LLC  Consumer goods: Non-durable  Term Loan  Loan  3M USD LIBOR+   4.00%   0.00%   4.25%   8/5/2024    2,925,193    2,906,978    2,897,170 
WP CITYMD BIDCO LLC  Services: Consumer  Term Loan B (1/21)  Loan  6M USD LIBOR+   3.75%   0.75%   4.50%   8/13/2026    3,465,000    3,437,657    3,471,791 
Xperi Corporation  High Tech Industries  Term Loan  Loan  1M USD LIBOR+   4.00%   0.00%   4.11%   6/1/2025    2,854,798    2,706,612    2,874,439 
Zekelman Industries, Inc.  Metals & Mining  Term Loan (01/20)  Loan  1M USD LIBOR+   2.00%   0.00%   2.11%   1/25/2027    970,775    970,775    968,551 
                                        $595,249,474   $592,020,041 

 

   Number of Shares   Cost   Fair Value 
Cash and cash equivalents               
U.S. Bank Money Market (c)   114,145,406   $114,145,406   $114,145,406 
Total cash and cash equivalents   114,145,406   $114,145,406   $114,145,406 

 

(a)All or a portion of this investment has an unfunded commitment as of February 28, 2021
(b)As of February 28, 2021, the investment was in default and on non-accrual status.
(c)Included within cash and cash equivalents in Saratoga CLO’s Statements of Assets and Liabilities as of February 28, 2021.

 

LIBOR—London Interbank Offered Rate

 

1W USD LIBOR—The 1 week USD LIBOR rate as of February 28, 2021 was 0.09%.

1M USD LIBOR—The 1 month USD LIBOR rate as of February 28, 2021 was 0.12%.

2M USD LIBOR—The 2 month USD LIBOR rate as of February 28, 2021 was 0.15%.

3M USD LIBOR—The 3 month USD LIBOR rate as of February 28, 2021 was 0.19%.

6M USD LIBOR—The 6 month USD LIBOR rate as of February 28, 2021 was 0.20%.

12M USD LIBOR - The 12 month USD LIBOR rate as of February 28, 2021 was 0.28%

3M PL WIBOR - The 3 month PL WIBOR rate as of February 28, 2021, was 0.21%

Prime—The Prime Rate as of February 28, 2021 was 3.25%.

 

55

 

 

Note 5. Income Taxes

 

SIA-Avionte, Inc., SIA-GH Inc., SIA-MAC, Inc., SIA-PP Inc., SIA-TG, Inc., SIA-TT, Inc., SIA-Vector, Inc., and SIA-VR, Inc., each 100% owned by the Company, are each filing standalone C Corporation tax returns for federal and state purposes. As separately regarded entities for tax purposes, these entities are taxed at normal corporate rates. For tax purposes, any distributions by the entities to the parent company would generally need to be distributed to the Company’s shareholders. Generally, such distributions of the entities’ income to the Company’s shareholders will be considered as qualified dividends for tax purposes. The entities’ taxable net income will differ from U.S. GAAP net income because of deferred tax temporary differences arising from net operating losses and unrealized appreciation and deprecation of securities held. Deferred tax assets and liabilities are measured using enacted corporate federal and state tax rates expected to apply to taxable income in the years in which those net operating losses are utilized and the unrealized gains and losses are realized. Deferred tax assets and deferred tax liabilities are netted off by entity, as allowed. The recoverability of deferred tax assets is assessed and a valuation allowance is recorded to the extent that it is more likely than not that any portion of the deferred tax asset will not be realized on the basis of a history of operating losses combined with insufficient projected taxable income or other taxable events in the taxable blockers.

 

The Company may distribute a portion of its realized net long term capital gains in excess of realized net short term capital losses to its stockholders, but may also decide to retain a portion, or all, of its net capital gains and elect to pay the 21% U.S. federal tax on the net capital gain, potentially in the form of a “deemed distribution” to its stockholders. Income tax (provision) relating to an election to retain its net capital gains, including in the form of a deemed distribution, is included as a component of income tax (provision) benefit from realized gains on investments, depending on the character of the underlying taxable income (ordinary or capital gains), on the consolidated statements of operations.

 

Deferred tax assets and liabilities, and related valuation allowance as of May 31, 2021 and February 28, 2021 were as follows:

 

   May 31, 2021   February 28, 2021 
Total deferred tax assets  $2,144,029   $2,108,556 
Total deferred tax liabilities   (2,217,264)   (1,987,120)
Valuation allowance on net deferred tax assets   (2,107,492)   (2,044,100)
Net deferred tax liability  $(2,180,727)  $(1,922,664)

 

As of May 31, 2021, the valuation allowance on deferred tax assets was $2.1 million, which represents the federal and state tax effect of net operating losses and unrealized losses that we do not believe we will realize through future taxable income. Any adjustments to the Company’s valuation allowance will depend on estimates of future taxable income and will be made in the period such determination is made.

 

Net deferred tax (benefit) expense for the three months ended May 31, 2021 includes $0.2 million net change in unrealized appreciation (depreciation) on investments and $0.0 million net change in total operating expense, in the consolidated statement of operations, respectively. Net deferred tax (benefit) expense for the three months ended May 31, 2020 includes $(0.3) million net change in unrealized appreciation (depreciation) on investments and $(0.01) million net change in total operating expense, in the consolidated statement of operations, respectively.

 

Deferred tax temporary differences may include differences for state taxes and joint venture interests.

 

Federal and state income tax provisions (benefits) on investments for three months ended May 31, 2021 and May 31, 2020:

 

   For the three months ended 
   May 31, 2021   May 31, 2020 
Current          
Federal  $-   $- 
State   -    - 
Net current expense   -    - 
Deferred          
Federal   (127,850)   (245,474)
State   (130,213)   (31,211)
Net deferred expense   (258,063)   (276,685)
Net tax provision  $(258,063)  $(276,685)

 

56

 

 

Note 6. Agreements and Related Party Transactions

 

Investment Advisory and Management Agreement

 

On July 30, 2010, the Company entered into the Management Agreement with our Manager. The initial term of the Management Agreement was two years, with automatic, one-year renewals at the end of each year, subject to certain approvals by our board of directors and/or the Company’s stockholders. On July 6, 2021, our board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, our Manager implements our business strategy on a day-to-day basis and performs certain services for us, subject to oversight by our board of directors. Our Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, we have agreed to pay our Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive management fee.

 

Base Management Fee and Incentive Management Fee

 

The base management fee of 1.75% per year is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters. The base management fee is paid quarterly following the filing of the most recent 10-Q.

 

The incentive management fee consists of the following two parts:

 

The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, our Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. Our Manager will receive 100.0% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter; and 20.0% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter. There is no accumulation of amounts on the hurdle rate from quarter to quarter, and accordingly there is no claw back of amounts previously paid if subsequent quarters are below the quarterly hurdle rate, and there is no delay of payment if prior quarters are below the quarterly hurdle rate.

 

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the fiscal year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis on each investment in the Company’s portfolio, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and our Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

 

For the three months ended May 31, 2021 and May 31, 2020, the Company incurred $2.8 million and $2.2 million in base management fees, respectively. For the three months ended May 31, 2021 and May 31, 2020, the Company incurred $1.6 million and $1.4 million in incentive fees related to pre-incentive fee net investment income, respectively. For the three months ended May 31, 2021 and May 31, 2020, the Company accrued an expense of $3.7 million and an expense of $(3.3) million in incentive fees related to capital gains.

 

The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of May 31, 2021, the base management fees accrual was $2.8 million and the incentive fees accrual was $3.7 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 28, 2021, the base management fees accrual was $2.4 million and the incentive fees accrual was $13.8 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

 

57

 

 

Administration Agreement

 

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with our Manager, pursuant to which our Manager, as our administrator, has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide managerial assistance on our behalf to those portfolio companies to which we are required to provide such assistance. The initial term of the Administration Agreement was two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. The amount of expenses payable or reimbursable thereunder by the Company was capped at $1.0 million for the initial two-year term of the Administration Agreement and subsequent renewals. On July 8, 2015, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company thereunder, which had not been increased since the inception of the agreement, to $1.3 million. On July 7, 2016, our board of directors approved the renewal of the Administration Agreement for an additional one-year term. On October 5, 2016, our board of directors determined to increase the cap on the payment or reimbursement of expenses by the Company under the Administration Agreement, from $1.3 million to $1.5 million, effective November 1, 2016. On July 11, 2017, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company from $1.5 million to $1.75 million, effective August 1, 2017. On July 9, 2018, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company from $1.75 million to $2.0 million, effective August 1, 2018. On July 9, 2019, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company from $2.0 million to $2.225 million effective August 1, 2019. On July 7, 2020, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company from $2.225 million to $2.775 million effective August 1, 2020. On July 6, 2021, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company from $2.775 million to $3.0 million effective August 1, 2021.

 

For the three months ended May 31, 2021 and May 31, 2020, we recognized $0.7 million and $0.6 million in administrator expenses, respectively, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses. As of May 31, 2021, $0.7 million of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities. As of February 28, 2021, $0.3 million of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities.

 

Saratoga CLO

 

On August 7, 2018, the Company entered into an unsecured loan agreement with CLO 2013-1 Warehouse, a wholly-owned subsidiary of Saratoga CLO, pursuant to which CLO 2013-1 Warehouse may borrow from time to time up to $25 million from the Company in order to provide capital necessary to support warehouse activities. The CLO 2013-1 Warehouse Loan, which expired on February 7, 2020, bears interest at an annual rate of 3M USD LIBOR + 7.5%.

 

On December 14, 2018, the Company completed the third refinancing and issuance of the 2013-1 Reset CLO Notes. This refinancing, among other things, extended the Saratoga CLO reinvestment period to January 2021, and extended its legal maturity to January 2030. A non-call period ending January 2020 was also added. In addition, and as part of the refinancing, the Saratoga CLO has also been upsized from $300 million in assets to approximately $500 million. As part of this refinancing and upsizing, the Company invested an additional $13.8 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $2.5 million in aggregate principal amount of the Class F-R-2 Notes tranche and $7.5 million in aggregate principal amount of the Class G-R-2 Notes tranche at par. Concurrently, the existing $4.5 million of Class F notes and $20.0 million CLO 2013-1 Warehouse Loan were repaid. The Company also paid $2.0 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. During the year ended February 29, 2020, the Company received full payment of $1.7 million from the Saratoga CLO for such transaction costs.

 

58

 

 

In conjunction with the third refinancing and issuance of the 2013-1 Reset CLO Notes on December 14, 2018, the Company is no longer entitled to receive an incentive management fee from Saratoga CLO. See Note 4 for additional information.

 

On February 26, 2021, the Company completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, and extended its legal maturity to April 2033. A non-call period ending February 2022 was also added. In addition, and as part of the refinancing, the Saratoga CLO has also been upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, the Company invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million CLO 2013-1 Warehouse 2 Loan were repaid. The Company also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. As of May 31, 2021, there remained an outstanding receivable of $2.6 million for such transaction costs which is presented as due from affiliate on the Company’s consolidated statement of assets and liabilities.

 

For the three months ended May 31, 2021 and May 31, 2020, we recognized management fee income of $0.8 million and $0.6 million, respectively, related to the Saratoga CLO.

 

For the three months ended May 31, 2021 and May 31, 2020, the Company neither bought nor sold any investments from the Saratoga CLO.

 

Note 7. Borrowings

 

Credit Facility

 

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200.0% after giving effect to such leverage, or, if we obtain the required approvals from our independent directors and/or stockholders, 150.0%. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing. Our asset coverage ratio, as defined in the 1940 Act, was 251.0% as of May 31, 2021 and 347.1% as of February 28, 2021. On April 16, 2018, as permitted by the Small Business Credit Availability Act, which was signed into law on March 23, 2018, our non-interested board of directors approved of our becoming subject to a minimum asset coverage ratio of 150.0% under Sections 18(a)(1) and 18(a)(2) of the Investment Company Act, as amended. The 150.0% asset coverage ratio became effective on April 16, 2019.

 

On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral were used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.

 

On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $45.0 million senior secured revolving credit facility with Madison Capital Funding LLC (the “Credit Facility”), in each case, to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our total assets, other than those held by SBIC LP, have been pledged under the Credit Facility to secure our obligations thereunder.

 

59

 

 

On February 24, 2012, we amended the Credit Facility to, among other things:

 

expand the borrowing capacity under the Credit Facility from $40.0 million to $45.0 million;

 

extend the period during which we may make and repay borrowings under the Credit Facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may, upon the occurrence of an event of default, by action of the lenders or automatically, be terminated. All borrowings and other amounts payable under the Credit Facility are due and payable five years after the end of the Revolving Period; and

 

remove the condition that we may not acquire additional loan assets without the prior written consent of Madison Capital Funding LLC.

 

On September 17, 2014, we entered into a second amendment to the Credit Facility to, among other things:

 

extend the commitment termination date from February 24, 2015 to September 17, 2017;

 

extend the maturity date of the Credit Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

 

reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

 

reduce the floor on base rate borrowings from 3.00% to 2.25%, and on LIBOR borrowings from 2.00% to 1.25%.

 

On May 18, 2017, we entered into a third amendment to the Credit Facility to, among other things:

 

extend the commitment termination date from September 17, 2017 to September 17, 2020;

 

extend the final maturity date of the Credit Facility from September 17, 2022 to September 17, 2025 (unless terminated sooner upon certain events);

 

reduce the floor on base rate borrowings from 2.25% to 2.00%;

 

reduce the floor on LIBOR borrowings from 1.25% to 1.00%; and

 

reduce the commitment fee rate from 0.75% to 0.50% for any period during which the ratio of advances outstanding to aggregate commitments, expressed as a percentage, is greater than or equal to 50%.

 

On April 24, 2020, we entered into a fourth amendment to the Credit Facility to, among other things:

 

permit certain amendments related to the Paycheck Protection Program (“Permitted PPP Amendment”) to Loan Asset Documents;

 

exclude certain debt and interest amounts allowed by the Permitted PPP Amendments from certain calculations related to Net Leverage Ratio, Interest Coverage Ratio and EBITDA; and

 

exclude such Permitted PPP Amendments from constituting a Material Modification.

 

On September 14, 2020, we entered into a fifth amendment to the Credit Facility to, among other things:

 

extend the commitment termination date of the Credit Facility from September 17, 2020 to September 17, 2021, with no change to the maturity date of September 17, 2025.

 

provide for the transition away from the LIBOR Rate in the market, and

 

expand the definition of “Eligible Loan Asset” to allow investments with certain recurring revenue features to qualify as Collateral and be included in the borrowing base.

 

60

 

 

In addition to any fees or other amounts payable under the terms of the Credit Facility, an administrative agent fee per annum equal to $0.1 million is payable in equal monthly installments in arrears.

 

As of May 31, 2021 and February 28, 2021, there were $39.0 million and $0.0 million, respectively, borrowed under the Credit Facility. During the applicable periods, the Company was in compliance with all of the limitations and requirements of the Credit Facility. Financing costs of $3.4 million related to the Credit Facility have been capitalized and are being amortized over the term of the facility.

 

For the three months ended May 31, 2021 and May 31, 2020, we recorded $0.2 million and $0.1 million of interest expense related to the Credit Facility, respectively, which includes commitment and administrative agent fees. For the three months ended May 31, 2021 and May 31, 2020, we recorded $0.04 million and $0.02 million of amortization of deferred financing costs related to the Credit Facility, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2021, the weighted average interest rate on the outstanding borrowings under the Credit Facility was 6.37%, and the average dollar amount of outstanding borrowings under the Credit Facility was $4.1 million.

 

The Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. The Credit Facility has an eight-year term, consisting of a three-year period (the “Revolving Period”), under which the Company may make and repay borrowings, and a final maturity five years from the end of the Revolving Period. Availability on the Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the Borrowing Base. Funds may be borrowed at the greater of the prevailing one-month LIBOR rate and 1.00%, plus an applicable margin of 4.75%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 2.00%, and the applicable margin over such alternative base rate is 3.75%. In addition, the Company will pay the lenders a commitment fee of 0.75% per year (or 0.50% if the ratio of advances outstanding to aggregate commitments is greater than or equal to 50%) on the unused amount of the Credit Facility for the duration of the Revolving Period.

 

Our borrowing base under the Credit Facility was $51.1 million subject to the Credit Facility cap of $45.0 million at May 31, 2021. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission (“SEC”). Accordingly, the May 31, 2021 borrowing base relies upon the valuations set forth in the Annual Report on Form 10-K for the period ended February 28, 2021. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

 

SBA Debentures

 

Our wholly-owned SBIC subsidiaries are able to borrow funds from the SBA against regulatory capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA.

 

On August 14, 2019, the Company’s wholly-owned subsidiary, SBIC II LP, received an SBIC license from the SBA. The new license provides up to $175.0 million in additional long-term capital in the form of SBA debentures. As a result of the 2016 omnibus spending bill signed into law in December 2015, the maximum amount of SBA-guaranteed debentures that affiliated SBIC funds can have outstanding was increased from $225.0 million to $350.0 million. With this license approval, Saratoga can grow its SBA relationship from $150.0 million to $325.0 million of committed capital.

 

As of May 31, 2021, we have funded SBIC LP and SBIC II LP with an aggregate total of equity capital of $75.0 million and $84.0 million, respectively, and have $168.0 million in SBA-guaranteed debentures outstanding, of which $124.0 million is held in SBIC LP and $44.0 million held in SBIC II LP. SBA debentures are non-recourse to us, have a 10-year maturity, and may be prepaid at any time without penalty. The interest rate of SBA debentures is fixed at the time of issuance, often referred to as pooling, at a market-driven spread over 10-year U.S. Treasury Notes. SBA current regulations limit the amount that SBIC LP and SBIC II LP may borrow to a maximum of $150.0 million and $175.0 million, respectively, which is up to twice its potential regulatory capital.

 

61

 

 

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $19.5 million and have average annual fully taxed net income not exceeding $6.5 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to ‘‘smaller’’ concerns as defined by the SBA. A smaller concern is one that has a tangible net worth not exceeding $6.0 million and has average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

 

SBIC LP and SBIC II LP are subject to regulation and oversight by the SBA, including requirements with respect to maintaining certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that SBIC II LP will receive SBA-guaranteed debenture funding, which is dependent upon SBIC II LP continuing to be in compliance with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to SBIC LP and SBIC II LP assets over our stockholders and debtholders in the event we liquidate SBIC LP and SBIC II LP or the SBA exercises its remedies under the SBA-guaranteed debentures issued by SBIC LP and SBIC II LP upon an event of default.

 

The Company received exemptive relief from the SEC to permit it to exclude the debt of SBIC subsidiaries guaranteed by the SBA from the definition of senior securities in the asset coverage test under the 1940 Act. This allows the Company increased flexibility under the asset coverage test by permitting it to borrow up to $325.0 million more than it would otherwise be able to absent the receipt of this exemptive relief. On April 16, 2018, as permitted by the Small Business Credit Availability Act, which was signed into law on March 23, 2018, the non-interested board of directors of the Company approved of the Company becoming subject to a minimum asset coverage ratio of 150.0% from 200% under Sections 18(a)(1) and 18(a)(2) of the Investment Company Act, as amended. The 150.0% asset coverage ratio became effective on April 16, 2019.

 

As noted above, as of May 31, 2021, there was $168.0 million of SBA debentures outstanding and as of February 28, 2021, there was $158.0 million of SBA debentures outstanding. The carrying amount of the amount outstanding of SBA debentures approximates its fair value, which is based on a waterfall analysis showing adequate collateral coverage and would be classified as a Level 3 liability within the fair value hierarchy. Financing costs of $5.0 million and $2.5 million related to the SBA debentures issued by SBIC LP and SBIC II LP, respectively, have been capitalized and are being amortized over the term of the commitment and drawdown.

 

For the three months ended May 31, 2021 and May 31, 2020, we recorded $1.2 million and $1.2 million of interest expense related to the SBA debentures, respectively. For the three months ended May 31, 2021 and May 31, 2020, we recorded $0.2 million and $0.2 million of amortization of deferred financing costs related to the SBA debentures, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. The weighted average interest rate during the three months ended May 31, 2021 and May 31, 2020 on the outstanding borrowings of the SBA debentures was 2.93% and 3.16%, respectively. During the three months ended May 31, 2021 and May 31, 2020, the average dollar amount of SBA debentures outstanding was $158.4 million and $157.4 million, respectively.

 

In December 2015, the 2016 omnibus spending bill approved by Congress and signed into law by the President increased the amount of SBA-guaranteed debentures that affiliated SBIC funds can have outstanding from $225.0 million to $350.0 million, subject to SBA approval. SBA regulations previously limited the amount of SBA-guaranteed debentures that an SBIC may issue to $150.0 million when it has at least $75.0 million in regulatory capital but this has increased to $175.0 million for new licenses when it has at least $87.5 million in regulatory capital. Affiliated SBICs are permitted to issue up to a combined maximum amount of $350.0 million in SBA-guaranteed debentures when they have at least $175.0 million in combined regulatory capital.

 

Notes

 

In May 10, 2013, the Company issued $48.3 million in aggregate principal amount of 7.50% fixed-rate notes due 2020 (the “2020 Notes”). The 2020 Notes were redeemed in full on January 13, 2017 and are no longer listed on the NYSE.

 

62

 

 

On May 29, 2015, the Company entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. through which the Company may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the 2020 Notes through an At-the-Market (“ATM”) offering. Prior to the 2020 Notes being redeemed in full, the Company had sold 539,725 bonds with a principal of $13.5 million at an average price of $25.31 for aggregate net proceeds of $13.4 million (net of transaction costs).

 

On December 21, 2016, the Company issued $74.5 million in aggregate principal amount of our 6.75% fixed-rate notes due 2023 (the “2023 Notes”) for net proceeds of $71.7 million after deducting underwriting commissions of approximately $2.3 million and offering costs of approximately $0.5 million. The net proceeds from the offering were used to repay all of the outstanding indebtedness under the 2020 Notes, which amounted to $61.8 million, and for general corporate purposes in accordance with our investment objective and strategies.

 

On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.5 million, respectively, in aggregate principal amount of the $74.5 million in aggregate principal amount of issued and outstanding 2023 Notes. The 2023 Notes were listed on the NYSE under the trading symbol “SAB” with a par value of $25.00 per share, and have been delisted following the redemption.

 

On August 28, 2018, the Company issued $40.0 million in aggregate principal amount of our 6.25% fixed-rate notes due 2025 (the “6.25% 2025 Notes”) for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.3 million. The issuance included the full exercise of the underwriters’ option to purchase an additional $5.0 million aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest on the 6.25% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year, beginning November 30, 2018. The 6.25% 2025 Notes mature on August 31, 2025 and commencing August 28, 2021, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.6 million related to the 6.25% 2025 Notes have been capitalized and are being amortized over the term of the 6.25% 2025 Notes.

 

On February 5, 2019, the Company completed a re-opening and up-sizing of its existing 6.25% 2025 Notes by issuing an additional $20.0 million in aggregate principal amount for net proceeds of $19.2 million after deducting underwriting commissions of approximately $0.6 million and discount of $0.2 million. Offering costs incurred were approximately $0.2 million. The issuance included the full exercise of the underwriters’ option to purchase an additional $2.5 million aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest rate, interest payment dates and maturity remain unchanged from the existing 6.25% 2025 Notes issued in August 2018. The net proceeds from this offering were used for general corporate purposes in accordance with our investment objective and strategies. The financing costs and discount of $1.0 million related to the 6.25% 2025 Notes have been capitalized and are being amortized over the term of the 6.25% 2025 Notes.

 

As of May 31, 2021, the total 6.25% 2025 Notes outstanding was $60.0 million. The 6.25% 2025 Notes are listed on the NYSE under the trading symbol “SAF” with a par value of $25.00 per share.

 

As of May 31, 2021, the carrying amount and fair value of the 6.25% 2025 Notes was $60.0 million and $60.9 million, respectively. The fair value of the 6.25% 2025 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2021, the carrying amount and fair value of the 6.25% 2025 Notes was $60.0 million and $61.2 million, respectively.

 

For the three months ended May 31, 2021 and May 31, 2020, we recorded $0.9 million and $0.9 million, respectively, of interest expense and $0.1 million and $0.1 million, respectively, of amortization of deferred financing costs related to the 6.25% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2021 and May 31, 2020, the average dollar amount of 6.25% 2025 Notes outstanding was $60.0 million and $60.0 million, respectively.

 

As discussed above, during the fourth quarter of 2020 fiscal year, the Company redeemed $74.45 million in aggregate principal amount of issued outstanding 2023 Notes.

 

63

 

 

On June 24, 2020, the Company issued $37.5 million in aggregate principal amount of our 7.25% fixed-rate notes due 2025 (the “7.25% 2025 Notes”) for net proceeds of $36.3 million after deducting underwriting commissions of approximately $1.2 million. Offering costs incurred were approximately $0.3 million. On July 6, 2020, the underwriters exercised their option in full to purchase an additional $5.625 million in aggregate principal amount of its 7.25% 2025 Notes. Net proceeds to the Company were $5.4 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 7.25% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.25% per year, beginning August 31, 2020. The 7.25% 2025 Notes mature on June 30, 2025 and commencing June 24, 2022, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.6 million related to the 7.25% 2025 Notes have been capitalized and are being amortized over the term of the 7.25% 2025 Notes.

 

As of May 31, 2021, the total 7.25% 2025 Notes outstanding was $43.1 million. The 7.25% 2025 Notes are listed on the NYSE under the trading symbol “SAK” with a par value of $25.00 per share.

 

As of May 31, 2021, the carrying amount and fair value of the 7.25% 2025 Notes was $43.1 million and $45.7 million, respectively. The fair value of the 7.25% 2025 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2021, the carrying amount and fair value of the 7.25% 2025 Notes was $43.1 million and $45.7 million, respectively.

 

For the three months ended May 31, 2021 and May 31, 2020, we recorded $0.8 million and $0.0 million, respectively, of interest expense and $0.08 million and $0.0 million, respectively, of amortization of deferred financing costs related to the 7.25% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2021 and May 31, 2020, the average dollar amount of the 7.25% 2025 Notes outstanding was $43.1 million and $0.0 million respectively.

 

On July 9, 2020, the Company issued $5.0 million aggregate principal amount of our 7.75% fixed-rate Notes due in 2025 (the “7.75% Notes 2025”) for net proceeds of $4.8 million after deducting underwriting commissions of approximately $0.2 million. Offering costs incurred were approximately $0.1 million. Interest on the 7.75% Notes 2025 is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.75% per year, beginning August 31, 2020. The 7.75% Notes 2025 mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.3 million related to the 7.75% Notes 2025 have been capitalized and are being amortized over the term of the Notes.

 

As of May 31, 2021, the total 7.75% Notes 2025 outstanding was $5.0 million The 7.75% Notes 2025 are not listed and have a par value of $25.00 per share. As of May 31, 2021, there was $5.0 million of 7.75% Notes 2025 outstanding and as of February 28, 2021, there was $5.0 million outstanding. The carrying amount of the amount outstanding of 7.75% Notes 2025 approximates its fair value, which is based on a waterfall analysis showing adequate collateral coverage and would be classified as a Level 3 liability within the fair value hierarchy.

 

For the three months ended May 31, 2021 and May 31, 2020, we recorded $0.1 million and $0.0 million, respectively, of interest expense and $0.02 million and $0.0 million, respectively, of amortization of deferred financing costs related to the 7.75% Notes 2025. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2021 and May 31, 2020 the average dollar amount of 7.75% Notes 2025 outstanding was $5.0 million and $0.0 million respectively.

 

On December 29, 2020, the Company issued $5.0 million aggregate principal amount of our 6.25% fixed-rate notes due in 2027 (the “6.25% Notes 2027”). Offering costs incurred were approximately $0.1 million. Interest on the 6.25% Notes 2027 is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year, beginning February 28, 2021. The 6.25% Notes 2027 mature on December 29, 2027 and may be redeemed in whole or in part at any time or from time to time at our option, on or after December 29, 2024. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.1 million related to the 6.25% Notes 2027 have been capitalized and are being amortized over the term of the Notes.

 

64

 

 

On January 28, 2021, the Company issued $10.0 million aggregate principal amount of our 6.25% fixed rate Notes due in 2027 (the “6.25% Notes 2027”) for net proceeds of $9.7 million after deducting underwriting commissions of approximately $0.3 million. Offering costs incurred were approximately $0.0 million. Interest on the 6.25% Notes 2027 is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year, beginning February 28, 2021. The 6.25% Notes 2027 mature on January 28, 2027 and commencing January 28, 2023, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.3 million related to the 6.25% Notes 2027 have been capitalized and are being amortized over the term of the Notes.

 

As of May 31, 2021, the total 6.25% Notes 2027 outstanding was $15.0 million The 6.25% Notes 2027 are not listed and have a par value of $25.00 per share. As of May 31, 2021, there was $15.0 million of 6.25% Notes 2027 outstanding and as of February 28, 2021, there was $15.0 million outstanding. The carrying amount of the amount outstanding of 6.25% Notes 2027 approximates its fair value, which is based on a waterfall analysis showing adequate collateral coverage and would be classified as a Level 3 liability within the fair value hierarchy.

 

For the three months ended May 31, 2021 and May 31, 2020, we recorded $0.2 million and $0.0 million, respectively, of interest expense and $0.02 million and $0.0 million, respectively, of amortization of deferred financing costs related to the 6.25% Notes 2027. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2021 and May 31, 2020 the average dollar amount of 6.25% Notes 2027 outstanding was $15.0 million and $0.0 million respectively.

 

On March 10, 2021, the Company issued $50.0m aggregate principal amount of our 4.375% fixed-rate Notes due in 2026 (the “4.375% Notes 2026”) for net proceeds of $49.0 million after deducting underwriting commissions of approximately $1.0 million. Offering costs incurred were approximately $0.2 million. Interest on the 4.375% Notes 2026 is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.375% per year, beginning August 28, 2021. The 4.375% Notes 2026 mature on February 28, 2026 and may be redeemed in whole or in part at any time or from time to time at the Company’s option at par plus a “make-whole” premium, if applicable. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.2 million related to the 4.375% Notes 2026 have been capitalized and are being amortized over the term of the Notes.

 

As of May 31, 2021, the total 4.375% Notes 2026 outstanding was $50.0 million The 4.375% Notes 2026 are not listed and have a par value of $25.00 per share. As of May 31, 2021, there was $50.0 million of 4.375% Notes 2026 outstanding and as of February 28, 2021, there was $0.0 million outstanding. The carrying amount of the amount outstanding of 4.375% Notes 2026 approximates its fair value, which is based on a waterfall analysis showing adequate collateral coverage and would be classified as a Level 3 liability within the fair value hierarchy.

 

For the three months ended May 31, 2021 and May 31, 2020, we recorded $0.5 million and $0.0 million, respectively, of interest expense and $0.06 million and $0.0 million, respectively, of amortization of deferred financing costs related to the 4.375% Notes 2026. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2021 and May 31, 2020 the average dollar amount of 4.375% Notes 2026 outstanding was $50.0 million and $0.0 million respectively.

 

65

 

 

Senior Securities

 

Information about our senior securities is shown in the following table as of May 31, 2021 for the fiscal year periods indicated in the table, unless otherwise noted.

 

SENIOR SECURITIES

(dollar amounts in thousands, except per share data)

 

Class and Year (1)(2)   Total Amount Outstanding Exclusive of Treasury Securities(3)     Asset Coverage per Unit(4)     Involuntary Liquidating Preference per Share(5)     Average Market Value per Share(6)  
    (in thousands)  
Credit Facility with Madison Capital Funding                                
Fiscal year 2022 (as of May 31, 2021)   $ 39,000     $ 2,510       -       N/A  
Fiscal year 2021 (as of February 28, 2021)   $ -     $ 3,471       -       N/A  
Fiscal year 2020 (as of February 29, 2020)   $ -     $ 6,071       -       N/A  
Fiscal year 2019 (as of February 28, 2019)   $ -     $ 2,345       -       N/A  
Fiscal year 2018 (as of February 28, 2018)   $ -     $ 2,930       -       N/A  
Fiscal year 2017 (as of February 28, 2017)   $ -     $ 2,710       -       N/A  
Fiscal year 2016 (as of February 29, 2016)   $ -     $ 3,025       -       N/A  
Fiscal year 2015 (as of February 28, 2015)   $ 9,600     $ 3,117       -       N/A  
Fiscal year 2014 (as of February 28, 2014)   $ -     $ 3,348       -       N/A  
Fiscal year 2013 (as of February 28, 2013)   $ 24,300     $ 5,421       -       N/A  
Fiscal year 2012 (as of February 29, 2012)   $ 20,000     $ 5,834       -       N/A  
Fiscal year 2011 (as of February 28, 2011)   $ 4,500     $ 20,077       -       N/A  
Fiscal year 2010 (as of February 28, 2010)   $ -     $ -       -       N/A  
Fiscal year 2009 (as of February 28, 2009)   $ -     $ -       -       N/A  
Fiscal year 2008 (as of February 29, 2008)   $ -     $ -       -       N/A  
Fiscal year 2007 (as of February 28, 2007)   $ -     $ -       -       N/A  
7.50% Notes due 2020(7)                                
Fiscal year 2017 (as of February 28, 2017)   $ -     $ -       -       N/A  
Fiscal year 2016 (as of February 29, 2016)   $ 61,793     $ 3,025       -     $ 25.24 (8)
Fiscal year 2015 (as of February 28, 2015)   $ 48,300     $ 3,117       -     $ 25.46 (8)
Fiscal year 2014 (as of February 28, 2014)   $ 48,300     $ 3,348       -     $ 25.18 (8)
Fiscal year 2013 (as of February 28, 2013)   $ -     $ -       -       N/A  
Fiscal year 2012 (as of February 29, 2012)   $ -     $ -       -       N/A  
Fiscal year 2011 (as of February 28, 2011)   $ -     $ -       -       N/A  
Fiscal year 2010 (as of February 28, 2010)   $ -     $ -       -       N/A  
Fiscal year 2009 (as of February 28, 2009)   $ -     $ -       -       N/A  
Fiscal year 2008 (as of February 29, 2008)   $ -     $ -       -       N/A  
Fiscal year 2007 (as of February 28, 2007)   $ -     $ -       -       N/A  
6.75% Notes due 2023(9)                                
Fiscal year 2020 (as of February 29, 2020)   $ -     $ -       -       N/A  
Fiscal year 2019 (as of February 28, 2019)   $ 74,451     $ 2,345       -     $ 25.74 (10)
Fiscal year 2018 (as of February 28, 2018)   $ 74,451     $ 2,930       -     $ 26.05 (10)
Fiscal year 2017 (as of February 28, 2017)   $ 74,451     $ 2,710       -     $ 25.89 (10)
6.25% Notes due 2025                                
Fiscal year 2022 (as of May 31, 2021)   $ 60,000     $ 2,510       -     $ 25.58 (11)
Fiscal year 2021 (as of February 28, 2021)   $ 60,000     $ 3,471             $ 24.24 (11)
Fiscal year 2020 (as of February 29, 2020)   $ 60,000     $ 6,071       -     $ 25.75 (11)
Fiscal year 2019 (as of February 28, 2019)   $ 60,000     $ 2,345       -     $ 24.97 (11)
7.25% Notes due 2025                                
Fiscal year 2022 (as of May 31, 2021)   $ 43,125     $ 2,510       -     $ 26.61 (11)
Fiscal year 2021 (as of February 28, 2021)   $ 43,125     $ 3,471             $ 25.77 (11)
7.75% Notes due 2025                                
Fiscal year 2022 (as of May 31, 2021)   $ 5,000     $ 2,510       -     $ 25.00 (12)
Fiscal year 2021 (as of February 28, 2021)   $ 5,000     $ 3,471       -     $ 25.00 (12)
4.375% Notes due 2026                                
Fiscal year 2022 (as of May 31, 2021)   $ 50,000     $ 2,510       -     $ 25.00 (12)
6.25 Notes due 2027                                
Fiscal year 2022 (as of May 31, 2021)   $ 15,000     $ 2,510       -     $ 25.00 (12)
Fiscal year 2021 (as of February 28, 2021)   $ 15,000     $ 3,471       -     $ 25.00 (12)

 

66

 

 

 

(1)We have excluded our SBA-guaranteed debentures from this table because the SEC has granted us exemptive relief that permits us to exclude such debentures from the definition of senior securities in the 150% asset coverage ratio we are required to maintain under the 1940 Act.

(2)This table does not include the senior securities of our predecessor entity, GSC Investment Corp., relating to a revolving securitized credit facility with Deutsche Bank, in light of the fact that the Company was under different management during the time that such credit facility was outstanding.

(3)Total amount of senior securities outstanding at the end of the period presented.

(4)Asset coverage per unit is the ratio of our total assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness, calculated on a total basis.

(5)The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. The “—” indicates information which the Securities and Exchange Commission expressly does not require to be disclosed for certain types of senior securities.

(6)Not applicable for credit facility because not registered for public trading.

(7)On January 13, 2017, the Company redeemed in full its 2020 Notes. The Company used a portion of the net proceeds from the 2023 Notes offering, which was completed in December 2016, to redeem the 2020 Notes in full.

(8)Based on the average daily trading price of the 2020 Notes on the NYSE.

(9)On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.45 million, respectively, in aggregate principal amount of the $74.45 million in aggregate principal amount of issued and outstanding 2023 Notes.

(10)Based on the average daily trading price of the 2023 Notes on the NYSE.

(11)Based on the average daily trading price of the 2025 Notes on the NYSE.

(12)The carrying value of this unlisted security approximates its fair value, based on a waterfall analysis showing adequate collateral coverage.

 

67

 

 

Note 8. Commitments and Contingencies

 

Contractual Obligations

 

The following table shows our payment obligations for repayment of debt and other contractual obligations at May 31, 2021:

 

       Payment Due by Period 
Long-Term Debt Obligations  Total   Less Than 1 Year   1 - 3 Years   3 - 5 Years   More Than 5 Years 
   ($ in thousands) 
Revolving credit facility  $39,000   $-   $-   $39,000   $- 
SBA debentures   168,000    -    24,000    53,660    90,340 
6.25% 2025 Notes   60,000    -    -    60,000    - 
7.25% 2025 Notes   43,125    -    -    43,125    - 
7.75% 2025 Notes   5,000    -    -    5,000    - 
4.375% 2026 Notes   50,000    -    -    50,000    - 
6.25% 2027 Notes   15,000    -    -    -    15,000 
Total Long-Term Debt Obligations  $380,125   $-   $24,000   $250,785   $105,340 

 

Off-Balance Sheet Arrangements

 

As of May 31, 2021 and February 28, 2021, the Company’s off-balance sheet arrangements consisted of $55.0 million and $58.8 million, respectively, of unfunded commitments outstanding to provide debt financing to its portfolio companies or to fund limited partnership interests. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s consolidated statements of assets and liabilities and are not reflected in the Company’s consolidated statements of assets and liabilities.

 

A summary of the unfunded commitments outstanding as of May 31, 2021 and February 28, 2021 is shown in the table below (dollars in thousands):

 

   May 31, 2021   February 28, 2021 
At Company’s discretion          
Artemis Wax Corp.  $15,000   $- 
Book4Time, Inc.   2,000    2,000 
CLEO Communications Holding, LLC   630    630 
Granite Comfort, LP   5,000    - 
GreyHeller LLC   11,000    15,000 
Netreo Holdings, LLC   1,000    10,000 
Passageways, Inc.   5,000    5,000 
Top Gun Pressure Washing, LLC   175    3,175 
Village Realty Holdings LLC   -    10,000 
Total   39,805    45,805 
           
At portfolio company’s discretion - satisfaction of certain financial and nonfinancial covenants required          
Artemis Wax Corp.   3,404    - 
GoReact   800    2,000 
HemaTerra Holding Company, LLC   2,000    2,000 
New England Dental Partners   4,500    6,000 
Passageways, Inc.   2,000    2,000 
Procurement Partners, LLC   1,000    1,000 
Zollege PBC   1,500    - 
    15,204    13,000 
Total  $55,009   $58,805 

 

68

 

 

Note 9. Directors Fees

 

The independent directors each receive an annual fee of $70,000. They also receive $3,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $1,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of $12,500 and the chairman of each other committee receives an annual fee of $6,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of net asset value or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as such term is defined in the 1940 Act). For the three months ended May 31, 2021 and May 31, 2020, we incurred $0.09 million and $0.06 million for directors’ fees and expenses, respectively. As of May 31, 2021 and February 28, 2021, $0.09 million and $0.07 million in directors’ fees and expenses were accrued and unpaid, respectively. As of May 31, 2021, we had not issued any common stock to our directors as compensation for their services.

 

Note 10. Stockholders’ Equity

 

On May 16, 2006, GSC Group, Inc. capitalized the LLC, by contributing $1,000 in exchange for 67 shares, constituting all of the issued and outstanding shares of the LLC.

 

On March 20, 2007, the Company issued 95,995.5 and 8,136.2 shares of common stock, priced at $150.00 per share, to GSC Group and certain individual employees of GSC Group, respectively, in exchange for the general partnership interest and a limited partnership interest in GSC Partners CDO III GP, LP, collectively valued at $15.6 million. At this time, the 6.7 shares owned by GSC Group in the LLC were exchanged for 6.7 shares of the Company.

 

On March 28, 2007, the Company completed its IPO of 725,000 shares of common stock, priced at $150.00 per share, before underwriting discounts and commissions. Total proceeds received from the IPO, net of $7.1 million in underwriter’s discount and commissions, and $1.0 million in offering costs, were $100.7 million.

 

On July 30, 2010, our Manager and its affiliates purchased 986,842 shares of common stock at $15.20 per share. Total proceeds received from this sale were $15.0 million.

 

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

 

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements (the “Share Repurchase Plan”). On October 7, 2015, our board of directors extended the Share Repurchase Plan for another year and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 400,000 shares of its common stock. On October 5, 2016, our board of directors extended the Share Repurchase Plan for another year to October 15, 2017 and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 600,000 shares of its common stock. On October 10, 2017, January 8, 2019 and January 7, 2020, our board of directors extended the Share Repurchase Plan for another year to October 15, 2018, January 15, 2020 and January 15, 2021, respectively, each time leaving the number of shares unchanged at 600,000 shares of its common stock. On May 4, 2020, our board of directors increased the Share Repurchase Plan to 1.3 million shares of common stock. On January 5, 2021, our board of directors extended the Shares Repurchase Plan for another year to January 15, 2022, leaving the number of shares unchanged at 1.3 million shares of common stock. As of May 31, 2021, the Company purchased 448,812 shares of common stock, at the average price of $18.49 for approximately $8.3 million pursuant to the Share Repurchase Plan. During the three months ended May 31, 2021, the Company purchased 40,000 shares of common stock, at the average price of $25.09 for approximately $1.0 million pursuant to the Share Repurchase Plan.

 

69

 

 

On March 16, 2017, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to time, up to $30.0 million of our common stock through an ATM offering. Subsequent to this, BB&T Capital Markets and B. Riley FBR, Inc. were also added to the agreement. On July 11, 2019, the amount of the common stock to be offered was increased to $70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $130.0 million. As of May 31, 2021, the Company sold 3,992,018 shares for gross proceeds of $97.1 million at an average price of $24.77 for aggregate net proceeds of $95.9 million (net of transaction costs). During the three months ended May 31, 2021, there was no activity related to the ATM offering.

 

On July 13, 2018, the Company issued 1,150,000 shares of its common stock priced at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75 million. The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million. The Company also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of its common stock, which was not exercised.

 

The Company adopted Rule 3-04/Rule 8-03(a)(5) under Regulation S-X (Note 2). Pursuant to the regulation, the Company has presented a reconciliation of the changes in each significant caption of stockholders’ equity as shown in the tables below:

 

   Common Stock   Capital in Excess of   Total Distributable Earnings     
   Shares   Amount   Par Value   (Loss)   Net Assets 
Balance at February 29, 2020   11,217,545   $11,218   $289,476,991   $14,798,644   $304,286,853 
Increase (Decrease) from Operations:                         
Net investment income   -    -    -    9,018,314    9,018,314 
Net realized gain (loss) from investments   -    -    -    8,480    8,480 
Net change in unrealized appreciation (depreciation) on investments   -    -    -    (31,950,369)   (31,950,369)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   -    -    -    267,740    267,740 
Decrease from Shareholder Distributions:                         
Distributions of investment income – net   -    -    -    -    - 
Capital Share Transactions:                         
Proceeds from issuance of common stock   -    -    -    -    - 
Stock dividend distribution   -    -    -    -    - 
Repurchases of common stock   -    -    -    -    - 
Offering costs   -    -    -    -    - 
Balance at May 31, 2020   11,217,545   $11,218   $289,476,991   $(7,857,191)  $281,631,018 
Increase (Decrease) from Operations:                         
Net investment income   -    -    -    5,334,713    5,334,713 
Net realized gain (loss) from investments   -    -    -    11,929    11,929 
Net change in unrealized appreciation (depreciation) on investments   -    -    -    16,580,401    16,580,401 
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   -    -    -    (116,521)   (116,521)
Decrease from Shareholder Distributions:                         
Distributions of investment income – net   -    -    -    (4,487,015)   (4,487,015)
Capital Share Transactions:                         
Proceeds from issuance of common stock   -    -    -    -    - 
Stock dividend distribution   47,098    46    774,944    -    774,990 
Repurchases of common stock   (90,321)   (90)   (1,550,327)   -    (1,550,417)
Repurchase fees   -    -    (1,740)   -    (1,740)
Offering costs   -    -    -    -    - 
Balance at August 31, 2020   11,174,322   $11,174   $288,699,868   $9,466,316   $298,177,358 

 

70

 

 

   Common Stock   Capital in Excess of   Total Distributable Earnings     
   Shares   Amount   Par Value   (Loss)   Net Assets 
Increase (Decrease) from Operations:                         
Net investment income   -    -    -    4,471,102    4,471,102 
Net realized gain (loss) from investments   -    -    -    1,798    1,798 
Income tax (provision) benefit from realized gain on investments                  (3,895,354)   (3,895,354)
Net change in unrealized appreciation (depreciation) on investments   -    -    -    5,998,830    5,998,830 
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   -    -    -    (210,057)   (210,057)
Decrease from Shareholder Distributions:                         
Distributions of investment income – net   -    -    -    (4,581,469)   (4,581,469)
Capital Share Transactions:                         
Proceeds from issuance of common stock   -    -    -    -    - 
Stock dividend distribution   45,706    46    805,883    -    805,929 
Repurchases of common stock   (50,000)   (50)   (914,194)   -    (914,244)
Repurchase fees   -    -    (1,003)   -    (1,003)
Offering costs   -    -    -    -    - 
Balance at November 30, 2020   11,170,028   $11,170   $288,590,554   $11,251,166   $299,852,890 
Increase (Decrease) from Operations:                         
Net investment income   -    -    -    4,288,996    4,288,996 
Net realized gain (loss) from investments   -    -    -    (8,726,013)   (8,726,013)
Income tax (provision) benefit from realized gain on investments   -    -    -    -    - 
Realized losses on extinguishment of debt                  (128,617)   (128,617)
Net change in unrealized appreciation (depreciation) on investments   -    -    -    14,337,460    14,337,460 
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   -    -    -    (515,796)   (515,796)
Decrease from Shareholder Distributions:                         
Distributions of investment income – net   -    -    -    (4,678,514)   (4,678,514)
Capital Share Transactions:                         
Proceeds from issuance of common stock   -    -    -    -    - 
Stock dividend distribution   41,388    41    900,124    -    900,165 
Repurchases of common stock   (50,000)   (50)   (1,143,748)   -    (1,143,798)
Repurchase fees   -    -    (1,003)   -    (1,003)
Offering costs   -    -    -    -    - 
Tax reclassification of stockholders’ equity in accordance with generally accepted accounting principles   -    -    16,529,030    (16,529,030)   - 
Balance at February 28, 2021   11,161,416   $11,161   $304,874,957   $(700,348)  $304,185,770 
Increase (Decrease) from Operations:                         
Net investment income   -    -    -    2,555,935    2,555,935 
Net realized gain (loss) from investments   -    -    -    1,910,141    1,910,141 
Net change in unrealized appreciation (depreciation) on investments   -    -    -    16,812,577    16,812,577 
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   -    -    -    (230,144)   (230,144)
Decrease from Shareholder Distributions:                         
Distributions of investment income – net   -    -    -    (4,799,405)   (4,799,405)
Capital Share Transactions:                         
Proceeds from issuance of common stock   -    -    -    -    - 
Stock dividend distribution   38,580    39    914,063    -    914,102 
Repurchases of common stock   (40,000)   (40)   (1,003,380)   -    (1,003,420)
Repurchase fees   -    -    (800)   -    (800)
Offering costs   -    -    -    -    - 
Balance at May 31, 2021   11,159,995   $11,160   $304,784,840   $15,548,756   $320,344,756 

 

71

 

 

Note 11. Earnings Per Share

 

In accordance with the provisions of FASB ASC Topic 260, “Earnings per Share” (“ASC 260”), basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

 

The following information sets forth the computation of the weighted average basic and diluted net increase in net assets resulting from operations per share for the three months ended May 31, 2021 and May 31, 2020 (dollars in thousands except share and per share amounts):

 

   For the three months ended 
Basic and Diluted  May 31, 2021   May 31, 2020 
Net increase (decrease) in net assets resulting from operations  $21,049   $(22,656)
Weighted average common shares outstanding   11,170,045    11,217,545 
Weighted average earnings (loss) per common share  $1.88   $(2.02)

 

Note 12. Dividend

 

On May 27, 2021, the Company declared a dividend of $0.44 per share payable on June 29, 2021, to common stockholders of record on June 15, 2021. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company's DRIP. Based on shareholder elections, the dividend consisted of approximately $4.1 million in cash and 33,099 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.03 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 16, 17, 18, 21, 22, 23, 24, 25, 28 and 29, 2021.

 

During the three months ended May 31, 2020, there were no dividends declared.

 

The following table summarizes dividends declared for the three months ended May 31, 2021 (dollars in thousands except per share amounts):

 

Date Declared  Record Date  Payment Date  Amount Per Share   Total Amount* 
March 22, 2021  April 8, 2021  April 22, 2021  $0.43   $4,799 
Total dividends declared        $0.43   $4,799 

 

 

*Total amount is calculated based on the number of shares outstanding at the date of record.

 

72

 

 

Note 13. Financial Highlights

 

The following is a schedule of financial highlights as of and for the three months ended May 31, 2021 and May 31, 2020:

 

Per share data  May 31, 2021   May 31, 2020 
Net asset value at beginning of period  $27.25   $27.13 
Net investment income(1)   0.23    0.80 
Net realized and unrealized gain and losses on investments(1)   1.65    (2.82)
Net increase in net assets resulting from operations   1.88    (2.02)
Distributions declared from net investment income   (0.43)   - 
Total distributions to stockholders   (0.43)   - 
Issuance of common stock above net asset value (2)   -    - 
Repurchases of common stock(3)   0.01    - 
Dilution(4)   (0.01)   - 
Net asset value at end of period  $28.70   $25.11 
Net assets at end of period  $320,344,756   $281,631,018 
Shares outstanding at end of period   11,159,995    11,217,545 
Per share market value at end of period  $25.55   $15.18 
Total return based on market value(5)(6)   12.71%   (33.74)%
Total return based on net asset value(5)(7)   7.24%   (7.45)%
Ratio/Supplemental data:          
Ratio of net investment income to average net assets(8)   8.25%   10.33%
Expenses:          
Ratio of operating expenses to average net assets(9)   5.92%   4.84%
Ratio of incentive management fees to average net assets(5)   1.69%   (0.63)%
Ratio of interest and debt financing expenses to average net assets(9)   5.51%   3.47%
Ratio of total expenses to average net assets(8)   13.12%   7.68%
Portfolio turnover rate(5)(10)   2.43%   1.93%
Asset coverage ratio per unit(11)   2,510    5,694 
Average market value per unit          
Revolving Credit Facility(12)   N/A     N/A 
SBA Debentures Payable(12)   N/A     N/A 
6.75% Notes Payable 2023(13)   N/A     N/A 
6.25% Notes Payable 2025  $25.58   $22.15 
7.25% Notes Payable 2025  $26.61     N/A 
7.75% Notes Payable 2025(12)   N/A     N/A 
4.375% Notes Payable(12)   N/A    N/A 
6.25% Notes Payable 2027(12)   N/A    N/A 

 

 

(1)Per share amounts are calculated using the weighted average shares outstanding during the period.
(2)The continuous issuance of common stock may cause an incremental increase in net asset value per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company in excess of net asset value per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date multiplied by (B) the differences between the net proceeds per share and the net asset value per share on each share transaction date, divided by (ii) the total shares outstanding during the period.
(3)Represents the anti-dilutive impact on the net asset value per share (“NAV”) of the Company due to the repurchase of common shares. See Note 10, Stockholders’ Equity.
(4)Represents the dilutive effect of issuing common stock below net asset value per share during the period in connection with the satisfaction of the Company’s annual RIC distribution requirement and may include the impact of the different share amounts used for different items (weighted average basic common shares outstanding for the corresponding year and actual common shares outstanding at the end of the year) in the per common share data calculation and rounding impacts. See Note 12, Dividend.

 

73

 

 

(5)Ratios are not annualized.
(6)Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s DRIP. Total investment return does not reflect brokerage commissions.
(7)Total investment return is calculated assuming a purchase of common shares at the current net asset value on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s DRIP. Total investment return does not reflect brokerage commissions.
(8)Ratios are annualized. Incentive management fees included within the ratio are not annualized.
(9)Ratios are annualized.
(10)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.
(11)Asset coverage ratio per unit is the ratio of the carrying value of our total consolidated assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage ratio per unit is expressed in terms of dollar amounts per $1,000 of indebtedness. Asset coverage ratio per unit does not include unfunded commitments. The inclusion of unfunded commitments in the calculation of the asset coverage ratio per unit would not cause us to be below the required amount of regulatory coverage.
(12)The Revolving Credit Facility, SBA Debentures, 7.75% Notes Payable 2025, 4.375% Notes Payable and 6.25% Notes Payable are not registered for public trading.
(13)On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.5 million, respectively, in aggregate principal amount of the $74.5 million in aggregate principal amount of issued and outstanding 2023 Notes and are no longer listed on the NYSE.

 

Note 14. Subsequent Events

 

The Company has evaluated subsequent events through the filing of this Form 10-Q and determined that there have been no events that have occurred that would require adjustments to the Company’s consolidated financial statements and disclosures in the consolidated financial statements except for the following:

 

Subsequent to May 31, 2021, the global outbreak of the coronavirus pandemic has adversely affected some of the Company’s investments and continues to have adverse consequences on the U.S. and global economies. The ultimate economic fallout from the pandemic, and the long-term impact on economies, markets, industries and individual portfolio companies, remains uncertain. At the time of this filing, there is no indication of a reportable subsequent event impacting the Company’s financial statements for the three months ended May 31, 2021. The Company cannot predict the extent to which its financial condition and results of operations will be adversely affected at this time. The potential impact to our results will depend to a large extent on future developments and new information that may emerge regarding the duration and severity of COVID-19. The Company continues to observe and respond to the evolving COVID-19 environment and its potential impact on areas across its business.

 

74

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion should be read in conjunction with our consolidated financial statements and related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under “Note about Forward-Looking Statements” and Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended February 28, 2021.

 

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

 

The forward-looking statements contained in this Quarterly Report on Form 10-Q involve risks and uncertainties, including statements as to:

 

our future operating results and the impact of coronavirus (“COVID-19”) pandemic thereon;

 

the introduction, withdrawal, success and timing of business initiatives and strategies;

 

changes in political, economic or industry conditions, the interest rate environment or financial and capital markets, which could result in changes in the value of our assets;

 

pandemics or other serious public health events, such as the recent global outbreak of COVID-19;

 

the relative and absolute investment performance and operations of our Investment Manager;

 

the impact of increased competition;

 

our ability to turn potential investment opportunities into transactions and thereafter into completed and successful investments;

 

the unfavorable resolution of any future legal proceedings;

 

our business prospects and the prospects of our portfolio companies, including our and their ability to achieve our respective objectives as a result of the current COVID-19 pandemic;

 

the impact of investments that we expect to make and future acquisitions and divestitures;

 

our contractual arrangements and relationships with third parties;

 

the dependence of our future success on the general economy and its impact on the industries in which we invest and the impact of the COVID-19 pandemic thereon;

 

the ability of our portfolio companies to achieve their objectives;

 

our expected financings and investments;

 

our regulatory structure and tax status, including our ability to operate as a business development company (“BDC”), or to operate our small business investment company (“SBIC”) subsidiaries, and to continue to qualify to be taxed as a regulated investment company (“RIC”);

 

75

 

 

the adequacy of our cash resources and working capital;

 

the timing of cash flows, if any, from the operations of our portfolio companies and the impact of the COVID-19 pandemic thereon;

 

the impact of interest rate volatility on our results, particularly because we use leverage as part of our investment strategy;

 

the impact of legislative and regulatory actions and reforms and regulatory, supervisory or enforcement actions of government agencies relating to us or our Manager;

 

the impact of changes to tax legislation and, generally, our tax position;

 

our ability to access capital and any future financings by us;

 

the ability of our Manager to attract and retain highly talented professionals; and

 

the ability of our Manager to locate suitable investments for us and to monitor and effectively administer our investments and the impacts of the COVID-19 pandemic thereon.

 

The following statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:

 

changes in laws and regulations, changes in political, economic or industry conditions, and changes in the interest rate environment, including with respect to the anticipated discontinuation of LIBOR, or other conditions affecting the financial and capital markets, including with respect to changes resulting from or in response to, or potentially even the absence of changes as a result of, the impact of the COVID-19 pandemic;

 

the length and duration of the COVID-19 outbreak in the United States as well as worldwide, and the magnitude of its impact and time required for economic recovery, including with respect to the impact of travel restrictions and other isolation and quarantine measures on the ability of the Manager’s investment professionals to conduct in-person diligence on, and otherwise monitor, existing and future investments;

 

an economic downturn and the time period required for robust economic recovery therefrom, including the current economic downturn as a result of the impact of the COVID-19 pandemic, which may have a material impact on our portfolio companies’ results of operations and financial condition, which could lead to the loss of some or all of our investments in certain portfolio companies and have a material adverse effect on our results of operations and financial condition 

 

a contraction of available credit, an inability or unwillingness of our lenders to fund their commitments to us and/or an inability to access capital markets or additional sources of liquidity, including as a result of the impact and duration of the COVID-19 pandemic, could have a material adverse effect on our results of operations and financial condition and impair our lending and investment activities;

 

risks associated with possible disruption in our portfolio companies’ operations due to wars and other forms of conflict, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics; and

 

the risks, uncertainties and other factors we identify in “Risk Factors” in our most recent Annual Report on Form 10-K under Part I, Item 1A, in our quarterly reports on Form 10-Q, including this report, and in our other filings with the SEC that we make from time to time.

 

76

 

 

Such forward-looking statements may include statements preceded by, followed by or that otherwise include terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “project,” “should,” “will” and “would” or the negative of these terms or other comparable terminology.

 

We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this quarterly report on Form 10-Q, and we assume no obligation to update any such forward-looking statements. Actual results could differ materially from those anticipated in our forward-looking statements, and future results could differ materially from historical performance. We undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law or SEC rule or regulation. You are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

 

The following analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes thereto contained elsewhere in this quarterly report on Form 10-Q.

 

OVERVIEW

 

We are a Maryland corporation that has elected to be treated as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”). Our investment objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from our investments. We invest primarily in senior and unitranche leveraged loans and mezzanine debt issued by private U.S. middle market companies, which we define as companies having earnings before interest, tax, depreciation and amortization (“EBITDA”) of between $2 million and $50 million, both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. Although we have no current intention to do so, to the extent we invest in private equity funds, we will limit our investments in entities that are excluded from the definition of “investment company” under Section 3(c)(1) or Section 3(c)(7) of the 1940 Act, which includes private equity funds, to no more than 15.0% of its net assets. We have elected and qualified to be treated as a RIC under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

 

COVID-19 Update

 

On March 11, 2020, the World Health Organization declared the novel coronavirus, or COVID-19, as a pandemic, and on March 13, 2020 the United States declared a national emergency with respect to COVID-19. The outbreak of COVID-19 has severely impacted global economic activity and caused significant volatility and negative pressure in financial markets. The global impact of the outbreak has led to, and for an unknown period of time will continue to lead to, disruptions in local, regional, national and global markets and economies affected thereby, including the United States. The COVID-19 pandemic and restrictive measures taken to contain or mitigate its spread have caused, and are continuing to cause, business shutdowns, or the re-introduction of business shutdowns, cancellations of events and restrictions on travel, significant reductions in demand for certain goods and services, reductions in business activity and financial transactions, supply chain interruptions and overall economic and financial market instability both globally and in the United States. In addition, although the U.S. Food and Drug Administration authorized vaccines for emergency use starting in December 2020, it is unclear when “herd immunity” will be achieved and when the restrictions that were imposed to slow the spread of the virus will be lifted entirely. The delay in distributing the vaccines could lead people to continue to self-isolate and not participate in the economy at pre-pandemic levels for a prolonged period of time. Even after the COVID-19 pandemic subsides, the U.S. economy and most other major global economies may continue to experience a recession. As a result, COVID-19 presents material uncertainty and risks with respect to the underlying value of the Company’s portfolio companies, the Company’s business, financial condition, results of operations and cash flows, such as the potential negative impact to financing arrangements, company decisions to delay, defer and/or modify the character of dividends in order to preserve liquidity, increased costs of operations, changes in law and/or regulation, and uncertainty regarding government and regulatory policy.

 

77

 

 

We have evaluated subsequent events from June 1, 2021 through July 7, 2021. However, as the discussion in this Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations relates to the Company’s financial statements for the quarter-ended May 31, 2021, the analysis contained herein may not fully account for impacts relating to the COVID-19 pandemic. In that regard, for example, as of May 31, 2021, the Company valued its portfolio investments in conformity with U.S. GAAP based on the facts and circumstances known by the Company at that time, or reasonably expected to be known at that time. Due to the overall volatility that the COVID-19 pandemic has caused during the months that followed our May 31, 2021 valuation, any valuations conducted now or in the future in conformity with U.S. GAAP could result in a lower fair value of our portfolio. The potential impact to our results going forward will depend to a large extent on future developments and new information that may emerge regarding the duration and severity of COVID- 19 and the actions taken by authorities and other entities to contain the coronavirus or treat its impact, all of which are beyond our control. Accordingly, the Company cannot predict the extent to which its financial condition and results of operations will be affected at this time.

 

Corporate History

 

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, as described below we engaged Saratoga Investment Advisors to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

 

As a result of the event of default under a revolving securitized credit facility with Deutsche Bank we previously had in place, in December 2008 we engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us. On April 14, 2010, GSC Investment Corp. entered into a stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates and an assignment, assumption and novation agreement with Saratoga Investment Advisors, pursuant to which GSC Investment Corp. assumed certain rights and obligations of Saratoga Investment Advisors under a debt commitment letter Saratoga Investment Advisors received from Madison Capital Funding LLC, which indicated Madison Capital Funding’s willingness to provide GSC Investment Corp. with a $40.0 million senior secured revolving credit facility, subject to the satisfaction of certain terms and conditions. In addition, GSC Investment Corp. and GSCP (NJ), L.P. entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.

 

On July 30, 2010, the transactions contemplated by the stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates were completed, the private sale of 986,842 shares of our common stock for $15.0 million in aggregate purchase price to Saratoga Investment Advisors and certain of its affiliates closed, the Company entered into the Credit Facility, and the Company began doing business as Saratoga Investment Corp.

 

We used the net proceeds from the private sale transaction and a portion of the funds available to us under the Credit Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under our revolving securitized credit facility with Deutsche Bank. The revolving securitized credit facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.

 

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

 

78

 

 

In January 2011, we registered for public resale of the 986,842 shares of our common stock issued to Saratoga Investment Advisors and certain of its affiliates.

 

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received an SBIC license from the Small Business Administration (“SBA”). On August 14, 2019, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC II LP (“SBIC II LP”), also received an SBIC license from the SBA.

 

In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50% fixed-rate unsecured notes due 2020 (the “2020 Notes”) for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. The 2020 Notes were listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per share. The 2020 Notes were redeemed in full on January 13, 2017 and are no longer listed on the NYSE.

 

On May 29, 2015, we entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. through which we may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the 2020 Notes through an At-the-Market (“ATM”) offering. Prior to the 2020 Notes being redeemed in full, the Company sold 539,725 bonds with a principal of $13.5 million at an average price of $25.31 for aggregate net proceeds of $13.4 million (net of transaction costs).

 

On December 21, 2016, we issued $74.5 million in aggregate principal amount of our 6.75% fixed-rate unsecured notes due 2023 (the “2023 Notes”) for net proceeds of $71.7 million after deducting underwriting commissions of approximately $2.3 million and offering costs of approximately $0.5 million. The issuance included the exercise of substantially all of the underwriters’ option to purchase an additional $9.8 million aggregate principal amount of 2023 Notes within 30 days. The 2023 Notes were listed on the NYSE under the trading symbol “SAB” with a par value of $25.00 per share. On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.5 million, respectively, in aggregate principal amount of the $74.5 million in aggregate principal amount of issued and outstanding 2023 Notes.

 

On March 16, 2017, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to time, up to $30.0 million of our common stock through an ATM offering. Subsequent to this, BB&T Capital Markets and B. Riley FBR, Inc. were also added to the agreement. On July 11, 2019, the amount of the common stock to be offered through this offering was increased to $70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $130.0 million. As of May 31, 2021, the Company sold 3,922,018 shares for gross proceeds of $97.1 million at an average price of $24.77 for aggregate net proceeds of $95.9 million (net of transaction costs). During the three months ended May 31, 2021, there was no activity related to the ATM offering.

 

On July 13, 2018, the Company issued 1,150,000 shares of its common stock priced at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75 million. The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million. The Company also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of its common stock, which was not exercised.

 

On August 28, 2018, the Company issued $40.0 million in aggregate principal amount of our 6.25% fixed-rate notes due 2025 (the “6.25% 2025 Notes”) for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.3 million. The issuance included the full exercise of the underwriters’ option to purchase an additional $5.0 million aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest on the 6.25% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year, beginning November 30, 2018. The 6.25% 2025 Notes mature on August 31, 2025 and commencing August 28, 2021, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.6 million related to the 6.25% 2025 Notes have been capitalized and are being amortized over the term of the 6.25% 2025 Notes.

 

79

 

 

On December 14, 2018, the Company completed the third refinancing of the Saratoga CLO (the “2013-1 Reset CLO Notes”). This refinancing, among other things, extended the Saratoga CLO reinvestment period to January 2021, and extended its legal maturity to January 2030. A non-call period of January 2020 was also added. In addition to and as part of the refinancing, the Saratoga CLO has also been upsized from $300 million in assets to approximately $500 million. As part of this refinancing and upsizing, the Company invested an additional $13.8 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $2.5 million in aggregate principal amount of the Class F-R-2 Notes tranche and $7.5 million in aggregate principal amount of the Class G-R-2 Notes tranche at par. Concurrently, the existing $4.5 million of Class F notes were repaid.

 

On February 5, 2019, the Company completed a re-opening and up-sizing of its existing 6.25% 2025 Notes by issuing an additional $20.0 million in aggregate principal amount for net proceeds of $19.2 million after deducting underwriting commissions of approximately $0.6 million and discount of $0.2 million. Offering costs incurred were approximately $0.2 million. The issuance included the full exercise of the underwriters’ option to purchase an additional $2.5 million aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest rate, interest payment dates and maturity remain unchanged from the existing 6.25% 2025 Notes issued in August 2018. The net proceeds from this offering were used for general corporate purposes in accordance with our investment objective and strategies. The financing costs and discount of $1.0 million related to the 6.25% 2025 Notes have been capitalized and are being amortized over the term of the 6.25% 2025 Notes. As of November 30, 2020, the total 6.25% 2025 Notes outstanding was $60.0 million. The 6.25% 2025 Notes are listed on the NYSE under the trading symbol “SAF” with a par value of $25.00 per share.

 

On August 14, 2019, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC II LP (“SBIC II LP”), also received an SBIC license from the SBA. The new license will provide up to $175.0 million in additional long-term capital in the form of SBA debentures.

 

On June 24, 2020, the Company issued $37.5 million in aggregate principal amount of our 7.25% fixed-rate notes due 2025 (the “7.25% 2025 Notes”) for net proceeds of $36.3 million after deducting underwriting commissions of approximately $1.2 million. Offering costs incurred were approximately $0.3 million. On July 6, 2020, the underwriters exercised their option in full to purchase an additional $5.625 million in aggregate principal amount of its 7.25% unsecured notes due 2025. Net proceeds to the Company were $5.4 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 7.25% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.25% per year, beginning August 31, 2020. The 7.25% 2025 Notes mature on June 30, 2025 and commencing June 24, 2022, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.6 million related to the 7.25% 2025 Notes have been capitalized and are being amortized over the term of the 7.25% 2025 Notes. The Company has received an investment grade private rating of “BBB” from Egan-Jones Ratings Company, an independent, unaffiliated rating agency. As of November 30, 2020, the total 7.25% 2025 Notes outstanding was $43.1 million. The 7.25% 2025 Notes are listed on the NYSE under the trading symbol “SAK” with a par value of $25.00 per share.

 

On July 9, 2020, the Company issued $5.0 million aggregate principal amount of our 7.75% fixed-rate Notes due in 2025 (the “7.75% 2025 Notes”) for net proceeds of $4.8 million after deducting underwriting commissions of approximately $0.2 million. Offering costs incurred were approximately $0.1 million. Interest on the 7.75% Notes 2025 is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.75% per year, beginning August 31, 2020. The 7.75% Notes 2025 mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.3 million related to the 7.75% Notes 2025 have been capitalized and are being amortized over the term of the Notes. As of November 30, 2020, the total 7.25% 2025 Notes outstanding was $5.0 million. The 7.75% 2025 Notes are unlisted and has a par value of $25.00 per share.

 

On December 29, 2020, the Company issued $5.0 million aggregate principal amount of our 6.25% fixed-rate Notes due in 2027 (the “6.25% Notes 2027”). Offering costs incurred were approximately $0.1 million. Interest on the 6.25% Notes 2027 is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year, beginning February 28, 2021. The 6.25% Notes 2027 mature on December 29, 2027 and may be redeemed in whole or in part at any time or from time to time at our option, on or after December 29, 2024. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.1 million related to the 6.25% Notes 2027 have been capitalized and are being amortized over the term of the Notes. The 6.25% 2027 Notes are unlisted and have a par value of $25.00 per share.

 

80

 

 

On January 28, 2021, the Company issued $10.0 million aggregate principal amount of our 6.25% fixed rate Notes due in 2027 (the “Second 6.25% Notes 2027”) for net proceeds of $9.7 million after deducting underwriting commissions of approximately $0.3 million. Offering costs incurred were approximately $0.0 million. Interest on the Second 6.25% Notes 2027 is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year, beginning February 28, 2021. The Second 6.25% Notes 2027 mature on January 28, 2027 and commencing January 28, 2023, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.3 million related to the Second 6.25% Notes 2027 have been capitalized and are being amortized over the term of the Notes. The Second 6.25% 2027 Notes are unlisted and have a par value of $25.00 per share.

 

On February 26, 2021, the Company completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, and extended its legal maturity to April 2033. A non-call period ending February 2022 was also added. In addition, and as part of the refinancing, the Saratoga CLO has also been upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, the Company invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million CLO 2013-1 Warehouse 2 Loan were repaid. The Company also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. As of May 31, 2021, there remained an outstanding receivable of $2.6 million for such transaction costs which is presented as due from affiliate on the Company’s consolidated statement of assets and liabilities.

 

On March 10, 2021, the Company issued $50.0m aggregate principal amount of our 4.375% fixed-rate Notes due in 2026 (the “4.375% Notes 2026”) for net proceeds of $49.0 million after deducting underwriting commissions of approximately $1.0 million. Offering costs incurred were approximately $0.2 million. Interest on the 4.375% Notes 2026 is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.375% per year, beginning August 28, 2021. The 4.375% Notes 2026 mature on February 28, 2026 and may be redeemed in whole or in part at any time or from time to time at the Company’s option at par plus a “make-whole” premium, if applicable. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.2 million related to the 4.375% Notes 2026 have been capitalized and are being amortized over the term of the Notes.

 

Critical Accounting Policies

 

Basis of Presentation

 

The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make certain estimates and assumptions affecting amounts reported in the Company’s consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies follows.

 

Investment Valuation

 

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold or its liabilities are to be transferred at the balance sheet date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

 

81

 

 

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third-party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from Saratoga Investment Advisors, the audit committee of our board of directors and a third party independent valuation firm. We use multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which the Company determines a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

 

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below: 

 

  Each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

 

  An independent valuation firm engaged by our board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year. We use a third-party independent valuation firm to value our investment in the subordinated notes of Saratoga CLO and the Class F-R-3 Notes tranche of the Saratoga CLO every quarter.

 

In addition, all our investments are subject to the following valuation process:

 

  The audit committee of our board of directors reviews and approves each preliminary valuation and Saratoga Investment Advisors and an independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

  Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of Saratoga Investment Advisors, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

 

Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flows that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and market comparables for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by Saratoga Investment Advisors and recommended to our board of directors. Specifically, we use Intex cash flows, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The cash flows use a set of inputs including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The inputs are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

 

82

 

 

Revenue Recognition

 

Income Recognition

 

Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortization of premiums on investments.

 

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

 

Payment-in-Kind Interest

 

The Company holds debt and preferred equity investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

 

Revenues

 

We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt or preferred equity investments may provide for a portion or all of the interest to be PIK. To the extent interest is PIK, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity or common equity securities that pay dividends on a current basis.

 

On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was initially refinanced in October 2013 with its reinvestment period extended to October 2016. On November 15, 2016, we completed a second refinancing of the Saratoga CLO with its reinvestment period extended to October 2018.

 

On December 14, 2018, we completed a third refinancing and upsize of the Saratoga CLO. The third Saratoga CLO refinancing, among other things, extended its reinvestment period to January 2021, and extended its legal maturity date to January 2030. A non-call period of January 2020 was also added. Following this refinancing, the Saratoga CLO portfolio increased from approximately $300.0 million in aggregate principal amount to approximately $500.0 million of predominantly senior secured first lien term loans. In addition to refinancing its liabilities, we invested an additional $13.8 million in all of the newly issued subordinated notes of the Saratoga CLO and also purchased $2.5 million in aggregate principal amount of the Class F-R-2 and $7.5 million in aggregate principal amount of the Class G-R-2 notes tranches at par, with a coupon of LIBOR plus 8.75% and LIBOR plus 10.00%, respectively. As part of this refinancing, we also redeemed our existing $4.5 million aggregate amount of the Class F notes tranche at par.

 

83

 

 

On February 26, 2021, the Company completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, and extended its legal maturity to April 2033. A non-call period ending February 2022 was also added. In addition, and as part of the refinancing, the Saratoga CLO has also been upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, the Company invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million CLO 2013-1 Warehouse 2 Loan were repaid. The Company also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. As of May 31, 2021, there remained an outstanding receivable of $2.6 million for such transaction costs which is presented as due from affiliate on the Company’s consolidated statement of assets and liabilities.

 

The Saratoga CLO remains effectively 100% owned and managed by Saratoga Investment Corp. We receive a base management fee of 0.10% per annum and a subordinated management fee of 0.40% per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. Prior to the second refinancing and the issuance of the 2013-1 Amended CLO Notes, we received a base management fee of 0.25% per annum and a subordinated management fee of 0.25% per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds.

 

Following the third refinancing and the issuance of the 2013-1 Reset CLO Notes on December 14, 2018, we are no longer entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%.

 

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets (“ASC 325-40”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

 

Expenses

 

Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to independent directors and administrator expenses, including our allocable portion of our administrator’s overhead. Our investment advisory and management fees compensate our Manager for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:

 

organization;

 

calculating our net asset value (including the cost and expenses of any independent valuation firm);

 

expenses incurred by our Manager payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;

 

expenses incurred by our Manager payable for travel and due diligence on our prospective portfolio companies;

 

interest payable on debt, if any, incurred to finance our investments;

 

offerings of our common stock and other securities;

 

investment advisory and management fees;

 

fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

 

84

 

 

transfer agent and custodial fees;

 

federal and state registration fees;

 

all costs of registration and listing our common stock on any securities exchange;

 

federal, state and local taxes;

 

independent directors’ fees and expenses;

 

costs of preparing and filing reports or other documents required by governmental bodies (including the U.S. Securities and Exchange Commission (“SEC”) and the SBA);

 

costs of any reports, proxy statements or other notices to common stockholders including printing costs;

 

our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

 

direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

 

administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the Administration Agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under an Administration Agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

 

Pursuant to the investment advisory and management agreement that we had with GSCP (NJ), L.P., our former investment adviser and administrator, we had agreed to pay GSCP (NJ), L.P. as investment adviser a quarterly base management fee of 1.75% of the average value of our total assets (other than cash or cash equivalents but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters and an incentive fee.

 

The incentive fee had two parts:

 

A fee, payable quarterly in arrears, equal to 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of the net assets at the end of the immediately preceding quarter, that exceeded a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter. Under this provision, in any fiscal quarter, our former investment adviser received no incentive fee unless our pre-incentive fee net investment income exceeded the hurdle rate of 1.875%. Amounts received as a return of capital were not included in calculating this portion of the incentive fee. Since the hurdle rate was based on net assets, a return of less than the hurdle rate on total assets could still have resulted in an incentive fee.

 

A fee, payable at the end of each fiscal year, equal to 20.0% of our net realized capital gains, if any, computed net of all realized capital losses and unrealized capital depreciation, in each case on a cumulative basis on each investment in the Company’s portfolio, less the aggregate amount of capital gains incentive fees paid to our former investment adviser through such date.

 

We deferred cash payment of any incentive fee otherwise earned by our former investment adviser if, during the then most recent four full fiscal quarters ending on or prior to the date such payment was to be made, the sum of (a) our aggregate distributions to our stockholders and (b) our change in net assets (defined as total assets less liabilities) (before taking into account any incentive fees payable during that period) was less than 7.5% of our net assets at the beginning of such period. These calculations were appropriately pro-rated for the first three fiscal quarters of operation and adjusted for any share issuances or repurchases during the applicable period. Such incentive fee would become payable on the next date on which such test had been satisfied for the most recent four full fiscal quarters or upon certain terminations of the investment advisory and management agreement. We commenced deferring cash payment of incentive fees during the quarterly period ended August 31, 2007 and continued to defer such payments through the quarterly period ended May 31, 2010. As of July 30, 2010, the date on which GSCP (NJ), L.P. ceased to be our investment adviser and administrator, we owed GSCP (NJ), L.P. $2.9 million in fees for services previously provided to us; of which $0.3 million has been paid by us. GSCP (NJ), L.P. agreed to waive payment by us of the remaining $2.6 million in connection with the consummation of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates described elsewhere in this Quarterly Report.

 

85

 

 

The terms of the investment advisory and management agreement with Saratoga Investment Advisors, our current investment adviser, are substantially similar to the terms of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:

 

The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to Saratoga Investment Advisors and, as a result, Saratoga Investment Advisors will be entitled to 20.0% of net gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.

 

Under the “catch up” provision, 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors. This will enable Saratoga Investment Advisors to receive 20.0% of all net investment income as such amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will receive 20.0% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

 

We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.

 

Capital Gains Incentive Fee

 

The Company records an expense accrual relating to the capital gains incentive fee payable by the Company to its Manager when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the Manager if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s Manager related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

 

New Accounting Pronouncements

 

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (“ASU 2020-04”). The amendments in ASU 2020-04 provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The standard is effective as of March 12, 2020 through December 31, 2022. Management does not believe this optional guidance has a material impact on the Company’s consolidated financial statements and disclosures.

 

86

 

 

Portfolio and Investment Activity

 

Investment Portfolio Overview

 

    May 31, 2021     February 28, 2021  
   

($ in millions)

 
Number of investments(1)     90       81  
Number of portfolio companies(2)     44       40  
Average investment per portfolio company(2)   $ 14.2     $ 12.6  
Average investment size(1)   $ 7.1     $ 6.5  
Weighted average maturity(3)     3.1 yrs       3.2 yrs  
Number of industries     31       31  
Non-performing or delinquent investments (fair value)   $ 2.2     $ 2.1  
Fixed rate debt (% of interest earning portfolio)(3)   $ 23.2(4.1% )   $ 23.3(4.8% )
Fixed rate debt (weighted average current coupon)(3)     9.7 %     9.8 %
Floating rate debt (% of interest earning portfolio)(3)   $ 538.4(95.9% )   $ 462.6(95.2% )
Floating rate debt (weighted average current spread over LIBOR)(3)(4)     7.8 %     7.4 %

 

 

(1) Excludes our investment in the subordinated notes of Saratoga CLO.

(2) Excludes our investment in the subordinated notes of Saratoga CLO and Class F-R-3 Note tranche of Saratoga CLO.

(3) Excludes our investment in the subordinated notes of Saratoga CLO and equity interests.

(4) Calculation uses either 1-month or 3-month LIBOR, depending on the contractual terms, and after factoring in any existing LIBOR floors.

 

During the three months ended May 31, 2021, we invested $119.2 million in new or existing portfolio companies and had $14.9 million in aggregate amount of exits and repayments resulting in net investments of $104.3 million for the period. During the three months ended May 31, 2020, we invested $39.0 million in new or existing portfolio companies and had $9.4 million in aggregate amount of exits and repayments resulting in net exits and repayments of $29.6 million for the period.

 

87

 

 

Portfolio Composition

 

Our portfolio composition at May 31, 2021 and February 28, 2021 at fair value was as follows:

 

   May 31, 2021   February 28, 2021 
   Percentage
of Total
Portfolio
   Weighted
Average
Current
Yield
   Percentage
of Total
Portfolio
   Weighted
Average
Current
Yield
 
First lien term loans   76.2%   9.4%   79.5%   9.5%
Second lien term loans   3.7    12.0    4.4    12.3 
Unsecured term loans   0.3    -    0.4    - 
Structured finance securities   7.9    13.3    9.0    11.6 
Equity interests   11.9    -    6.7    - 
Total   100.0%   8.6%   100.0%   9.1%

 

At May 31, 2021, our investment in the subordinated notes of Saratoga CLO, a collateralized loan obligation fund, had a fair value of $35.5 million and constituted 5.2% of our portfolio. This investment constitutes a first loss position in a portfolio that, as of May 31, 2021 and February 28, 2021, was composed of $685.6 million and $603.7 million, respectively, in aggregate principal amount of primarily senior secured first lien term loans. In addition, as of May 31, 2021, we also own $17.9 million in aggregate principal of the F-R-3 Notes in the Saratoga CLO, that only rank senior to the subordinated notes.

 

This investment is subject to unique risks. (See “Part 1. Item 1A. Risk Factors—Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility” in our Annual Report on Form 10-K for the fiscal year ended February 28, 2021).

 

We do not consolidate the Saratoga CLO portfolio in our consolidated financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, at May 31, 2021, $667.0 million or 98.9% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and one Saratoga CLO portfolio investments were in default with a fair value of $0.002 million. At February 28, 2021, $584.6 million or 98.7% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and four Saratoga CLO portfolio investments were in default with a fair value of $0.8 million. For more information relating to the Saratoga CLO, see the audited financial statements for Saratoga in our Annual Report on Form 10-K for the fiscal year ended February 28, 2021.

 

Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system (“CMR”). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)—performing credit; (Yellow)—underperforming credit; (Red)—in principal payment default and/or expected loss of principal.

 

88

 

 

Portfolio CMR distribution

 

The CMR distribution for our investments at May 31, 2021 and February 28, 2021 was as follows:

 

Saratoga Investment Corp.

 

   May 31, 2021   February 28, 2021 
Color Score  Investments
at
Fair Value
   Percentage
of Total
Portfolio
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 
Green  $521,723    77.0%  $453,297    81.8%
Yellow   39,897    5.9    32,559    5.9 
Red   -    0.0    -    0.0 
N/A(1)   116,153    17.1    68,457    12.3 
Total  $677,773    100.0%  $554,313    100.0%

 

 

(1)Comprised of our investment in the subordinated notes of Saratoga CLO and equity interests.

 

The change in reserve from $1.2 million as of February 28, 2021 to $0.6 million as of May 31, 2021 was primarily related to the write-off of the interest accruals related to My Alarm Center, LLC, that we deemed non-recoverable.

 

The CMR distribution of Saratoga CLO investments at May 31, 2021 and February 28, 2021 was as follows:

 

Saratoga CLO

 

   May 31, 2021   February 28, 2021 
Color Score  Investments
at
Fair Value
   Percentage
of Total
Portfolio
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 
Green  $602,161    89.4%  $514,183    86.8%
Yellow   64,878    9.6    70,415    11.9 
Red   5,928    0.9    6,921    1.2 
N/A(1)   467    0.1    501    0.1 
Total  $673,434    100.0%  $592,020    100.0%

 

 

(1)Comprised of Saratoga CLO’s equity interests.

 

89

 

 

Portfolio composition by industry grouping at fair value

 

The following table shows our portfolio composition by industry grouping at fair value at May 31, 2021 and February 28, 2021:

 

Saratoga Investment Corp.

 

   May 31, 2021   February 28, 2021 
   Investments
At
Fair Value
   Percentage
of Total
Portfolio
   Investments
At
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 
IT Services  $91,661    13.5%  $73,087    13.2%
Education Software   89,699    13.2    88,090    15.9 
Healthcare Software   69,263    10.2    28,972    5.2 
Education Services   59,528    8.8    40,384    7.1 
Structured Finance Securities(1)   53,420    7.9    49,779    9.0 
Healthcare Services   41,953    6.2    42,410    7.7 
Sports Management   25,550    3.8    25,469    4.6 
Dental Practice Management Software   23,890    3.5    23,659    4.3 
Consumer Services   20,742    3.1    181    0.0 
HVAC Services and Sales   19,950    2.9    14,894    2.7 
Cyber Security   19,131    2.8    13,174    2.4 
Payroll Services   18,346    2.7    18,333    3.3 
Real Estate Services   18,186    2.7    18,032    3.3 
Corporate Governance   17,598    2.6    13,265    2.4 
Hospitality/Hotel   17,586    2.6    17,080    3.1 
Marketing Services   17,467    2.6    17,372    3.1 
Facilities Maintenance   10,731    1.6    6,193    1.1 
Public Safety/Local Government Software   10,205    1.5    -    0.0 
Industrial Products   9,032    1.3    9,047    1.6 
Waste Services   9,000    1.3    9,000    1.6 
Dental Practice Management   8,808    1.3    7,133    1.3 
Non-profit Services   5,500    0.8    5,554    1.0 
Healthcare Supply   5,329    0.8    5,422    1.0 
Field Service Management   4,021    0.6    4,018    0.7 
Office Supplies   3,399    0.5    3,610    0.7 
Corporate Education Software   3,108    0.5    1,050    0.2 
Restaurant   2,169    0.3    2,141    0.4 
Staffing Services   969    0.1    925    0.2 
Healthcare Products Manufacturing   564    0.1    567    0.1 
Consumer Products   522    0.1    475    0.1 
Financial Services   446    0.1    419    0.1 
Property Management   -    0.0    14,578    2.6 
Total  $677,773    100.0%  $554,313    100.0%

 

 

(1)Comprised of our investment in the subordinated notes, Class F-R-3 Notes of Saratoga CLO.

 

90

 

 

The following table shows Saratoga CLO’s portfolio composition by industry grouping at fair value at May 31, 2021 and February 28, 2021:

 

Saratoga CLO

 

   May 31, 2021   February 28, 2021 
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 
Banking, Finance, Insurance & Real Estate  $117,906    17.5%  $105,326    17.9%
Services: Business   69,543    10.3    55,588    9.4 
High Tech Industries   56,509    8.5    50,106    8.5 
Healthcare & Pharmaceuticals   48,618    7.2    46,689    7.9 
Services: Consumer   45,182    6.7    31,604    5.4 
Telecommunications   32,173    4.8    29,878    5.1 
Aerospace & Defense   28,600    4.3    25,952    4.4 
Automotive   26,524    3.9    19,159    3.2 
Chemicals, Plastics, & Rubber   23,117    3.4    23,302    3.9 
Hotel, Gaming & Leisure   22,315    3.3    20,515    3.4 
Media: Advertising, Printing & Publishing   21,700    3.3    19,826    3.3 
Containers, Packaging & Glass   19,347    2.9    18,822    3.2 
Beverage, Food & Tobacco   19,687    2.9    17,998    3.1 
Consumer goods: Non-durable   19,129    2.8    19,343    3.3 
Consumer goods: Durable   17,146    2.5    13,143    2.1 
Capital Equipment   12,406    1.8    9,961    1.7 
Construction & Building   12,081    1.8    5,362    0.9 
Retail   11,686    1.7    12,880    2.1 
Media: Broadcasting & Subscription   8,958    1.3    9,426    1.6 
Forest Products & Paper   8,937    1.3    6,954    1.2 
Utilities: Oil & Gas   8,166    1.2    8,235    1.3 
Media: Diversified & Production   7,912    1.2    6,035    1.0 
Metals & Mining   7,475    1.1    6,127    1.0 
Transportation: Consumer   5,891    0.9    6,183    1.0 
Wholesale   5,804    0.9    5,841    1.0 
Transportation: Cargo   5,234    0.8    5,812    1.0 
Energy: Electricity   3,820    0.6    4,547    0.8 
Utilities: Electric   4,175    0.6    4,209    0.7 
Energy: Oil & Gas   1,912    0.3    2,208    0.4 
Environmental Industries   1,481    0.2    989    0.2 
Total  $673,434    100.0%  $592,020    100.0%

 

91

 

 

Portfolio composition by geographic location at fair value

 

The following table shows our portfolio composition by geographic location at fair value at May 31, 2021 and February 28, 2021. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

 

   May 31, 2021   February 28, 2021 
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 
Southeast  $192,393    28.4%  $167,397    30.2%
West   171,118    25.2    145,907    26.3 
Midwest   114,942    17.0    110,125    19.9 
Other   74,616    11.0    39,334    7.1 
Northeast   39,931    5.9    13,174    2.4 
Northwest   19,131    2.8    7,314    1.3 
Southwest(1)   65,642    9.7    71,062    12.8 
Total  $677,773    100.0%  $554,313    100.0%

 

 

(1)Comprised of our investment in the subordinated notes, Class F-R-2 Notes and Class G-R-2 Notes of Saratoga CLO, Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd and foreign investments.

 

Results of operations

 

Operating results for the three months ended May 31, 2021 and May 31, 2020 was as follows:

 

   For the three months ended 
   May 31, 2021   May 31, 2020 
   ($ in thousands) 
Total investment income  $16,816   $13,297 
Total operating expenses   14,260    4,279 
Net investment income   2,556    9,018 
Net realized gain (loss) from investments   1,910    8 
Income tax (provision) benefit from realized gain on investments   -    - 
Net change in unrealized appreciation (depreciation) on investments   16,813    (31,950)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   (230)   268 
Net increase (decrease) in net assets resulting from operations  $21,049   $(22,656)

 

92

 

 

Investment income

 

The composition of our investment income for three months ended May 31, 2021 and May 31, 2020 was as follows:

 

   For the three months ended 
   May 31, 2021   May 31, 2020 
   ($ in thousands) 
Interest from investments  $13,687   $12,150 
Interest from cash and cash equivalents   -    12 
Management fee income   818    635 
Structuring and advisory fee income   1,302    313 
Other income   1,009    187 
Total investment income  $16,816   $13,297 

 

For the three months ended May 31, 2021, total investment income increased $3.5 million, or 26.5% to $16.8 million from $13.3 million for the three months ended May 31, 2020. Interest income from investments increased $1.5 million, or 12.6%, to $13.7 million for the three months ended May 31, 2021 from $12.2 million for the three months ended May 31, 2020. This reflects the impact of the increase of $195.0 million, or 40.3% in total investments at May 31, 2021 from $482.9 million at May 31, 2020, offset by (i) the reduction in LIBOR during this same period and (ii) the increase in equity positions that are not interest-bearing. At May 31, 2021, the weighted average current yield on investments was 8.6%, down from 9.6% at May 31, 2020, which offset some of the impact resulting from the increased investments.

 

For the three months ended May 31, 2021 and May 31, 2020, total PIK income was $0.3 million and $0.7 million, respectively.

 

Management fee income reflects the fee income received for managing the Saratoga CLO. For the three months ended May 31, 2021 and May 31, 2020, total management fee income was $0.8 million and $0.6 million, respectively, with the increase reflecting the upsizing of the CLO last quarter and greater management fees being earned on the increased assets under management in the CLO.

 

For the three months ended May 31, 2021 and 2020, total structuring and advisory fee income was $1.3 million and $0.3 million, respectively. Structuring and advisory fee income represents fee income earned and received performing certain investment and advisory activities during the closing of new investments.

 

For the three months ended May 31, 2021 and 2020, other income was $1.0 million and $0.2 million, respectively. Other income includes dividends received, origination fees and prepayment income fees and is recorded in the consolidated statements of operations when earned.

 

93

 

 

Operating expenses

 

The composition of our operating expenses for the three months ended May 31, 2021 and May 31, 2020 was as follows:

 

   For the three months ended 
   May 31, 2021   May 31, 2020 
   ($ in thousands) 
Interest and debt financing expenses  $4,341   $2,564 
Base management fees   2,759    2,160 
Incentive management fees expense (benefit)   5,263    (1,858)
Professional fees   507    387 
Administrator expenses   694    556 
Insurance   86    68 
Directors fees and expenses   92    60 
General & administrative and other expenses   491    351 
Income tax expense (benefit)   28    (9)
Total operating expenses  $14,260   $4,279 

 

For the three months ended May 31, 2021, total operating expenses increased $10.0 million, or 233.3% compared to the three months ended May 31, 2020.

 

For the three months ended May 31, 2021, interest and debt financing expenses increased $1.8 million, or 69.3% compared to the three months ended May 31, 2020. The increase is primarily attributable to a increase in average outstanding debt from $217.4 million for the three months ended May 31, 2020 to $286.2 million for the three months ended May 31, 2021, primarily reflecting the issuance of various Notes during the year ended February 28, 2021, including the 7.25% 2025 Notes, the 7.75% 2025 Notes and the 6.25% 2027 Notes, and the issuance of the 4.375% 2026 Notes during the quarter ended May 31, 2021.

 

For the three months ended May 31, 2021, the weighted average interest rate on our outstanding indebtedness was 5.27% compared to 4.01% for the three months ended May 31, 2020. The increase in weighted average interest rate was primarily driven by the issuance of the various higher-rate Notes noted above over the past year.

 

As of May 31, 2021 and February 28, 2021, the SBA debentures represented 44.2% and 56.2% of overall debt, respectively.

 

For the three months ended May 31, 2021, base management fees increased $0.6 million, or 27.7% from $2.2 million to $2.8 million compared to the three months ended May 31, 2020. The increase in base management fees results from the 27.7% increase in the average value of our total assets, less cash and cash equivalents, from $489.8 million for the three months ended May 31, 2020 to $625.5 million for the three months ended May 31, 2021.

 

For the three months ended May 31, 2021, incentive management fees increased $7.1 million, or 383.2%, compared to the three months ended May 31, 2020. The first part of the incentive management fees increased from $1.4 million for the three months ended May 31, 2020 to $1.6 million for the three months ended May 31, 2021, reflecting the increased performance during this quarter. The incentive management fees related to capital gains increased from a $(3.3) million benefit for the three months ended May 31, 2020 to a $3.7 million expense for the three months ended May 31, 2021, reflecting the incentive fee income on net unrealized depreciation recognized last year and the incentive fee expense on net unrealized appreciation this quarter across numerous investments.

 

For the three months ended May 31, 2021, professional fees increased $0.1 million, or 31.1%, compared to the three months ended May 31, 2020.

 

For the three months ended May 31, 2021, administrator expenses increased $0.1 million, or 24.7%, compared to the three months ended May 31, 2020. These increases during the period are primarily attributable to an increase to the cap on the payment or reimbursements of expenses by the Company.

 

94

 

 

As discussed above, the increase in interest and debt financing expenses for the three months ended May 31, 2021 compared to the three months ended May 31, 2020 is primarily attributable to a increase in the average dollar amount of outstanding debt. During the three months ended May 31, 2021 and May 31, 2020, the average borrowings outstanding under the Credit Facility was $4.1 million and $0.0 million, respectively. For the three months ended May 31, 2021 and May 31, 2020, the average borrowings outstanding of SBA debentures was $158.4 million and $157.4 million, respectively. For the three months ended May 31, 2021 and May 31, 2020, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 2.93% and 3.16%, respectively. During the three months ended May 31, 2021 and May 31, 2020, the average dollar amount of our 6.25% fixed-rate 2025 Notes outstanding was $60.0 million and $60.0 million, respectively. During the three months ended May 31, 2021 and May 31, 2020, the weighted average dollar amount of our 7.25% fixed-rate 2025 Notes outstanding was $43.1 million and $0.0 million, respectively. During the three months ended May 31, 2021 and May 31, 2020, the weighted average dollar amount of our 7.75% fixed-rate 2025 Notes outstanding was $5.0 million and $0.0 million, respectively. During the three months ended May 31, 2021 and May 31, 2020, the average dollar amount of our 6.25% fixed-rate 2027 Notes outstanding was $15.0 million and $0.0 million, respectively. During the three months ended May 31, 2021 and May 31, 2020, the average dollar amount of our 4.375% fixed-rate 2026 Notes outstanding was $50.0 million and $0.0 million, respectively.

 

For the three months ended May 31, 2021 and May 31, 2020, there were income tax expense (benefits) of $0.03 million and $(0.01) million, respectively. This relates to net deferred federal and state income tax expense (benefit) with respect to operating gains and losses and income derived from equity investments held in the taxable blockers.

 

Net realized gains (losses) on sales of investments

 

For the three months ended May 31, 2021, the Company had $14.9 million of sales, repayments, exits or restructurings resulting in $1.9 million of net realized gains.

 

Three Months ended May 31, 2021

 

Issuer  Asset Type  Gross Proceeds   Cost   Net
Realized
Gain (Loss)
 
V Rental Holdings LLC  Equity Interests  $2,276,055   $365,914   $1,910,141 

 

The $1.9 million of net realized gains was from the sales of the equity position in the Company’s V Rental Holdings LLC investment.

 

For the three months ended May 31, 2020, the Company had $9.4 million of sales, repayments, exits or restructurings resulting in $0.01 million of net realized gains.

 

Net change in unrealized appreciation (depreciation) on investments

 

For the three months ended May 31, 2021, our investments had a net change in unrealized appreciation of $16.8 million versus a net change in unrealized depreciation of $32.0 million for the three months ended May 31, 2020. The most significant cumulative net change in unrealized appreciation (depreciation) for the three months ended May 31, 2021 were the following (dollars in thousands):

 

Three Months ended May 31, 2021

 

Issuer  Asset Type  Cost   Fair Value   Total
Unrealized
Appreciation
(Depreciation)
   YTD Change
in Unrealized
Appreciation
(Depreciation)
 
Saratoga Investment Corp. CLO 2013-1, Ltd.  Structured Finance Securities  $33,412   $35,546   $2,134   $4,531 
Passageways, Inc.  First Lien Term Loan & Equity Interests   10,954    17,598    6,645    4,333 
Netreo Holdings, LLC  First Lien Term Loan & Equity Interests   23,792    33,604    9,812    4,224 
Schoox, Inc.  Equity Interests   1,050    3,108    2,058    2,058 
GreyHeller LLC  First Lien Term Loan & Equity Interests   14,032    19,131    5,098    1,996 
Top Gun Pressure Washing, LLC  First Lien Term Loan & Equity Interests   10,902    10,731    (171)   896 
Destiny Solutions Inc.  First Lien Term Loan & Equity Interests   45,709    47,395    1,686    659 
V Rental Holdings LLC  Equity Interests   -    -    -    (1,843)

 

95

 

 

The $4.5 million of unrealized appreciation in our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. was driven by improved market performance, combined with outperformance achieved from the assets in the CLO.

 

The $4.3 million net change in unrealized appreciation in our investment in Passageways, Inc. was driven by growth, including a potential upcoming acquisition.

 

The $4.2 million net change in unrealized appreciation in our investment in Netreo Holdings, LLC was driven by growth and improved financial performance.

 

The $2.1 million net change in unrealized appreciation in our investment in Schoox, Inc. was driven by new customers and increased customer demand.

 

The $2.0 million net change in unrealized appreciation in our investment in GreyHeller LLC was driven by improved financial performance.

 

The $0.9 million net change in unrealized appreciation in our investment in Top Gun Pressure Washing, LLC was driven by improved financial performance.

 

The $0.7 million net change in unrealized appreciation in our investment in Destiny Solutions Inc. was driven by improved financial performance and the potential of an upcoming acquisition.

 

The $1.8 million net change in unrealized depreciation in our investment in Village Realty Holdings, LLC was driven by the sale of that investment, resulting in a reversal of previously recognized unrealized appreciation reclassified to realized gains.

 

The most significant cumulative net change in unrealized appreciation for the three months ended May 31, 2020 were the following (dollars in thousands):

 

Three Months ended May 31, 2020

 

Issuer  Asset Type  Cost   Fair Value   Total
Unrealized
Appreciation
   YTD Change
in Unrealized
Appreciation
 
Knowland Group, LLC  Second Lien Term Loans  $15,379   $11,445   $(3,934)  $(3,827)
C2 Educational Systems  First Lien Term Loan   15,987    12,872    (3,115)   (3,134)
Saratoga Investment Corp. CLO 2013-1, Ltd.  Structured Finance Securities   22,160    18,085    (4,075)   (3,112)
Elyria Foundry Company, L.L.C.  Second Lien Term Loan & Equity Interests   10,921    1,417    (9,504)   (1,759)
Destiny Solutions Inc.  First Lien Term Loan & Equity Interests   38,178    37,077    (1,101)   (1,640)
ArbiterSports, LLC  First Lien Term Loan   26,777    25,126    (1,651)   (1,625)
Village Realty Holdings LLC  First Lien Term Loan   11,025    9,763    (1,262)   (1,390)
Texas Teachers of Tomorrow, LLC  First Lien Term Loan & Equity Interests   19,533    18,520    (1,013)   (1,144)
Identity Automation Systems  First Lien Term Loan & Equity Interests   17,742    17,546    (196)   (959)
Kev Software Inc.  First Lien Term Loan   21,047    20,210    (837)   (952)
EMS LINQ, Inc.  First Lien Term Loan   14,771    13,875    (896)   (939)
inMotionNow, Inc.  First Lien Term Loan   14,084    13,273    (811)   (935)
CLEO Communications Holding, LLC  First Lien Term Loan   33,882    33,728    (154)   (924)

 

96

 

 

The net changes in unrealized depreciation noted above primarily relate to the impact of COVID-19, resulting in changes to market spreads, EBITDA multiples and/or revised portfolio company performance, following the events since March 2020.

 

Changes in net assets resulting from operations

 

For the three months ended May 31, 2021, we recorded a net increase in net assets resulting from operations of $21.0 million. Based on 11,170,045 weighted average common shares outstanding as of May 31, 2021, our per share net increase in net assets resulting from operations was $1.88 for the three months ended May 31, 2021. For the three months ended May 31, 2020, we recorded a net decrease in net assets resulting from operations of $22.7 million. Based on 11,217,545 weighted average common shares outstanding as of May 31, 2020, our per share net decrease in net assets resulting from operations was $2.02 for the three months ended May 31, 2020.

 

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

 

We intend to continue to generate cash primarily from cash flows from operations, including interest earned from our investments in debt in middle market companies, interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, future borrowings and future offerings of securities.

 

Although we expect to fund the growth of our investment portfolio through the net proceeds from future equity offerings, including our dividend reinvestment plan (“DRIP”), and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current net asset value per share and we are limited in our ability to sell our common stock at a price below net asset value per share, we have been and may continue to be limited in our ability to raise equity capital.

 

In addition, we intend to distribute to our stockholders substantially all of our operating taxable income in order to satisfy the distribution requirement applicable to RICs under the Code. In satisfying this distribution requirement, in accordance with certain applicable provisions of the Code and the Treasury regulations and a revenue procedure issued by the Internal Revenue Service (“IRS”), a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation that the aggregate amount of cash to be distributed to all stockholders must be at least 20% of the aggregate declared distribution. We may rely on the revenue procedure in future periods to satisfy our RIC distribution requirement.

 

Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200.0%, reduced to 150.0% effective April 16, 2019 following the approval received from the non-interested board of directors on April 16, 2018. This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was 251.0% as of May 31, 2021 and 347.1% as of February 28, 2021. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other debt-related markets, which may or may not be available on favorable terms, if at all.

 

Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies, to pay dividends or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

 

Madison revolving credit facility

 

Below is a summary of the terms of the senior secured revolving credit facility we entered into with Madison Capital Funding LLC (the “Credit Facility”) on June 30, 2010, which was most recently amended on September 14, 2020. (See Recent Developments).

 

Availability. The Company can draw up to the lesser of (i) $40.0 million (the “Facility Amount”) and (ii) the product of the applicable advance rate (which varies from 50.0% to 75.0% depending on the type of loan asset) and the value, determined in accordance with the Credit Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base”), in each case less (a) the amount of any undrawn funding commitments the Company has under any loan asset and which are not covered by amounts in the Unfunded Exposure Account referred to below (the “Unfunded Exposure Amount”) and outstanding borrowings. Each loan asset held by the Company as of the date on which the Credit Facility was closed was valued as of that date and each loan asset that the Company acquires after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

 

97

 

 

The Credit Facility contains limitations on the type of loan assets that are “eligible” to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, the Company may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.

 

Collateral. The Credit Facility is secured by substantially all of the assets of the Company (other than assets held by our SBIC subsidiary) and includes the subordinated notes (“CLO Notes”) issued by Saratoga CLO and the Company’s rights under the CLO Management Agreement (as defined below).

 

Interest Rate and Fees. Under the Credit Facility, funds are borrowed from or through certain lenders at the greater of the prevailing LIBOR rate and 1.00%, plus an applicable margin of 4.75%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 2.00%, and the applicable margin over such alternative base rate is 3.75%. In addition, the Company pays the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period (defined below). Accrued interest and commitment fees are payable monthly. The Company was also obligated to pay certain other fees to the lenders in connection with the closing of the Credit Facility.

 

Revolving Period and Maturity Date. The Company may make and repay borrowings under the Credit Facility for a period of three years following the closing of the Credit Facility (the “Revolving Period”). The Revolving Period may be terminated at an earlier time by the Company or, upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the Credit Facility are due and payable in full five years after the end of the Revolving Period.

 

Collateral Tests. It is a condition precedent to any borrowing under the Credit Facility that the principal amount outstanding under the Credit Facility, after giving effect to the proposed borrowings, not exceed the lesser of the Borrowing Base or the Facility Amount (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

 

Interest Coverage Ratio. The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Credit Facility, to accrued interest and commitment fees and any breakage costs payable to the lenders under the Credit Facility for the last 6 payment periods must equal at least 175.0%.

 

Overcollateralization Ratio. The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets and the CLO Notes (in each case, subject to certain adjustments) to outstanding borrowings under the Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

 

Weighted Average FMV Test. The aggregate adjusted or weighted value of “eligible” pledged loan assets as a percentage of the aggregate outstanding principal balance of “eligible” pledged loan assets must be equal to or greater than 72.0% and 80.0% during the one-year periods prior to the first and second anniversary of the closing date, respectively, and 85.0% at all times thereafter.

 

The Credit Facility also requires payment of outstanding borrowings or replacement of pledged loan assets upon the Company’s breach of its representation and warranty that pledged loan assets included in the Borrowing Base are “eligible” loan assets. Such payments or replacements must equal the lower of the amount by which the Borrowing Base is overstated as a result of such breach or any deficiency under the Collateral Tests at the time of repayment or replacement. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by the Company.

 

Priority of Payments. During the Revolving Period, the priority of payments provisions of the Credit Facility require, after payment of specified fees and expenses and any necessary funding of the Unfunded Exposure Account, that collections of principal from the loan assets and, to the extent that these are insufficient, collections of interest from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met. Similarly, following termination of the Revolving Period, collections of interest are required to be applied, after payment of certain fees and expenses, to cure any deficiencies in the Borrowing Base Test, the Interest Coverage Ratio and the Overcollateralization Ratio as of the relevant payment date.

 

Reserve Account. The Credit Facility requires the Company to set aside an amount equal to the sum of accrued interest, commitment fees and administrative agent fees due and payable on the next succeeding three payment dates (or corresponding to three payment periods). If for any monthly period during which fees and other payments accrue, the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets which do not pay cash interest at least quarterly exceeds 15.0% of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets, the Company is required to set aside such interest and fees due and payable on the next succeeding six payment dates. Amounts in the reserve account can be applied solely to the payment of administrative agent fees, commitment fees, accrued and unpaid interest and any breakage costs payable to the lenders.

 

98

 

 

Unfunded Exposure Account. With respect to revolver or delayed draw loan assets, the Company is required to set aside in a designated account (the “Unfunded Exposure Account”) 100.0% of its outstanding and undrawn funding commitments with respect to such loan assets. The Unfunded Exposure Account is funded at the time the Company acquires a revolver or delayed draw loan asset and requests a related borrowing under the Credit Facility. The Unfunded Exposure Account is funded through a combination of proceeds of the requested borrowing and other Company funds, and if for any reason such amounts are insufficient, through application of the priority of payment provisions described above.

 

Operating Expenses. The priority of payments provision of the Credit Facility provides for the payment of certain operating expenses of the Company out of collections on principal and interest during the Revolving Period and out of collections on interest following the termination of the Revolving Period in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $350,000 for each monthly payment date or $2.5 million for the immediately preceding period of twelve consecutive monthly payment dates. This ceiling can be increased by the lesser of 5.0% or the percentage increase in the fair market value of all the Company’s assets only on the first monthly payment date to occur after each one-year anniversary following the closing of the Credit Facility. Upon the occurrence of a Manager Event (described below), the consent of the administrative agent is required in order to pay operating expenses through the priority of payments provision.

 

Events of Default. The Credit Facility contains certain negative covenants, customary representations and warranties and affirmative covenants and events of default. The Credit Facility does not contain grace periods for breach by the Company of certain covenants, including, without limitation, preservation of existence, negative pledge, change of name or jurisdiction and separate legal entity status of the Company covenants and certain other customary covenants. Other events of default under the Credit Facility include, among other things, the following:

 

an Interest Coverage Ratio of less than 150.0%;

 

an Overcollateralization Ratio of less than 175.0%;

 

the filing of certain ERISA or tax liens;

 

the occurrence of certain “Manager Events” such as:

 

failure by Saratoga Investment Advisors and its affiliates to maintain collectively, directly or indirectly, a cash equity investment in the Company in an amount equal to at least $5.0 million at any time prior to the third anniversary of the closing date;

 

failure of the Management Agreement between Saratoga Investment Advisors and the Company to be in full force and effect;

 

indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed to replace such key person within 30 days;

 

resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed within 30 days; or

 

occurrence of any event constituting “cause” under the Collateral Management Agreement between the Company and Saratoga CLO (the “CLO Management Agreement”), delivery of a notice under Section 12(c) of the CLO Management Agreement with respect to the removal of the Company as collateral manager or the Company ceases to act as collateral manager under the CLO Management Agreement.

 

Conditions to Acquisitions and Pledges of Loan Assets. The Credit Facility imposes certain additional conditions to the acquisition and pledge of additional loan assets. Among other things, the Company may not acquire additional loan assets without the prior written consent of the administrative agent until such time that the administrative agent indicates in writing its satisfaction with Saratoga Investment Advisors’ policies, personnel and processes relating to the loan assets.

 

Fees and Expenses. The Company paid certain fees and reimbursed Madison Capital Funding LLC for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Madison Capital Funding LLC in connection with the Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates. These amounts totaled $2.0 million.

 

99

 

 

On February 24, 2012, we entered into a first amendment to the Credit Facility to, among other things:

 

expand the borrowing capacity under the Credit Facility from $40.0 million to $45.0 million;

 

extend the period during which we may make and repay borrowings under the Credit Facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may, upon the occurrence of an event of default, by action of the lenders or automatically, be terminated. All borrowings and other amounts payable under the Credit Facility are due and payable five years after the end of the Revolving Period; and

 

remove the condition that we may not acquire additional loan assets without the prior written consent of the administrative agent.

 

On September 17, 2014, we entered into a second amendment to the Credit Facility, among other things:

 

extend the commitment termination date from February 24, 2015 to September 17, 2017;

 

extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

 

reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

 

reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

 

On May 18, 2017, we entered into a third amendment to the Credit Facility to, among other things:

 

extend the commitment termination date from September 17, 2017 to September 17, 2020;

 

extend the final maturity date of the Credit Facility from September 17, 2022 to September 17, 2025;

 

reduce the floor on base rate borrowings from 2.25% to 2.00%;

 

reduce the floor on LIBOR borrowings from 1.25% to 1.00%; and

 

reduce the commitment fee rate from 0.75% to 0.50% for any period during which the ratio of advances outstanding to aggregate commitments, expressed as a percentage, is greater than or equal to 50%.

 

On April 24, 2020, we entered into a fourth amendment to the Credit Facility to, among other things:

 

permit certain amendments related to the Paycheck Protection Program (“Permitted PPP Amendment”) to Loan Asset Documents;

 

exclude certain debt and interest amounts allowed by the Permitted PPP Amendments from certain calculations related to Net Leverage Ratio, Interest Coverage Ratio and EBITDA; and

 

exclude such Permitted PPP Amendments from constituting a Material Modification.

 

On September 14, 2020, we entered into a fifth amendment to the Credit Facility to, among other things:

 

extend the commitment termination date of the Credit Facility from September 17, 2020 to September 17, 2021, with no change to the maturity date of September 17, 2025.

 

provide for the transition away from the LIBOR Rate in the market, and

 

expand the definition of “Eligible Loan Asset” to allow investments with certain recurring revenue features to qualify as Collateral and be included in the borrowing base.

 

100

 

 

As of May 31, 2021, we had $39.0 million outstanding borrowings under the Credit Facility and $168.0 million of SBA-guaranteed debentures outstanding (which are discussed below). As of February 28, 2021, we had no outstanding borrowings under the Credit Facility and $158.0 million of SBA-guaranteed debentures outstanding. Our borrowing base under the Credit Facility at May 31, 2021 and February 28, 2021 was $51.1 million and $38.9 million, respectively.

 

Our asset coverage ratio, as defined in the 1940 Act, was 251.0% as of May 31, 2021 and 347.1% as of February 28, 2021.

 

SBA-guaranteed debentures

 

In addition, we, through two wholly-owned subsidiaries, sought and obtained licenses from the SBA to operate an SBIC. In this regard, on March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC LP, received a license from the SBA to operate as an SBIC under Section 301(c) of the Small Business Investment Act of 1958 and on August 14, 2019, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC II LP, also received a license. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses.

 

The SBIC licenses allows our SBIC subsidiaries to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten-year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

 

SBA regulations previously limited the amount that our SBIC subsidiary may borrow to a maximum of $150.0 million when it has at least $75.0 million in regulatory capital, receives a capital commitment from the SBA and has been through an examination by the SBA subsequent to licensing. This maximum has been increased by SBA regulators for new licenses to $175.0 million of SBA debentures when it has at least $87.5 million in regulatory capital. The new license will provide up to $175.0 million in additional long-term capital in the form of SBA-guaranteed debentures. The SBIC LP and SBIC II LP are regulated by the SBA. As a result of the 2016 omnibus spending bill signed into law in December 2015, the maximum amount of SBA-guaranteed debentures that affiliated SBIC funds can have outstanding was increased from $225.0 million to $350.0 million. Our wholly-owned SBIC subsidiaries are able to borrow funds from the SBA against regulatory capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA. With this license approval, Saratoga can grow its SBA relationship from $150.0 million to $325.0 million of committed capital.

 

We received exemptive relief from the SEC to permit us to exclude the debt of our SBIC subsidiaries guaranteed by the SBA from the definition of senior securities in the asset coverage test under the 1940 Act. This allows us increased flexibility under the asset coverage test by permitting us to borrow up to $325.0 million more than we would otherwise be able to absent the receipt of this exemptive relief. On April 16, 2018, as permitted by the Small Business Credit Availability Act, which was signed into law on March 23, 2018, our non-interested board of directors approved of our becoming subject to a minimum asset coverage ratio of 150.0% from 200% under Sections 18(a)(1) and 18(a)(2) of the Investment Company Act, as amended. The 150.0% asset coverage ratio became effective on April 16, 2019.

 

As of May 31, 2021, our SBIC LP subsidiary had $75.0 million in regulatory capital and $124.0 million in SBA-guaranteed debentures outstanding and our SBIC II LP subsidiary had $84.0 million in regulatory capital and $44.0 million in SBA-guaranteed debentures outstanding.

 

Unsecured notes

 

In May 2013, the Company issued $48.3 million in aggregate principal amount of 7.50% fixed-rate notes due 2020 (the “2020 Notes”). The 2020 Notes were redeemed in full on January 13, 2017 and are no longer listed on the NYSE.

 

On May 29, 2015, we entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. through which we may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the 2020 Notes through an ATM offering. Prior to the 2020 Notes being redeemed in full, the Company had sold 539,725 bonds with a principal of $13.5 million at an average price of $25.31 for aggregate net proceeds of $13.4 million (net of transaction costs).

 

On December 21, 2016, we issued $74.5 million in aggregate principal amount of our 2023 Notes for net proceeds of $71.7 million after deducting underwriting commissions of approximately $2.3 million and offering costs of approximately $0.5 million. The net proceeds from the offering were used to repay all of the outstanding indebtedness under the 2020 Notes on January 13, 2017, which amounted to $61.8 million, and for general corporate purposes in accordance with our investment objective and strategies. On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.5 million, respectively, in aggregate principal amount of the $74.5 million in aggregate principal amount of issued and outstanding 2023 Notes and are no longer listed on the NYSE.

 

101

 

 

On August 28, 2018, the Company issued $40.0 million in aggregate principal amount of our 6.25% fixed-rate notes due 2025 (the “6.25% 2025 Notes”) for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.3 million. The issuance included the full exercise of the underwriters’ option to purchase an additional $5.0 million aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest on the 6.25% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year, beginning November 30, 2018. The 6.25% 2025 Notes mature on August 31, 2025 and commencing August 28, 2021, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.6 million related to the 6.25% 2025 Notes have been capitalized and are being amortized over the term of the 6.25% 2025 Notes. The 6.25% 2025 Notes are listed on the NYSE under the trading symbol “SAF” with a par value of $25.00 per share.

 

On February 5, 2019, the Company completed a re-opening and up-sizing of its existing 6.25% 2025 Notes by issuing an additional $20.0 million in aggregate principal amount for net proceeds of $19.2 million after deducting underwriting commissions of approximately $0.6 million and discount of $0.2 million. Offering costs incurred were approximately $0.2 million. The issuance included the full exercise of the underwriters’ option to purchase an additional $2.5 million aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest rate, interest payment dates and maturity remain unchanged from the existing 6.25% 2025 Notes issued in August 2018. The net proceeds from this offering were used for general corporate purposes in accordance with our investment objective and strategies. The financing costs and discount of $1.0 million related to the 6.25% 2025 Notes have been capitalized and are being amortized over the term of the 6.25% 2025 Notes.

 

At May 31, 2021, the total 6.25% 2025 Notes outstanding was $60.0 million.

 

In connection with the issuance of the 6.25% 2025 Notes, we agreed to the following covenants for the period of time during which the notes are outstanding:

 

we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. These provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings, or, if we obtain the required approvals from our independent directors and/or stockholders, 150% (after deducting the amount of such dividend, distribution or purchase price, as the case may be).

 

we will not declare any dividend (except a dividend payable in our stock), or declare any other distribution, upon a class of our capital stock, or purchase any such capital stock, unless, in every such case, at the time of the declaration of any such dividend or distribution, or at the time of any such purchase, we have an asset coverage (as defined in the 1940 Act) of at least 150.0%, as such obligation may be amended or superseded, after deducting the amount of such dividend, distribution or purchase price, as the case may be, and in each case giving effect to (i) any exemptive relief granted to us by the SEC, and (ii) any SEC no-action relief granted by the SEC to another BDC (or to us if we determine to seek such similar no-action or other relief) permitting the BDC to declare any cash dividend or distribution notwithstanding the prohibition contained in Section 18(a)(1)(B) as modified by such provisions of Section 61(a) of the 1940 Act as may be applicable to us from time to time, as such obligation may be amended or superseded, in order to maintain such BDC’s status as a regulated investment company under Subchapter M of the Code.

 

if, at any time, we are not subject to the reporting requirements of Sections 13 or 15(d) of the Securities Exchange Act of 1934, or the Exchange Act, to file any periodic reports with the SEC, we agree to furnish to holders of the 6.25% 2025 Notes and the Trustee, for the period of time during which the 6.25% 2025 Notes are outstanding, our audited annual consolidated financial statements, within 90 days of our fiscal year end, and unaudited interim consolidated financial statements, within 45 days of our fiscal quarter end (other than our fourth fiscal quarter). All such financial statements will be prepared, in all material respects, in accordance with applicable United States generally accepted accounting principles.

 

On June 24, 2020, the Company issued $37.5 million in aggregate principal amount of our 7.25% fixed-rate notes due 2025 (the “7.25% 2025 Notes”) for net proceeds of $36.3 million after deducting underwriting commissions of approximately $1.2 million. Offering costs incurred were approximately $0.3 million. On July 6, 2020, the underwriters exercised their option in full to purchase an additional $5.625 million in aggregate principal amount of its 7.25% unsecured notes due 2025. Net proceeds to the Company were $5.4 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 7.25% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.25% per year, beginning August 31, 2020. The 7.25% 2025 Notes mature on June 30, 2025 and commencing June 24, 2022, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.6 million related to the 7.25% 2025 Notes have been capitalized and are being amortized over the term of the 7.25% 2025 Notes. The Company has received an investment grade private rating of “BBB” from Egan-Jones Ratings Company, an independent, unaffiliated rating agency. The 7.25% 2025 Notes are listed on the NYSE under the trading symbol “SAK” with a par value of $25.00 per share. At November 30, 2020, the total 7.25% 2025 Notes outstanding was $43.1 million. 

 

102

 

 

On July 9, 2020, the Company issued $5.0 million aggregate principal amount of our 7.75% fixed-rate Notes due in 2025 (the “7.75% 2025 Notes”) for net proceeds of $4.8 million after deducting underwriting commissions of approximately $0.2 million. Offering costs incurred were approximately $0.1 million. Interest on the 7.75% Notes 2025 is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.75% per year, beginning August 31, 2020. The 7.75% Notes 2025 mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.3 million related to the 7.75% Notes 2025 have been capitalized and are being amortized over the term of the Notes. The 7.75% 2025 Notes are unlisted and have a par value of $25.00 per share.

 

At May 31, 2021, the total 7.75% 2025 Notes outstanding was $5.0 million.

 

On December 29, 2020, the Company issued $5.0 aggregate principal amount of our 6.25% fixed-rate Notes due in 2027 (the “6.25% Notes 2027”). Offering costs incurred were approximately $0.1 million. Interest on the 6.25% Notes 2027 is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year, beginning February 28, 2021. The 6.25% Notes 2027 mature on December 29, 2027 and may be redeemed in whole or in part at any time or from time to time at our option, on or after December 29, 2024. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.1 million related to the 6.25% Notes 2027 have been capitalized and are being amortized over the term of the Notes.

 

On January 28, 2021, the Company issued $10.0m aggregate principal amount of our 6.25% fixed rate Notes due in 2027 (the “Second 6.25% Notes 2027”) for net proceeds of $9.7 million after deducting underwriting commissions of approximately $0.3 million. Offering costs incurred were approximately $0.0 million. Interest on the 6.25% Notes 2027 is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year, beginning February 28, 2021. The 6.25% Notes 2027 mature on January 28, 2027 and commencing January 28, 2023, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.3 million related to the 6.25% Notes 2027 have been capitalized and are being amortized over the term of the Notes.

 

At May 31, 2021, the total 6.25% 2025 Notes outstanding was $15.0 million.

 

On March 10, 2021, the Company issued $50.0m aggregate principal amount of our 4.375% fixed-rate Notes due in 2026 (the “4.375% Notes 2026”) for net proceeds of $49.0 million after deducting underwriting commissions of approximately $1.0 million. Offering costs incurred were approximately $0.2 million. Interest on the 4.375% Notes 2026 is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.375% per year, beginning August 28, 2021. The 4.375% Notes 2026 mature on February 28, 2026 and may be redeemed in whole or in part at any time or from time to time at the Company’s option at par plus a “make-whole” premium, if applicable. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.2 million related to the 4.375% Notes 2026 have been capitalized and are being amortized over the term of the Notes.

 

At May 31, 2021, the total 4.375% Notes outstanding was $50.0 million

 

At May 31, 2021 and February 28, 2021, the fair value of investments, cash and cash equivalents and cash and cash equivalents, reserve accounts were as follows:

 

   May 31, 2021   February 28, 2021 
   Fair Value   Percentage of
Total
   Fair Value   Percentage of
Total
 
   ($ in thousands) 
Cash and cash equivalents  $318    0.0%  $18,828    3.2%
Cash and cash equivalents, reserve accounts   19,660    2.8    11,087    1.9 
First lien term loans   516,154    74.0    440,456    75.4 
Second lien term loans   25,422    3.6    24,930    4.3 
Unsecured term loans   2,169    0.3    2,141    0.4 
Structured finance securities   53,421    7.7    49,779    8.5 
Equity interests   80,607    11.6    37,007    6.3 
Total  $697,751    100.0%  $584,228    100.0%

 

103

 

 

On July 13, 2018, the Company issued 1,150,000 shares of its common stock priced at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75 million. The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million. The Company also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of its common stock, which was not exercised.

 

On March 16, 2017, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to time, up to $30.0 million of our common stock through an ATM offering. Subsequent to this, BB&T Capital Markets and B. Riley FBR, Inc. were also added to the agreement. On July 11, 2019, the amount of the common stock to be offered through this offering was increased to $70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $130.0 million. As of May 31, 2021, the Company sold 3,922,018 shares for gross proceeds of $97.1 million at an average price of $24.77 for aggregate net proceeds of $95.9 million (net of transaction costs). During the three months ended May 31, 2021, there was no activity related to the ATM offering.

 

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements (the “Share Repurchase Plan”). On October 7, 2015, our board of directors extended the Share Repurchase Plan for another year and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 400,000 shares of its common stock. On October 5, 2016, our board of directors extended the Share Repurchase Plan for another year to October 15, 2017 and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 600,000 shares of its common stock. On October 10, 2017, January 8, 2019 and January 7, 2020, our board of directors extended the Share Repurchase Plan for another year to October 15, 2018, January 15, 2020 and January 15, 2021, respectively, each time leaving the number of shares unchanged at 600,000 shares of its common stock. On May 4, 2020, our board of directors increased the Share Repurchase Plan to 1.3 million shares of common stock. On January 5, 2021, our board of directors extended the Shares Repurchase Plan for another year to January 15, 2022, leaving the number of shares unchanged at 1.3 million shares of common stock. As of May 31, 2021, the Company purchased 448,812 shares of common stock, at the average price of $18.49 for approximately $8.3 million pursuant to the Share Repurchase Plan. During the three months ended May 31, 2021, the Company purchased 40,000 shares of common stock, at the average price of $25.09 for approximately $1.0 million pursuant to the Share Repurchase Plan.

 

On May 27, 2021, the Company declared a dividend of $0.44 per share payable on June 29, 2021, to common stockholders of record on June 15, 2021. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company's DRIP. Based on shareholder elections, the dividend consisted of approximately $4.1 million in cash and 33,099 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.03 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 16, 17, 18, 21, 22, 23, 24, 25, 28 and 29, 2021.

 

On March 22, 2021, the Company declared a dividend of $0.43 per share payable on April 22, 2021, to common stockholders of record on April 8, 2021. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $3.9 million in cash and 38,580 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.69 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on April 9,12, 13, 14, 15, 16, 19, 20, 21 and 22, 2021.

 

On January 5, 2021, our board of directors declared a dividend of $0.42 per share, which was paid on February 10, 2021, to common stockholders of record as of January 26, 2021. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 41,388 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.75 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on January 28, 29 and February 1, 2, 3, 4, 5, 8, 9 and 10, 2021.

 

On October 7, 2020, our board of directors declared a dividend of $0.41 per share, which was paid on November 10, 2020, to common stockholders of record as of October 26, 2020. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 45,706 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.63 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on October 28, 29, 30 and November 2, 3, 4, 5, 6, 9 and 10, 2020.

 

104

 

 

On July 7, 2020, the Company declared a dividend of $0.40 per share payable on August 12, 2020, to common stockholders of record on July 27, 2020. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $3.7 million in cash and 47,098 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.45 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on July 30, 31 and August 3, 4, 5, 6, 7, 10, 11 and 12, 2020.

 

On January 8, 2020, the Company declared a dividend of $0.56 per share, which was paid on February 6, 2020, to common stockholders of record on January 24, 2020. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $5.4 million in cash and 35,682 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.44 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on January 24, 27, 28, 29, 30, 31 and February 3, 4, 5 and 6, 2020.

 

On August 27, 2019, the Company declared a dividend of $0.56 per share, which was paid on September 26, 2019, to common stockholders of record on September 13, 2019. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $4.5 million in cash and 34,575 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.34 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 13, 16, 17, 18, 19, 20, 23, 24, 25 and 26, 2019.

 

On May 28, 2019, our board of directors declared a dividend of $0.55 per share, which was paid on June 27, 2019, to common stockholders of record as of June 13, 2019. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $3.6 million in cash and 31,545 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.65 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2019.

 

On February 26, 2019, our board of directors declared a dividend of $0.54 per share, which was paid on March 28, 2019, to common stockholders of record as of March 14, 2019. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $3.5 million in cash and 31,240 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.36 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 18, 19, 20, 21, 22, 25, 26, 27 and 28, 2019.

 

On November 27, 2018, our board of directors declared a dividend of $0.53 per share, which was paid on January 2, 2019, to common stockholders of record on December 17, 2018. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 30,796 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $18.88 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on December 18, 19, 20, 21, 24, 26, 27, 28, 31, 2018 and January 2, 2019.

 

On August 28, 2018, our board of directors declared a dividend of $0.52 per share, which was paid on September 27, 2018, to common stockholders of record as of September 17, 2018. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 25,862 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.35 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2018.

 

On May 30, 2018, our board of directors declared a dividend of $0.51 per share, which was paid on June 27, 2018, to common stockholders of record as of June 15, 2018. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $2.7 million in cash and 21,562 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.72 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2018.

 

105

 

 

On February 26, 2018, our board of directors declared a dividend of $0.50 per share, which was paid on March 26, 2018, to common stockholders of record as of March 14, 2018. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $2.6 million in cash and 25,354 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $19.91 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 13, 14, 15, 16, 19, 20, 21, 22, 23 and 26, 2018.

 

On November 29, 2017, our board of directors declared a dividend of $0.49 per share, which was paid on December 27, 2017, to common stockholders of record on December 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 25,435 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.14 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 13, 14, 15, 18, 19, 20, 21, 22, 26 and 27, 2017.

 

On August 28, 2017, our board of directors declared a dividend of $0.48 per share, which was paid on September 26, 2017, to common stockholders of record on September 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $2.2 million in cash and 33,551 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.19 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 13, 14, 15, 18, 19, 20, 21, 22, 25 and 26, 2017.

 

On May 30, 2017, our board of directors declared a dividend of $0.47 per share, which was paid on June 27, 2017, to common stockholders of record on June 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $2.3 million in cash and 26,222 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.04 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 14, 15, 16, 19, 20, 21, 22, 23, 26 and 27, 2017.

 

On February 28, 2017, our board of directors declared a dividend of $0.46 per share, which was paid on March 28, 2017, to common stockholders of record as of March 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 29,096 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.38 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2017.

 

On January 12, 2017, our board of directors declared a dividend of $0.45 per share, which was paid on February 9, 2017, to common stockholders of record as of January 31, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $1.6 million in cash and 50,453 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.25 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on January 27, 30, 31 and February 1, 2, 3, 6, 7, 8 and 9, 2017.

 

On October 5, 2016, our board of directors declared a dividend of $0.44 per share, which was paid on November 9, 2016, to common stockholders of record as of October 31, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,548 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.12 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on October 27, 28, 31 and November 1, 2, 3, 4, 7, 8 and 9, 2016.

 

On August 8, 2016, our board of directors declared a special dividend of $0.20 per share, which was paid on September 5, 2016, to common stockholders of record as of August 24, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $0.7 million in cash and 24,786 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.06 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on August 22, 23, 24, 25, 26, 29, 30, 31 and September 1 and 2, 2016.

 

106

 

 

On July 7, 2016, our board of directors declared a dividend of $0.43 per share, which was paid on August 9, 2016, to common stockholders of record as of July 29, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,167 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.32 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on July 27, 28, 29 and August 1, 2, 3, 4, 5, 8 and 9, 2016.

 

On March 31, 2016, our board of directors declared a dividend of $0.41 per share, which was paid on April 27, 2016, to common stockholders of record as of April 15, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 56,728 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.43 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on April 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2016.

 

On January 12, 2016, our board of directors declared a dividend of $0.40 per share, which was paid on February 29, 2016, to common stockholders of record as of February 1, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $1.4 million in cash and 66,765 newly issued shares of common stock, or 1.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.11 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on February 16, 17, 18, 19, 22, 23, 24, 25, 26 and 29, 2016.

 

On October 7, 2015, our board of directors declared a dividend of $0.36 per share, which was paid on November 30, 2015, to common stockholders of record as of November 2, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 61,029 newly issued shares of common stock, or 1.1% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.53 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on November 16, 17, 18, 19, 20, 23, 24, 25, 27 and 30, 2015.

 

On July 8, 2015, our board of directors declared a dividend of $0.33 per share, which was paid on August 31, 2015, to common stockholders of record as of August 3, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 47,861 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.28 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on August 18, 19, 20, 21, 24, 25, 26, 27, 28 and 31, 2015.

 

On May 14, 2015, our board of directors declared a special dividend of $1.00 per share, which was paid on June 5, 2015, to common stockholders of record on as of May 26, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock, or 2.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.47 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on May 22, 26, 27, 28, 29 and June 1, 2, 3, 4 and 5, 2015.

 

On April 9, 2015, our board of directors declared a dividend of $0.27 per share, which was paid on May 29, 2015, to common stockholders of record as of May 4, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.78 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on May 15, 18, 19, 20, 21, 22, 26, 27, 28 and 29, 2015.

 

On September 24, 2014, our board of directors declared a dividend of $0.22 per share, which was paid on February 27, 2015, to common stockholders of record on February 2, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.97 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on February 13, 17, 18, 19, 20, 23, 24, 25, 26 and 27, 2015.

 

107

 

 

Also, on September 24, 2014, our board of directors declared a dividend of $0.18 per share, which was paid on November 28, 2014, to common stockholders of record on November 3, 2014. Shareholders had the option to receive payment of the dividend in cash or receive shares of common stock pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.

 

On October 30, 2013, our board of directors declared a dividend of $2.65 per share, which was paid on December 27, 2013, to common stockholders of record as of November 13, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. This dividend was declared in reliance on certain private letter rulings issued by the IRS concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which 95% of equaled the volume weighted average trading price per share of the common stock on December 11, 13, and 16, 2013.

 

On November 9, 2012, our board of directors declared a dividend of $4.25 per share, which was paid on December 31, 2012, to common stockholders of record as of November 20, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share. Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.

 

On November 15, 2011, our board of directors declared a dividend of $3.00 per share, which was paid on December 30, 2011, to common stockholders of record as of November 25, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.0 million or $0.60 per share. Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.

 

On November 12, 2010, our board of directors declared a dividend of $4.40 per share to shareholders payable in cash or shares of our common stock, in accordance with the provisions of the IRS Revenue Procedure 2010-12, which allows a publicly-traded regulated investment company to satisfy its distribution requirements with a distribution paid partly in common stock provided that at least 10.0% of the distribution is payable in cash. The dividend was paid on December 29, 2010 to common shareholders of record on November 19, 2010. Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.

 

On November 13, 2009, our board of directors declared a dividend of $18.25 per share, which was paid on December 31, 2009, to common stockholders of record as of November 25, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $0.25 per share. Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.

 

We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.

 

108

 

 

Contractual obligations

 

The following table shows our payment obligations for repayment of debt and other contractual obligations at May 31, 2021:

 

       Payment Due by Period 
Long-Term Debt Obligations  Total   Less Than 1 Year   1 - 3 Years   3 - 5 Years   More Than 5 Years 
   ($ in thousands) 
Revolving credit facility  $39,000   $-   $-   $39,000   $- 
SBA debentures   168,000    -    24,000    53,660    90,340 
6.25% 2025 Notes   60,000    -    -    60,000    - 
7.25% 2025 Notes   43,125    -    -    43,125    - 
7.75% 2025 Notes   5,000    -    -    5,000    - 
4.375% 2026 Notes   50,000    -    -    50,000    - 
6.25% 2027 Notes   15,000    -    -    -    15,000 
Total Long-Term Debt Obligations  $380,125   $-   $24,000   $250,785   $105,340 

 

Off-balance sheet arrangements

 

As of May 31, 2021 and February 28, 2021, the Company’s off-balance sheet arrangements consisted of $55.0 million and $58.8 million, respectively, of unfunded commitments outstanding to provide debt financing to its portfolio companies or to fund limited partnership interests. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s consolidated statements of assets and liabilities and are not reflected in the Company’s consolidated statements of assets and liabilities.

 

A summary of the unfunded commitments outstanding as of May 31, 2021 and February 28, 2021 is shown in the table below (dollars in thousands):

 

   May 31, 2021   February 28, 2021 
At Company’s discretion          
Artemis Wax Corp.  $15,000   $- 
Book4Time, Inc.   2,000    2,000 
CLEO Communications Holding, LLC   630    630 
Granite Comfort, LP   5,000    - 
GreyHeller LLC   11,000    15,000 
Netreo Holdings, LLC   1,000    10,000 
Passageways, Inc.   5,000    5,000 
Top Gun Pressure Washing, LLC   175    3,175 
Village Realty Holdings LLC   -    10,000 
Total   39,805    45,805 
           
At portfolio company’s discretion - satisfaction of certain financial and nonfinancial covenants required          
Artemis Wax Corp.   3,404    - 
GoReact   800    2,000 
HemaTerra Holding Company, LLC   2,000    2,000 
New England Dental Partners   4,500    6,000 
Passageways, Inc.   2,000    2,000 
Procurement Partners, LLC   1,000    1,000 
Zollege PBC   1,500    - 
    15,204    13,000 
Total  $55,009   $58,805 

 

109

 

 

Recent Developments

 

Subsequent to May 31, 2020, the global outbreak of the coronavirus pandemic has adversely affected some of the Company’s investments and continues to have adverse consequences on the U.S. and global economies. The ultimate economic fallout from the pandemic, and the long-term impact on economies, markets, industries and individual portfolio companies, remains uncertain. At the time of this filing, there is no indication of a reportable subsequent event impacting the Company’s financial statements for the three months ended May 31, 2021. The Company cannot predict the extent to which its financial condition and results of operations will be adversely affected at this time. The potential impact to our results will depend to a large extent on future developments and new information that may emerge regarding the duration and severity of COVID-19. The Company continues to observe and respond to the evolving COVID-19 environment and its potential impact on areas across its business.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Our business activities contain elements of market risk. We consider our principal market risk to be the fluctuation in interest rates. Managing this risk is essential to our business. Accordingly, we have systems and procedures designed to identify and analyze our risks, to establish appropriate policies and thresholds and to continually monitor this risk and thresholds by means of administrative and information technology systems and other policies and processes. In addition, U.S. and global capital markets and credit markets have experienced a higher level of stress due to the global COVID-19 pandemic, which has resulted in an increase in the level of volatility across such markets and a general decline in value of the securities held by us.

 

Interest rate risk is defined as the sensitivity of our current and future earnings to interest rate volatility, including relative changes in different interest rates, variability of spread relationships, the difference in re-pricing intervals between our assets and liabilities and the effect that interest rates may have on our cash flows. Changes in the general level of interest rates can affect our net interest income, which is the difference between the interest income earned on interest earning assets and our interest expense incurred in connection with our interest-bearing debt and liabilities. Changes in interest rates can also affect, among other things, our ability to acquire leveraged loans, high yield bonds and other debt investments and the value of our investment portfolio.

 

Our investment income is affected by fluctuations in various interest rates, including LIBOR and the prime rate. A large portion of our portfolio is, and we expect will continue to be, comprised of floating rate investments that utilize LIBOR. In connection with the COVID-19 pandemic, the U.S. Federal Reserve and other central banks have reduced certain interest rates and LIBOR has decreased. A prolonged reduction in interest rates will reduce our gross investment income and could result in a decrease in our net investment income if such decreases in LIBOR are not offset by a corresponding increase in the spread over LIBOR that we earn on any portfolio investments, a decrease in in our operating expenses, including with respect to our income incentive fee, or a decrease in the interest rate of our floating interest rate liabilities tied to LIBOR. Our interest expense is affected by fluctuations in LIBOR only on our revolving credit facility. At May 31, 2021, we had $380.1 million of borrowings outstanding, of which $39.0 million borrowings outstanding on the revolving credit facility as of May 31, 2021.

 

We have analyzed the potential impact of changes in interest rates on interest income from investments. Assuming that our investments as of May 31, 2021 were to remain constant for a full fiscal year and no actions were taken to alter the existing interest rate terms, a hypothetical change of a 1.0% increase in interest rates would cause a corresponding increase of approximately $0.5 million to our interest income. Conversely, a hypothetical change of a 1.0% decrease in interest rates would cause a corresponding decrease of approximately $0.02 million to our interest income.

 

Changes in interest rates would have no impact to our current interest and debt financing expense, as all our borrowings except for our credit facility are fixed rate, and our credit facility is currently undrawn.

 

Although management believes that this measure is indicative of our sensitivity to interest rate changes, it does not adjust for potential changes in credit quality, size and composition of the assets on the statements of assets and liabilities and other business developments that could magnify or diminish our sensitivity to interest rate changes, nor does it account for divergences in LIBOR and the commercial paper rate, which have historically moved in tandem but, in times of unusual credit dislocations, have experienced periods of divergence. Accordingly, no assurances can be given that actual results would not materially differ from the potential outcome simulated by this estimate.

 

110

 

 

For further information, the following table shows the approximate annualized increase or decrease in the components of net investment income due to hypothetical base rate changes in interest rates, assuming no changes in our investments and borrowings as of May 31, 2021. 

 

   Increase   (Increase)   Increase   Increase 
Basis  (Decrease)   Decrease   (Decrease) in Net   (Decrease) in Net 
Point  in Interest   in Interest   Investment   Investment 
Change  Income   Expense   Income   Income per Share 
   ($ in thousands)     
-100  $(23)  $-   $(23)  $(0.00)
-50   (23)   -    (23)   (0.00)
-25   (23)   -    (23)   (0.00)
25   45    -    45    0.00 
50   101    -    101    0.01 
100   452    (51)   401    0.04 
200   3,467    (441)   3,026    0.27 
300   8,562    (831)   7,731    0.69 
400   14,029    (1,221)   12,808    1.15 

 

ITEM 4. CONTROLS AND PROCEDURES

 

(a)As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). Based on that evaluation, our chief executive officer and our chief financial officer have concluded that our current disclosure controls and procedures are effective in facilitating timely decisions regarding required disclosure of any material information relating to us that is required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

(b)There have been no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) of Exchange Act) that occurred during the quarter ended November 30, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

111

 

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

Neither we nor our wholly-owned subsidiaries, Saratoga Investment Funding LLC and Saratoga Investment Corp. SBIC LP and Saratoga Investment Corp. SBIC II LP, are currently subject to any material legal proceedings.

 

Item 1A. Risk Factors

 

In addition to information set forth in this report, you should carefully consider the “Risk Factors” discussed in our most recent Annual Report on Form 10-K filed with the SEC, which could materially affect our business, financial condition and/or operating results. Other than as set forth below, there have been no material changes during the three months ended May 31, 2021 to the risk factors discussed in “Item 1A. Risk Factors” of our Annual Report on Form 10-K. Additional risks or uncertainties not currently known to us or that we currently deem to be immaterial also may materially affect our business, financial condition and/or operating results.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Not applicable.

 

Item 3. Defaults Upon Senior Securities

 

Not applicable.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

112

 

 

ITEM 6. EXHIBITS

 

Listed below are the exhibits which are filed as part of this report (according to the number assigned to them in Item 601 of Regulation S-K):

 

EXHIBIT INDEX

 

Exhibit Number   Description
3.1(a)   Articles of Incorporation of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Form 10-Q for the quarterly period ended May 31, 2007).
3.1(b)   Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed August 3, 2010).
3.1(c)   Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed August 13, 2010).
3.2   Third Amended and Restated Bylaws of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 10-Q filed January 6, 2021)
4.1   Specimen certificate of Saratoga Investment Corp.’s common stock, par value $0.001 per share. (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-169135, filed on September 1, 2010).
4.2   Registration Rights Agreement dated July 30, 2010 between GSC Investment Corp., GSC CDO III L.L.C., and the investors party thereto (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
4.3   Dividend Reinvestment Plan (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on September 24, 2014).
4.4   Form of Indenture by and between the Company and U.S. Bank National Association, as trustee (incorporated by reference to Saratoga Investment Corp.’s Pre-Effective Amendment No. 2 to the Registration Statement on Form N-2, File No. 333-186323 filed April 30, 2013).
4.5   Form of Second Supplemental Indenture between the Company and U.S. Bank National Association (incorporated by reference to Amendment No. 2 to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-214182, filed on December 12, 2016).
4.6   Form of Global Note (incorporated by reference to Exhibit 4.5 hereto, and Exhibit A therein).
4.7   Form of Third Supplemental Indenture between the Company and U.S. Bank National Association (incorporated by reference to Post- Effective Amendment No. 9 to the Registrant’s Registration Statement on Form N-2, File No. 333-216344, filed on August 28, 2018).
4.8   Form of Global Note (incorporated by reference to Exhibit 4.7 hereto, and Exhibit A therein).
4.9   Form of Articles Supplementary Establishing and Fixing the Rights and Preferences of Preferred Stock (incorporated by reference to Saratoga Investment Corp.’s registration statement on Form N-2 Pre-Effective Amendment No. 1, File No. 333-196526, filed on December 5, 2014).
4.10   Description of Securities. (incorporated by reference to Saratoga Investment Corp.’s Annual Report on Form 10-K filed on May 5, 2021).
4.11   Fourth Supplemental Indenture between the Company and U.S. Bank National Association, as trustee, relating to the 7.25% Note due 2025 (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K (File No. 814-00732) filed on June 24, 2020).
4.12   Form of 7.25% Notes due 2025 (incorporated by reference to Exhibit 4.11 hereto).
4.13   Eighth Supplemental Indenture between the Company and U.S. Bank National Association, as trustee, relating to the 4.375% Note due 2026 (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K (File No. 814-00732) filed on March 10, 2021).
4.14   Form of 4.375% Notes due 2026 (incorporated by reference to Exhibit 4.13 hereto).
10.1   Investment Advisory and Management Agreement dated July 30, 2010 between GSC Investment Corp. and Saratoga Investment Advisors, LLC (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
10.2   Custodian Agreement dated March 21, 2007 between GSC Investment LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Form 10-Q for the quarterly period ended May 31, 2007).
10.3   Administration Agreement dated July 30, 2010 between GSC Investment Corp. and Saratoga Investment Advisors, LLC (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).

 

113

 

 

10.4   Trademark License Agreement dated July 30, 2010 between Saratoga Investment Advisors, LLC and GSC Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
10.5   Credit, Security and Management Agreement dated July 30, 2010 by and among GSC Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
10.6   Form of Indemnification Agreement between Saratoga Investment Corp. and each officer and director of Saratoga Investment Corp. (incorporated by reference to Amendment No. 2 to Saratoga Investment Corp.’s Registration Statement on Form N-2 filed on January 12, 2007).
10.7   Amendment No. 1 to Credit, Security and Management Agreement dated February 24, 2012 by and among Saratoga Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on February 29, 2012).
10.8   Amended and Restated Indenture, dated as of November 15, 2016, among Saratoga Investment Corp. CLO 2013-1, Ltd., Saratoga Investment Corp. CLO 2013-1, Inc. and U.S. Bank National Association. (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-216344, filed on February 28, 2017).
10.9   Amended and Restated Collateral Management Agreement, dated October 17, 2013, by and between Saratoga Investment Corp. and Saratoga Investment Corp. CLO 2013-1, Ltd. (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-196526, filed on December 5, 2014).
10.10   Amendment No. 2 to Credit, Security and Management Agreement dated September 17, 2014 by and among Saratoga Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on September 18, 2014).
10.11   Amendment No. 3 to Credit, Security and Management Agreement, dated May 18, 2017, by and among Saratoga Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on May 18, 2017).
10.12   Equity Distribution Agreement dated March 16, 2017, by and among Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Ladenburg Thalmann and Co. Inc. and BB&T Capital Markets, a division of BB&T Securities, LLC (incorporated by reference to Saratoga Investment Corp.’s Post-Effective Amendment No. 1 to the Registration Statement on Form N-2, File No. 333-216344, filed on March 16, 2017).
10.13   Amendment No. 1 to the Equity Distribution Agreement dated October 12, 2017, by and among Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Ladenburg Thalmann and Co. Inc., BB&T Capital Markets, a division of BB&T Securities, LLC, and FBR Capital Markets & Co. (incorporated by reference to Saratoga Investment Corp.’s Post-Effective Amendment No. 2 to the Registration Statement on Form N-2, File No. 333-216344, filed on October 12, 2017).
10.14   Amendment No. 2 to the Equity Distribution Agreement dated January 11, 2018, by and among Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Ladenburg Thalmann and Co. Inc., BB&T Capital Markets, a division of BB&T Securities, LLC, and FBR Capital Markets & Co. (incorporated by reference to Saratoga Investment Corp.’s Post-Effective Amendment No. 3 to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-216344, filed on January 11, 2018).
10.15   Amendment No. 3 to the Equity Distribution Agreement dated October 16, 2018, by and among Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Ladenburg Thalmann and Co. Inc., BB&T Capital Markets, a division of BB&T Securities, LLC, and B. Riley FBR, Inc. (incorporated by reference to Post-Effective Amendment No. 1 to the registrant’s Registration Statement on Form N-2, File No. 333-227116, filed on October 16, 2018).
10.16   Amendment No. 4 to the Equity Distribution Agreement dated July 11, 2019, by and among Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Ladenburg Thalmann and Co. Inc., BB&T Capital Markets, a division of BB&T Securities, LLC, and B. Riley FBR, Inc. (incorporated by reference to Post-Effective Amendment No. 5 to the registrant’s Registration Statement on Form N-2, File No. 333-227116, filed on July 12, 2019).
10.17   Amendment No. 5 to the Equity Distribution Agreement dated October 10, 2019, by and among Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Ladenburg Thalmann and Co. Inc., BB&T Capital Markets, a division BB&T Securities, LLC, and B. Riley FBR, Inc. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on October 10, 2019).
10.18   Amendment No. 4 to Credit, Security and Management Agreement, dated April 24, 2020, by and among Saratoga Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on April 29, 2020).

 

114

 

 

10.19   Amendment No. 5 to Credit, Security and Management Agreement, dated September 14, 2020, by and among Saratoga Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on September 17, 2020).
10.20   Amended and Restated Collateral Management Agreement, dated February 26, 2021, by and between Saratoga Investment Corp. and Saratoga Investment Corp. CLO 2013-1, Ltd. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on March 4, 2021).
10.21   Amended and Restated Collateral Administration Agreement, dated February 26, 2021, by and between Saratoga Investment Corp., Saratoga Investment Corp. CLO 2013-1, Ltd. and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on March 4, 2021).
11   Computation of Per Share Earnings (included in Note 11 to the consolidated financial statements contained in this report).
14   Code of Ethics of the Company adopted under Rule 17j-1 (incorporated by reference to Amendment No.7 to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-138051, filed on March 22, 2007).
21.1   List of Subsidiaries (incorporated by reference to Saratoga Investment Corp.’s Annual Report on Form 10-K filed on May 6, 2020).
31.1*   Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
31.2*   Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
32.1*   Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
32.2*   Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

 

 

*Filed herewith

 

115

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SARATOGA INVESTMENT CORP.
     
Date: July 7, 2021 By: /s/ CHRISTIAN L. OBERBECK
    Christian L. Oberbeck
    Chief Executive Officer
     
  By: /s/ HENRI J. STEENKAMP
    Henri J. Steenkamp
    Chief Financial Officer and Chief Compliance Officer

 

 

116